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Inside cover: Artistic rendering of interdigitations formed between confluent 
MCF10A cells described in this thesis and by Tang et al. (2014). 
Interdigitations are established over 12-24 hours following EGF withdrawal 
and can be rapidly dissolved (1-3 hours) following reapplication of EGF. Actin 
cables project from the tips of these interdigitations and actin 
polymerisation/myosin II activity is required for their dissolution. Interdigitated 
cells are restricted in their ability to undergo lateral movement within a 
confluent monolayer. Red spots represent the desmosomes that are enriched 
within interdigitations. Original image: Septavera Sharvia. 
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Abstract 
 
Molecular mechanisms governing the plasticity of cellular boundaries in confluent 
epithelial monolayers are poorly characterised. In this thesis, we report a drastic 
reorganisation of cellular boundaries, provoked by the prolonged withdrawal of EGF 
from non-malignant mammary epithelial cells, MCF10A and HMT-3522 cells. EGF 
withdrawal induces actin-rich interdigitations that protrude into neighbouring cells 
and are enriched in desmosomes. These protrusions allow the cellular sheets to 
resist mechanical and osmotic perturbation. Mobility of the cells within monolayers is 
also restricted. Overexpression of constitutively active Rac opposes interdigitations 
and induces membrane ruffling. EGF application reverses the interdigitations rapidly 
in a process that requires actin polymerisation and actomyosin contraction. We 
report here a simple in vitro system that can be utilised as a visual readout to 
dissect novel signaling pathways specific to EGFR activation and mammary 
morphogenesis. This thesis focuses on the initial efforts to characterise this 
dramatic remodeling of cellular boundaries and will discuss the potential 
investigations that can be pursued further hereon. 
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Executive summary 
 
This thesis consists of six chapters. Chapters 1 and 6 present the introduction and 
final discussion of the results obtained throughout the 4 years of my PhD. The 
remaining Chapters 2, 3, and 4 record the results that have been attained. Each 
result chapter is presented with a separate introduction, discussion and 
accompanied by results figures and movies (listed after Table of Contents). The 
copies of time-lapse imaging recorded are saved on the appended DVD. Results 
presented in this thesis have also been recently published in Cell Reports 
referenced below and the hard copy of this manuscript is attached in the 
Appendices.  
 
Tang, W.Y.Y., Beckett, A.J., Prior, I.A., Coulson, J.M., Urbé, S. and Clague, M.J. 
(2014) Plasticity of mammary cell boundaries governed by EGF and actin 
remodeling, Cell Reports, vol. 8, September 25, 1-9. 
 
Chapter 1 of this thesis forms the introduction that sets the scene for subsequent 
results. This chapter explores the beginnings and evolution of research on EGF 
signalling and is followed by an introduction to the culture of non-tumorigenic 
mammary epithelial cells used to generate the results reported here, MCF10A with 
their isogenic counterparts (licensed from Horizon Discovery Ltd.; Methods: Table 
2.4) and HMT-3522 cells. In accordance to the title of this thesis, the subsequent 
sections introduce the effect of EGF signalling on the structural regulation of cell 
shape involving cell-cell junctions and the actin cytoskeleton. Physiological 
relevance of interdigitations reported in the literature are explored followed by a brief 
summary and graphical abstract summarising the results of this thesis. Chapter 2 
catalogues the materials and methods that have been used to undertake 
experiments described throughout this book. 
 
Chapters 3 and 4 present the morphological and preliminary mechanistic 
characterisation of the MCF10A and the isogenic counterparts (listed in Methods: 
Table 2.4) in two-dimensional (2D) and three-dimensional (3D) assays using 
immunofluorescence microscopy. EGF associated signalling profiles of these cells 
are also examined using Western Blotting procedures.  The formation and reversal 
of interdigitations are explored as separate processes utilising different experimental 
configurations. Similarities and differences of the cell phenotype between the 
MCF10A isogenic cells are analysed in the discussion sections of both chapters. 
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Chapter 5 focuses on the ultrastructure, junction and cytoskeleton-related aspects of 
this drastic reversible remodelling of cell membranes. Here, I have included 
Transmission Electron Microscope (TEM) images obtained from a fruitful 
collaboration with the TEM unit at the University of Liverpool (Alison Beckett and Ian 
Prior). Subsequent discoveries following on from this ultrastructural analysis are 
reported in the context of EGF signalling and the regulation of cell-cell junctions and 
actin cytoskeleton. In addition, preliminary results linking microtubule and Golgi 
apparatus organisation to this phenomenon are explored. The functional 
consequences of the formation of interdigitations are revealed. This chapter 
discusses tantalising links between EGF and GTPase signalling that regulate the 
reorganisation of the cytoskeleton and the number of cell-cell junctions. Chapter 6 
discusses the results and implications of previous chapters, limitations and 
proposes future perspectives.  
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1.1 Epidermal Growth Factor Receptor (EGFR) signalling pathway 
1.1.1 Discovery of EGF and the elucidation of its receptor 
For decades, Epidermal Growth Factor Receptor (EGFR) signalling has been 
studied in key cellular processes including cell survival, proliferation and cytoskeletal 
arrangements (Yarden and Sliwkowski, 2001). This has stemmed from early growth 
factor research back in 1952 when Rita Levi-Montalcini discovered that mouse 
tumour cells secreted a factor that promoted neurite outgrowth in chicken embryos 
(Levi-Montalcini et al., 1952). Her subsequent work with Stanley Cohen led to the 
discovery of nerve growth factor (NGF) purified from snake venom and mouse 
salivary-gland extracts and a novel growth factor, which when injected, induced 
precocious eyelid opening and tooth eruption in newborn mice (Cohen, 1962; Cohen 
et al., 1957; Levi-Montalicini et al., 1960) This novel growth factor was termed 
epidermal growth factor (EGF) and they were awarded the Nobel Prize in 
Physiology or Medicine in 1986 for their discoveries. 
 
Their discovery of EGF subsequently led to studies that identified the EGF receptors 
using 125I-labelled EGF and fibroblasts from different species. The receptor was 
further characterised as a 170kDa membrane component that was phosphorylated 
in response to EGF treatment in A-431 epidermoid carcinoma cells (Carpenter et al., 
1975; 1978). The EGFR is the founding member of the ErbB family of receptor 
tyrosine kinases that together coordinate complex signalling systems that underpin 
organogenesis and differentiation of several cell lineages (Citri and Yarden, 2006). 
The ErbB family also comprise of 3 other members: HER2/Neu/ErbB2, HER3/ 
ErbB3 and HER4/ErbB4. It includes an extracellular-binding domain, a 
transmembrane domain and an intracellular domain containing active tyrosine 
kinase (Yarden and Sliwkowski, 2001). The EGFR can be activated by different 
ligands containing the EGF motif that is ~40 amino acids in length with 6 cysteines 
arranged as amino acid disulphide bridges (Schneider and Wolf, 2009). These 
bridges are between C1 and C3, C2 and C4, C5 and C6 to form the ABC loops 
(Figure 1.1). Ligands include EGF, transforming growth factor-α (TGFα), heparin-
binding EGF-like growth factor (HB-EGF), betacellulin (BTC), amphiregulin (AREG), 
epiregulin (EREG), epigen (EPGN) and neuregulins (NRG) (Scneider and Wolf, 
2009). The ligands are differentially expressed depending on tissue type (Yarden 
and Sliwkowski, 2001).  
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Figure 1.1. The structures of the EGF and its receptor. The  schematic 
representation of the secondary structure of the EGF motif (~40 amino acids) 
show interaction between the six conserved cysteines and the resulting loops 
(A, B and C). The single amino acid between B and C loops is known as the 
‘hinge residue’ proposed to function as a hinge where both segments of the 
protein can move. (Adapted from Schneider and Wolf, 2009).(B) Ligand bind-
ing to domain I and III of EGFR allows conformation change that exposes 
dimerisation site on domain II to dimerise EGFR and allow downstream phos-
phorylation on the cytoplasmic tails of receptors. PM, plasma membrane; TM, 
transmembrane, roman numerals, domain numbers. (Adapted from Lemmon 
and Schlessinger, 2010; Kumar et al., 2008). 
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The first effort to partially clone the gene of EGFR obtained from A431 cells 
disclosed high amino acid sequence homology to the oncogenic kinase of avian 
erythroblastosis virus (v-ErbB) that transformed chicken fibroblasts (Downward et 
al., 1984). Subsequent revelation of the full cDNA sequence of human EGFR 
isolated from normal placental cells and A431 tumour cells showed that the virus 
had maintained only the kinase portion of the chicken EGFR omitting the 
extracellular domain (Ullrich et al., 1984). The cDNA of EGFR was overexpressed in 
oncogenic A431 cells when compared to placental cells. That was further supported 
by the findings that revealed elevated EGFR levels in head and neck squamous 
carcinoma (HNSCC) tissue specimens (Hendler et al., 1984). This subversion of the 
EGFR kinase activity by the avian virus was proposed to promote tumorigenesis. 
 
A few years previously, Hunter and Sefton discovered that protein can be modified 
by tyrosine phosphorylation in sarcoma tumour virus, v-Src (Hunter and Sefton, 
1980). This was the first indication that deregulated protein tyrosine phosphorylation 
may drive tumorigenesis. Building on this discovery, Ullrich and colleagues 
discovered that the ligand of the insulin receptor (IR), insulin, activated a chimeric 
receptor comprising of extracellular region of IR combined with transmembrane and 
intracellular domains of the EGFR (Riedel et al., 1986). This and other studies 
subsequently established that receptor tyrosine kinases (RTKs) dimerise and are 
autophosphorylated at key tyrosine residues of their catalytic domains in response 
to ligand activation (Gschwind et al., 2004; Schlessinger, 1988).  
 
1.1.2 Mechanism of EGFR activation 
EGFR consist of 4 extracellular subdomains (I-IV), a transmembrane domain, 
intracellular juxtamembrane domain followed by the kinase domain and the C-
terminal tail that has phosphorylation sites to provide docking sites for downstream 
effector signalling molecules (Citri and Yarden, 2006). Bivalent ligand binding to the 
extracellular domains I and III of the EGFR leads to a conformational change that 
exposes domain II (dimerisation arm). This allows dimerisation of EGFRs (Figure 
1.1; Lemmon and Schlessinger, 2010). DOMAINS II in inactive receptors interact 
with extracellular domain IV in a ‘tethered’ conformation to inhibit ligand binding and 
receptor dimerisation. Formation of homo- or heterodimers of EGFR and members 
of the ErbB family is succeeded by the formation of asymmetric kinase domain 
dimer in the juxtamembrane region. This head-to- tail configuration catalyses the 
trans and autophosphorylation of tyrosine sites on the C-terminal tail of the 
receptors (Kumar et al., 2008). Phosphorylation of tyrosine residues in the C-
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terminal tail provides docking sites for multiple downstream effectors (Schulze et al., 
2005; Figure 1.2). 
 
The identity of ligand and dimerisation partners of EGFR dictate the 
autophosphorylation sites on the dimerised EGFR which in turn allows the binding 
and activation of specific cytoplasmic target proteins, although degeneracy of 
effectors binding to the EGFR has been reported (Yarden and Sliwkowski, 2001; 
Citri and Yarden, 2006). For example, Grb2 (growth factor receptor bound protein 2) 
is able to associate directly to the EGFR but also through Shc (Src homology 2 
domain containing transforming protein 1). Although the Grb2 binding to the EGFR 
may be redundant, the different modes of binding of Grb2 to the EGFR may recruit 
different effector proteins and the duration of binding may alter the biological 
outputs. 
 
1.1.3 Canonical downstream signalling pathways regulated by EGFR 
 EGF stimulation initiates multiple signalling cascades including the phosphatidyl-
inositol 3 kinase, PI3K and several mitogen activated protein kinase, MAPK 
pathways (Figure 1.3) of which the ERK pathway is best understood (Katz et al., 
2007).  
 
The PI3K signalling pathway can be activated by different ligands that bind to the 
receptors in the ErbB family. For example, Neuregulin 1 (NRG1) preferentially binds 
to Erb3 which heterodimerises with ErbB2 to activate PI3K (Roskoski, 2014). PI3K 
phosphorylates phosphatidylinositol 4,5-biphosphate (PIP2) to form 
phosphatidylinositol 3,4,5-triphosphate (PIP3) that binds and activate Akt (Figure 
1.3). The PI3K-Akt pathway relays pro-survival signals throughout the cytoplasm 
and in the nucleus. For example, PI3K-AKT signals inhibit translocation of 
transcription factor FOXO (Forkhead family of transcription factor) into the nucleus, 
thus inhibiting transcription of pro-apoptotic FOXO target genes such as Bcl2 family 
members (Fu and Tindall, 2008; Nyati et al., 2006).  
 
Stimulation of EGFR by EGF activates the RAS-MAPK cascade either directly via 
the Grb2 adaptor protein or indirectly via Shc1 adaptor proteins (Nyati et al., 2006; 
Yarden and Sliwkowski, 2001). Ras in turn is activated by its guanine nucleotide 
exchange factor (GEF), son of sevenless (SOS) (Figure 1.3). Activated Ras then 
binds to Raf (MAP kinase kinase kinase) to trigger phosphorylation of MEK1/2 
(mitogen-activated protein kinase kinase 1/2) and ERK1/2 (extracellular signal-
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Figure 1.2. A simplified schematic view of EGFR showing key phosphory-
lation residues and main downstream cascades.  Ligand binding activates 
receptor to form homo or heterodimers that activate auto or trans-
phosphorylation sites within the C-terminus as annotated above (Schulze et 
al., 2005). Y845 phosphorylation (Src kinase phosphorylation site in purple) 
maintains receptor in an activated state by stabilising the activation loop to 
regulate signal transducer and activator of transcription 5b (STAT5b) activity. 
Y974 acts as docking site for adaptor protein 2 (AP-2) binding motif to allow 
receptor internalisation upon ligand stimulation. Phosphorylated Y992 site 
allows binding of phospholipase Cγ (PLCγ) to activate the Protein kinase C 
(PKC) signalling pathway. Phosphorylation at Y1045 forms a docking site for 
Cbl to facilitate receptor ubiquitylation and degradation. Phosphorylated sites 
at Y1068 and Y1086 allows binding of growth factor receptor-bound protein 2 
(Grb2) via its Src homology 2 (SH2) domain to activate downstream MAPK 
signalling. Binding of Protein tyrosine phosphatase, non receptor type 6 
(PTPN6) dephosphorylates EGFR. Receptors are not drawn to scale and this 
is not a comprehensive list of phospho-tyrosine binding sites (Adapted from 
Nyati et al., 2006; Olayioye et al., 2000).
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Figure 1.3. Main effector pathways activated by EGFR. Binding of ligand to 
EGFR can activate both the Ras/ MAPK and the PI3K/Akt signalling pathways. 
Recruitment of Grb2 via the SH2 domain activates SOS which binds and acti-
vate Ras. Activated Ras binds RAF to stimulate the MEK and MAPK leading to  
the translocation of ERK1/2 (component of MAPK) into the nucleus to activate 
various transcription factors such as ELK1. Ligand activation can also recruit 
adaptors Gab1 and Gab2 that binds to PI3K, allowing the phosphorylation of 
PIP2 to PIP3. PIP3 binds AKT at its pleckstrin homology (PH) domain and acti-
vated Akt recruits PDK1 to the membrane, activating downstream cascades of 
signals. The ligand and receptor dimer represent signal input, cascades and 
transcription factor reflect the relay of signals in cytoplasm and the nucleus 
which leads to biological outputs. The signalling cascades illustrated do not 
include all the known components in the given pathway and cross talk is not 
shown to simplify schema. Target proteins (coloured ovals) are not drawn to 
scale. Abbreviated protein names are listed in Abbreviations (Adapted from 
Nyati et al., 2006; Yarden and Sliwkowski, 2001).
Ligand
EGFR
PIP2 PIP3
Grb2SOS
RAS
RAF
MEK
MAPK
ELK1
PI3K
G
ab
2
G
ab
1
AKT PDK1
S6K mTOR BAD GSK3 FOXO
Cell membrane
Ligand & 
Receptor dimer
Cascades &
Transcription factors
Transcription, growth, survival Biological output
29
Chapter	  1:	  Introduction	   	   	  
	  	  
regulated kinases 1/2). Phosphorylated ERK is imported into the nucleus to activate 
various transcription activators such as ELK (ETS domain containing protein Elk-1) 
that allow target gene transcription (Katz et al., 2007). From a cell biological 
perspective, the key EGF-mediated responses defined are mitogenic and 
motogenic. 
 
1.1.4 Multi-layered network of EGFR signalling and its therapeutic potential 
Detailed characterisation of ErbB family structures and specificity of ligands led to 
the proposal that the parallel linear signalling cascades feed into multi-layered 
signalling networks to integrate extracellular stimuli to affect downstream 
transcription and biological outputs (Yarden and Sliwkowski, 2001). This ultimately 
provides many possible therapeutic targets for diseases that stem from aberrant 
ErbB family signalling events (Gschwind et al., 2004; Yarden and Sliwkowski, 2001; 
Yarden and Pines, 2012). Mutation and overexpression constitutively activate the 
network in a variety of carcinomas, rendering the ErbB family receptors as rational 
drug targets for therapeutic intervention (Gschwind et al., 2004).  
 
 Her2/ErbB2 receptor is found to be overexpressed in 20% to 25% of breast cancers 
and has been effectively targeted for therapy (Masuda et al., 2012). EGFR 
overexpression on the other hand is observed in all subtypes of breast cancer but is 
more commonly overexpressed in triple negative breast cancer (negative for 
oestrogen, progesterone and Her2) and inflammatory breast cancer (Masuda et al., 
2012). Approximately 20% of human breast cancer immunohistochemical samples 
have been characterised with EGFR overexpression, which negatively correlates 
with clinical prognosis and therapeutic response (Abd El-Rehim et al., 2004). 
Paradoxically, the ability of cells to redirect signals via parallel cascades allows 
tumour cells to develop resistance to targeted treatments. 
 
Mendelsohn and colleagues pioneered the development of mouse monoclonal 
antibodies that targeted extracellular epitopes of EGFR to limit EGF signalling in 
cultured tumour cell lines and rodent models (Gill et al., 1984; Kawamoto et al., 
1983; Sato et al., 1983). Almost in tandem, Umezawa et al. (1986) detected an 
inhibitor compound of EGFR autophosphorylation, Erbstatin isolated from the 
medium of Gram-positive bacteria. Subsequently, the design of EGFR inhibitors 
based on the structure of Erbstatin inhibited the proliferation of EGFR 
overexpressing A431 cells (Yaish et al., 1988). Nearly two decades later, Gefitinib 
was approved as a small molecule tyrosine kinase inhibitor to treat non-small cell 
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lung cancer (NSCLC) in Japan and America followed the year after (Cohen et al., 
2003; Fukuoka et al., 2003). However, the targeted action of small molecule 
inhibitors have been increasingly associated with cancer recurrence due to the 
ability of tumour genome to evolve and overcome drug therapies after prolonged 
treatment. It remains a caveat to develop effective cancer therapies that prevent or 
override drug resistance. 
 
1.1.5 Physiological relevance of EGF signalling 
The EGF was first discovered for its ability to induce early eyelid opening and tooth 
eruption in newborn mice (Cohen et al., 1962). Since then, endless studies have 
evaluated the relevance of EGF signalling in animal and cell models to mimic 
developmental and oncogenic processes. For example, mice lacking EGFR show 
defects in hair follicle, eyelid closing, heart valve and lung maturity. These effects 
were also recapitulated in mice that were deficient in EGFR ligands (Schneider and 
Wolf, 2009).  
 
EGF has not been reported to be important during involution of adult mouse 
mammary gland. Instead, addition reduced the number of ducts per mammary gland 
in the highly proliferative glands of pubertal mice (Coleman and Daniel, 1990; 
Watson and Khaled, 2008). EGF was reported to induce mammary epithelial cell 
branching in collagen organotypic culture and rescued mammary development of 
ovariectomised pubertal mice (Coleman et al., 1988; Nelson et al., 2006). The 
EGFR has also been found in either the stromal cells during mouse pubertal 
development or in luminal ductal epithelial cells during lactation suggesting specific 
roles in autocrine and paracrine signalling (DiAugustine et al., 1997; Wiesen et al., 
1999). Downstream of the EGFR, branching of the mammary duct depends on 
sustained MAPK signalling while proliferation of epithelial cells follows transient 
MAPK signalling (Gjorevski and Nelson 2011; Fata et al., 2007). This suggests that 
the EGFR in different cell types within the mammary gland plays different roles 
according to the available spatial-temporal cues at different phases of mammary 
morphogenesis. Also, EGF is known to stimulate mouse mammary cell 
differentiation and circulating levels in vivo increase during gestation (Okamoto and 
Oka, 1984).  
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1.2 Implication of EGFR signalling on cell-cell junctions 
Cell-cell adhesion is essential to maintain tissue integrity, allowing differentiation 
and communication within multicellular organisms and between cells and its 
environment (Wong, 2010; Franke 2009). Modulation of cell-cell adhesion occurs in 
epithelial-to-mesenchymal (EMT) transition that is important in development, wound 
healing and cancer cell metastasis (Kalluri and Weinberg, 2009; Lorch et al., 2004; 
Nekrasova and Green, 2013). The signalling cascades that relate alteration of 
intercellular adhesion to tumour invasion and metastasis are not well understood. 
EGFR activation has been shown to reduce intercellular adhesive strength in murine 
keratinocytes and also promote cancer cell metastasis (Kalluri and Weinberg, 2009; 
Yin et al., 2005).  
 
In vertebrates, cellular adhesion sites include tight junctions that act as epithelial 
barriers, gap junctions which binds neighbouring cells electrically and chemically, 
and cadherin-based anchoring junctions: Adherens junctions (AJ) and desmosomes 
that link transmembrane cadherin proteins to actin and intermediate filaments 
respectively (Figure 1.4). These junctions synergise to confer adhesive strength 
between cells (Huen et al., 2002). Both types of adhesive junctions are connected to 
the cytoskeleton via adaptor proteins.  One such, Plakoglobin (PG) is a constitutent 
of both AJ and desmosomes. Another, Desmoplakin (DP), is specific to 
desmosomes and is required for strong cellular adhesion and integrity of epithelia in 
vitro and in vivo (Figure 1.5). 
 
Desmosomes were first identified in vertebrates and are historically considered ‘spot 
weld’ sites of cell-cell adhesion that maintains the mechanical integrity of cells by 
tethering intermediate filaments to the plasma membrane (Garrod, 2010; Green et 
al., 2010; Nekrasova and Green, 2013). These are most abundant in stratified 
epithelia and appear as paired electron-dense plaques that between neighbouring 
cells and contain two members of the Cadherin family proteins, Desmogleins and 
Desmocollins (Dubash and Green, 2011; Franke, 2009). Mechanisms that govern 
the assembly of desmosomal components have not been substantively studied due 
to the biochemical insolubility of desmosomes (Nekrasova and Green, 2013).  
 
It has been reported that desmosomal assembly and stability can be regulated by 
the status of EGFR activation. Prolonged EGF stimulation (18 hours) in murine 
keratinocytes led to the phosphorylation of PG that promoted the dissociation of DP 
away from the desmosomes, to reduce intercellular strength (Yin et al., 2005). 
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Figure 1.4. Schematic representation of junctional complex in epithelial 
cells. The junctional complex in epithelial cells consist of tight junctions, adher-
ens junctions and desmosomes. Together with gap junctions these allow cells 
to function as polarised epithelial sheets. Hemidesmosomes are commonly 
found at the basal side where cells attach to subtratum. Geometrical shapes 
represent types of junctions as annotated. Light grey lines depict actin micro-
filaments connected to adherens junctions and black lines represent intermedi-
ate filaments tethered by desmosomes. (Adapted from Green and Gaudry, 
2000).
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Nucleus
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Figure 1.5. A simplified model of desmosomal components.  Desmo-
somes confer adhesive strength between cells. Desmosomal plaques consist 
of Cadherin family proteins, Desmocollin and Desmoglein which interact on  
apposing cell membranes. These are connected to adaptor molecules, Plako-
globin and Plakophilin which allows tethering of plaques to Desmoplakin. Des-
moplakin links the desmosomal plaques near cell membranes to intermediate 
filaments throughout cells. (Adapted from Fuchs and Raghavan, 2002).
Desmoplakin
Intermediate
filament
Desmocollin
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However, short term EGF application (1 hour) failed to mimic this observation. In 
squamous carcinoma cells, EGFR inhibition reduces phosphorylation of Dsg2 and 
PG leading to an opposite phenotype, where desmosome assembly and intercellular 
adhesive strength is enhanced (Klessner et al., 2009; Lorch et al., 2004; Nekrasova 
and Green, 2013). This enhancement of adhesive strength is proposed to be 
mediated by the inhibition of proteolytic shedding of Dsg2 ectodomain, allowing 
recruitment of desmosomal cadherin and DP to cell-cell borders. However, in these 
studies, the authors did not report whether these assembly processes are 
reversible. Klessner et al., (2009) speculated that the desmosome-associated 
components might become relevant therapeutic targets in cancers to oppose the 
loss of cellular adhesion that is common prior to the migration of cancer cells. 
 
Adherens junctions consist of cadherin/ catenin complex and nectin/ afadin complex 
which has been reviewed in detail elsewhere (Niessen and Gottardi, 2008). The 
discovery of the first component of AJ, E-cadherin (epithelia) was required to 
compact morula in the early stages of embryogenesis in chinese hamster lung cells, 
V79, in a calcium dependent manner (Takeichi 1977; Yoshida-Noro et al., 1984). In 
retrospect, cadherins have been reported to appear in single-celled organisms, ie. 
Monosiga brevicollis and is speculated to aid the binding of bacterial prey (King et 
al., 2008). Subsequent identification of other classical cadherins includes P-cadherin 
(placental), N-cadherin (neuronal) and VE-cadherin (vasoendothelial) (Pettitt, 2005). 
Assembly of AJ is reported to supersede the assembly of other intercellular 
junctions (Gumbiner et al., 1988; Green et al., 2010). Inactivation and ablation of the 
E-cadherin gene in mice caused perinatal death due to defective tight junction 
assembly, which led to leaky epidermal water barrier and disrupted the assembly of 
desmosomes (Tunggal et al., 2005; Lewis et al., 1997). Activation of EGFR has 
been reported to disrupt cell surface E-cadherin stability and induce motility (Duan 
et al., 2010). On the other hand, interaction of surface E-cadherin inhibits 
transphosphorylation of EGFR at Y845 and downstream activation of STAT5 (Signal 
Transducers and Activators of Transcription 5) that limits cell growth in confluent 
monolayers, termed cell-cell contact inhibition (Perrais et al., 2007). 
 
1.2.1 Endocytosis maintains dynamic junctions 
Endocytosis is the process of trafficking membrane bound components, activated 
receptors and solute molecules into cells to undergo different fates (Maxfield and 
McGraw 2004). The different endocytic routes commit trans-membrane proteins 
such as E-cadherin to achieve three main fates: recycling back to the membrane, 
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temporary sequestration of E-cadherin by routing proteins to sorting and recycling 
endosomes or trafficking to the late endosomes for lysosomal degradation (Bryant 
and Stow, 2004). 
 
Adherens junctions of cells can be regulated via endocytosis and the dysregulation 
in this process leads to pathogenicity (Green et al., 2010). Stimulation of cells with 
EGF favours the internalisation of E-cadherin leading to increased mobility (Duan et 
al., 2010) whilst inhibition of EGFR disrupts internalisation of E-cadherin and 
Desmoglein 2 to increase adhesion of tumour cells (Lorch et al., 2004; Klessner et 
al., 2009). Disruption of cadherins endocytosis has also been implicated in tumour 
progression (Mosesson et al., 2008). In non-malignant cells, E-cadherin is 
constantly internalised, recycled and turnover to maintain dynamicity of cell-cell 
adhesion especially in epithelial morphogenesis (Wirtz-Peitz and Zallen, 2009).  
 
Both adherens and desmosomal junctions are maintained in a calcium dependent 
manner. However, desmosomal junctions can achieve a hyper-adhesive state that is 
calcium independent in confluent and prolonged culture (Kimura et al., 2007). 
However, internalisation of desmosomal cadherins have been linked to the 
autoimmune disease pemphigus vulgaris (Green et al., 2010). Stimulation of human 
squamous carcinoma cells with pemphigus vulgaris  (PV) autoantibody induced 
clathrin and dynamin independent internalisation of soluble pool of Desmoglein 3 
proposed to disrupt assembly of nascent desmosomes (Aoyama and Kitajima, 
1999). Bo Van Deurs’ group reported internalisation of mature desmosomes upon 
chelation of calcium independent of clathrin dependent endocytosis but requires 
actin polymerisation (Holm et al., 1993).  
 
1.3 Regulation of cytoskeleton remodelling 
1.3.1 The cytoskeleton 
The cytoskeleton serves three main roles in eukaryotic organisms: to physically 
separate contents within cells, to allow traffic of intra and intercellular cargoes, and 
to allow force generation needed for cell movement and morphogenesis (Fletcher 
and Mullins, 2010). The most studied groups of cytoskeleton polymers include actin 
filaments, microtubules and intermediate filaments that have largely been studied as 
separate entities. However, burgeoning evidence of dynamic crosstalk between 
these filamentous polymers is emerging to provide clues as to how the cytoskeletal 
network co-ordinate molecular signals, cell shape and mechanics.  
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The different cellular polymers differ in mechanical stiffness, assembly programmes, 
polarity and associated molecular motors (Fletcher and Mullins, 2010). Microtubules 
are most rigid with complex assembly and disassembly programmes. These are 
dynamically unstable as microtubules can dynamically grow and rapidly shrink. 
During mitosis, the dynamic microtubules form the mitotic spindle to align and 
separate chromosomes. The rapidity of microtubule growth and shrinkage allows 
these polymers to sense space quicker than other polymers that respond to either 
chemotactic gradients or activity of other regulatory proteins (Fletcher and Mullin, 
2010). 
 
Actin filaments are less rigid but are able to form stiff, organised networks that can 
be either bundled or branched (Fletcher and Mullins, 2010). Bundled actin filaments 
are commonly seen in filopodial protrusions that allow chemical sensing in the 
intercellular environment (Gupton and Gertler, 2007). Branched filaments are 
enriched especially at the leading edges of motile cells or cells forming initial contact 
with neighbouring cells (Ridley, 2011; Hoelzle and Svitkina, 2012). These branches 
of filaments generate forces that allow shape changes to accommodate cell 
movements. The presence and location of actin regulators: nucleation factors such 
as Arp2/3 complex and formins dictate the organisation of networks formed (Ridley, 
2011; Section 1.3.3). Steady addition of nucleotide monomers to the growing end of 
actin filaments provide sustained mechanical forces to advance migrating cells 
(Fletcher and Mullins, 2010). 
 
Many cell types form intermediate filaments to allow cells to resist mechanical stress 
such as those seen in keratinocytes and airway epithelial cells (Fletcher and Mullins, 
2010). Actin and microtubules depend on nucleotide binding, hydrolysis and polarise 
to allow trafficking of molecular motors (Chang and Goldman, 2004). Intermediate 
filaments are not reported to have enzymatic activity and lack the ability to polarise 
compared to the actin and microtubule filaments (Fletcher and Mullins, 2010).  
Instead, these least stiff polymers resist tensile forces and can be cross-linked to 
each other, actin filaments and microtubules by plectins, which organises a subset 
of intermediate filaments in cells (Fletcher and Mullins, 2010). These networks 
extend in all directions, from the cell surface (to tether mature desmosomal plaques) 
to cage-like structures surrounding the nucleus that contains polymerised nuclear 
lamins (Chang and Goldman, 2004). When nuclear lamins are phosphorylated by 
cyclin-dependent kinase, this triggers the nuclear envelope initial breakdown in 
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mitosis, suggesting that they provide mechanical integrity to the eukaryotic nucleus 
(Fletcher and Mullins, 2010). 
 
1.3.2 Cell migration 
Cell migration requires changes in cell shape mediated by the actin cytoskeleton in 
response to extracellular stimuli (Schmidt and Hall, 1998). Movement of cells has 
been studied extensively in animal development and cell cultures (Friedl and 
Gilmour, 2009; Ridley, 2011). To move across substrates, cells at the front, ‘leading 
edge cells’ have to extend their membranes (Ridley, 2011). Currently, four types of 
membrane protrusions coordinated by actin polymerisation have been identified. 
Leading edge protrusions include lamellipodia, filopodia, invadopodia and 
membrane blebs. Each type of structure aids cell migration depending on the 
biological circumstance. For example, lamellipodia protrusions propel cells through 
extracellular matrix (ECM) in vivo (Friedl and Gilmour, 2009). Filopodia act as 
sensors for chemo-attractants and are involved in relaying signals between cells 
(Gupton and Gertler, 2007). Invadopodia are protrusions that enable the 
degradation of the ECM to allow cell invasion (Mader et al., 2011). In development, 
membrane blebbing has been reported to direct cell migration (Charras and Paluch, 
2008). These different types of protrusions can act separately or synergistically at 
the leading edge. For example, lamellipodia and filopodia coexist dynamically during 
the initial cell-cell junctions assembly in endothelial cells (Hoelzle and Svitkina, 
2012). 
 
1.3.3 Regulation of the actin cytoskeleton organisation 
Membrane associated complexes such as adherens junctions have been reported 
to act as nucleation sites of actin (Yamada and Geiger, 1997). Actin polymerisation 
is important to generate mechanical force for the cells to move forward. Numerous 
actin binding regulators mediate actin polymerisation, nucleation and cross linking to 
allow the dynamic assembly of actin monomers into polymers and eventually 
filamentous networks (Schmidt and Hall, 1998). One of the main drivers of new actin 
filament formation near membranes is the Arp2/3 complex (Actin related protein 2/3 
complex) (Ridley, 2011). WASP (Wiskott-Aldrich syndrome protein) acts as a 
nucleation-promoting factor to stimulate the activity of the Arp 2/3 complex 
(Stevenson et al., 2012). The Arp2/3 complex binds the side branches of actin 
filaments to nucleate new branched actin filaments via actin polymerisation. 
Dysregulated expression of these proteins has been implicated in diseases. For 
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example, N-WASP (Neural WASP) has been found to be overexpressed in human 
invasive ductal carcinoma (Yu et al., 2012).  
 
1.3.4 Regulation of the actin cytoskeleton orchestrated by GTPases signalling 
The network of actin cytoskeleton network also acts as a signalling hub in different 
cell structures (Schmidt and Hall, 1998; Yu et al., 2012). Ras homologous (Rho) 
family small GTPases are key signal regulators that integrate extracellular or 
intracellular stimuli with the assembly and organisation of actin cytoskeleton (Ridley, 
2011; Schmidt and Hall, 1998). The most conserved Rho GTPases associated with 
actin-specific structures and migration include the Rac, CDC42 and RhoA that drive 
the formation of lamellipodia, filopodia and stress fibres initially discovered in 
fibroblasts (Abercrombie et al., 1970; Boureux et al., 2007; Ridley, 2011; Ridley and 
Hall, 1992; 2004). These Rho GTPases function as binary switches that cycle 
between active GTP-bound form and inactive GDP-bound forms (Figure 1.6). These 
molecular switches are regulated by guanine nucleotide exchange factors (GEF), 
GTPase activating proteins (GAP) or guanine nucleotide dissociation inhibitors 
(GDI) (Cook et al., 2014). RhoGEFs favour the formation of Rho-GTP to Rho-GDP 
by accelerating the intrinsic exchange activity (Ridley, 2011). RhoGAPs stimulate 
the intrinsic GTP hydrolysis activity of Rho GTPases to form the inactive GDP-
bound state. RhoGDI binds Rho-GDP and sequesters the RhoGTPases from the 
cell membrane where RhoGTPases can be activated (Cook et al., 2014). The first 
RhoGEF discovered, Dbl from genomic DNA of the MCF7 human breast carcinoma 
cell line caused tumorigenic growth when transfected into NIH 3T3 fibroblasts 
(Fasano et al., 1984). Aberrant expression of GTPases and their regulators have 
since been implicated in cancer such as upregulation of Rac-GEF PRex1 in human 
breast cancer that leads to cancer metastasis (Sosa et al., 2010; Wertheimer et al., 
2012). In non-tumorigenic mammary epithelial cells, Rac1 activation via RacGEF 
Vav2 on cell membranes was implicated in the disassembly of adherens junctions 
implying the possibility of cell migration (Duan et al., 2011). 
 
1.3.5 EGF regulation of cell shape 
Upstream of the cytoskeletal signalling modulators, EGF has been shown 
separately to induce cell shape change and is implicated in cell motility. Often, this 
has been studied in oncogenic cell systems. For example, metastatic rat mammary 
adenoma cells, MTLn3 extend lamellipodia towards EGF upon stimulation (Bailly et 
al., 1998; Bailly et al., 2000). Invasive bladder cancer cells displayed higher levels of 
EGFR at the tumour regions than the sites further from the tumours (Rao et al., 
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Figure 1.6. Schematic representation of modulation of Rac activity by 
GEFs and GAPs. Rac GTPase cycles between active GTP-bound state to 
inactive GDP-bound state to regulate actin cytokeleton organisation.  This 
molecular switch is regulated by guanine nucleotide exchange factors (GEF)  
which accelerates the intrinsic exchange activity to favour the Rac-GTP bound 
form. In contrast, GTPase activating proteins (GAP) stimulate the intrinsic GTP 
hydrolysis activity of Rac to form Rac-GDP. (Adapted from Ridley, 2011; Wert-
heimer et al., 2012).
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1993). EGF also disrupts adhesion of weakly metastatic A431 cells by rounding up 
and ruffling (Chinkers et al., 1981). Non-malignant human mammary epithelial cells 
acquire dose dependent motility upon EGF stimulation (Joslin et al., 2007). The 
similar motogenic effects of EGF in both oncogenic and non-tumorigenic systems 
highlight the subversion of a normal cell feature into an oncogenic property.  
 
1.4 Physiological contexts of interdigitations in non-tumorigenic systems 
Interdigitations are common features in other complex epithelial cells and have been 
reported in kidney podocytes, keratinocytes and endothelial cells (Baluk et al., 2007; 
Hoelzle and Svitkina, 2012; Mundel et al., 1995; Vasioukhin et al 2000). 
Ultrastructural studies have described well-developed cytoplasmic interdigitations of 
mammary epithelial cells isolated from human donor post weaning breast milk  
(Russo et al., 1975). During early embryonic development and puberty, the 
elongated tips of mammary buds form multi-layered epithelia, and cells within the 
interior layers show prominent interdigitation and high levels of desmosomes (Ewald 
et al., 2012). 
 
Podocytes in kidney have been characterised to form interdigitating foot processes 
that attach to glomerular basement membrane (GBM) but remain connected via slit 
membranes (Mundel and Kriz, 1995). The gaps between digits allow ions and 
solutes to filter through the glomerulus. In keratinocytes and endothelial cell 
cultures, interdigitations form prior to the assembly of stable adherens junctions and 
cell-cell contact (Hoelzle and Svitkina, 2012; Vasioukhin et al., 2000). These 
structures require actin reorganisation and reflect basal phenomena in subconfluent 
cell cultures without ligand stimulation. Oak leaf-shaped lymphatic endothelial cells 
display striking interdigitations decorated by cadherins and tight junctions (Baluk et 
al., 2007; Yao and McDonald, 2014). These were reported to reside specifically at 
the initial rather than the distal lymphatics to facilitate flow of fluids especially in 
newborn mice (Pflicke et al., 2009; Yao and McDonald, 2014). In induced 
inflammation, digits regressed and fluid flow was disrupted. Despite burgeoning 
evidence of interdigitation in physiological systems, molecular pathways that control 
the decision between smooth and interdigitated cell boundaries have not been 
dissected in vitro. 
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1.5 Non-tumorigenic mammary epithelial cells 
1.5.1 MCF10A cells 
MCF10A are non-tumorigenic mammary epithelial cell, which were originally derived 
from subcutaneous mastectomy tissue of a 36 year-old parous, premenopausal 
woman diagnosed with benign fibrocystic disease (Tait et al., 1990; Soule et al., 
1990). These cells were spontaneously immortalised and were characterised as 
pseudodiploid luminal ductal cells (Tait et al., 1990). MCF10A cells are negative for 
oestrogen receptors, and have been classified as both basal and luminal of origin, 
depending on the method of classification. Histocytochemical staining of relevant 
keratins in MCF10A favours the luminal classification (Tait et al., 1990). On the 
other hand, technologies using DNA, CGH (Complete Genome Hybridisation) arrays 
and their phenotype in 3D culture tend to classify MCF10A as basal breast epithelial 
cells (Debnath et al., 2003; Neve et al., 2006; Charafe-Jauffret et al., 2006; Simpson 
et al., 2008). 
 
Modern single-nucleotide polymorphism (SNP) arrays revealed that immortalisation 
of MCF10A cells was due to the amplification of Myc on chromosome 8q24 and 
deletion of CDKN2A (cyclin-dependent kinase inhibitor 2A) gene on chromosome 
9q21.3 (Kadota et al., 2010). C-Myc is a proto-oncogene that acts as a 
multifunctional transcription factor regulating a myriad of cellular processes including 
cell cycle, growth, metabolism and genomic stability (Campaner and Amati, 2012). 
CDKN2A/ p16 induces cell cycle arrest in G1 and G2 phase, and the homozygous 
loss has been postulated to initiate the process of immortalisation of MCF10A cells 
(Cowell et al., 2005). Karyotypic analysis of late passage cells demonstrated the 
genetic stability of these cells in culture with relatively minimal rearrangements 
(Soule et al., 1990; Vitolo et al., 2009). Another group that used CGH arrays showed 
that MCF10A cells overexpress SLD5 (DNA replication complex GINS protein 
SLD5), THAP1 (THAP domain containing apoptosis associated protein 1) and 
TMEPAI (transforming growth factor-β (TGF-β)–induced transmembrane protein) 
(Neve et al., 2006). SLD5 in the GINS complex has been characterised as a novel 
factor to initiate and elongate DNA during DNA replication (MacNeill, 2010). THAP1 
is a DNA binding transcription factor that regulates endothelial cell proliferation and 
G1/S cell-cycle progression (Cayrol et al., 2007). TMEPAI overexpression has been 
linked to growth of breast cancer cells (Singha et al., 2010). Despite identification of 
these genetic aberrations, none have been reported to confer malignancy or 
transform MCF10A cells without exposure to external carcinogen.  
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Experimentally, MCF10A cells are characterised as ‘near normal mammary 
epithelial cells’ as growth in culture requires hormones and growth factors. In 2D cell 
culture, they organise into ‘cobblestone’ monolayers (Soule et al., 1990). They also 
grow and form three-dimensional structures in collagen and Matrigel (Debnath et al., 
2003; Soule et al., 1990). Crucially these cells lack anchorage-independent growth 
and tumorigenicity in nude mice (Soule et al., 1990).  
 
1.5.2 MCF10A cells in three-dimensional (3D) culture 
The mammary gland is a unique organ named after an entire class of animal and 
demonstrates remarkable plasticity throughout a mammalian’s lifetime from 
development to puberty and finally during pregnancy and lactation (Gjorevski and 
Nelson, 2011). It consists of a branching network of ducts lodged within an 
adipocyte rich environment (Campbell and Watson, 2009). The bilayer of luminal 
and myoepithelial cells maintains the ductal epithelium with the latter in contact with 
the basement membrane (Figure 1.7). Knowledge of the signals and mechanisms 
regulating gland remodelling in vivo remain fragmented due to the difficulty in 
mimicking the exact processes in vitro (Campbell and Watson, 2009).  
 
MCF10A cells have been cultured in 3D environments using different substrates 
such as collagen and reconstituted basement membrane, Matrigel. Culture in 
collagen allows formation of duct-like structures whereas in Matrigel, growth 
suppressed cyst-like acini spheroids form from MCF10A cells (Debnath et al., 2003; 
Soule et al., 1990; Chapter 3: Figure 3.10). 
 
The development of MCF10A cells into complex structures in vitro allows extensive 
research to interrogate the molecular mechanisms involved in mammary gland 
morphogenesis during normal processes and the subsequent dysregulation in 
cancers. Brugge and colleagues have dissected in detail the morphogenetic 
processes involved in the formation and polarisation of non-malignant MCF10A cells 
within acini (Debnath et al., 2003; Debnath et al., 2005). One of the important non-
malignant characteristics preserved in MCF10A acini is the suppression of 
proliferation and lumen clearance observed in the final stages of acini development. 
This parameter allows researchers to elucidate the effects of introducing oncogenic 
mutations in this aspect of mammary alveolar morphogenesis (Debnath et al., 2003; 
Isakoff et al., 2005). 
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Figure 1.7. Simplified schema of mammary duct and terminal end bud. In 
mature mammary glands, branches of mammary ducts are embedded within 
mammary fat pad. Mammary ducts consist of myoepithelial cells that surround 
luminal epithelial cells and attach to basement membrane. These ducts mature 
into terminal end buds during puberty. Terminal end buds contain body cells 
that have reduced polarity and undergo dynamic rearrangements with a 
surrounding layer of cap cells at the leading edge. (Adapted from Gjorevski 
and Nelson, 2011).
Luminal epithelial cell
Basement membrane
Myoepithelial cell
Body cell
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1.5.3 HMT-3522 cells 
HMT-3522 cells are a non-tumorigenic human mammary epithelial cell line 
characterised by Briand et al (1987). The cells were isolated from an explant of 
mammary tissue from a 50-year old Caucasian woman with non-malignant 
fibrocystic breast tissue, similar to MCF10A cells. Since then, HMT-3522 cells have 
been characterised in 2D culture as ‘normal human mammary epithelial cells that 
remain undifferentiated in subconfluent cultures and near diploid, non-tumorigenic in 
athymic mice. Although undifferentiated, they were originally classified as luminal 
due to their immunohistochemical expression of the luminal marker, cytokeratin 18 
(Briand and Lykkesfeldt, 2001). In 2D culture, the polygonal cells form characteristic 
small, and uniform islands.   
 
The HMT-3522 S1 cells that have been used in this thesis were obtained from 
ECACC (European Collection of Cell Cultures). These were derived from the 
original HMT-3522 cells (passage 34) cultured without collagen (Briand and 
Lykkesfeldt, 2001). The HMT-3522 cells have wild-type TP53. They show minor 
kartotypic abnormalities including the loss of chromosomes in group D 
(chromosomes 13-15) and the presence of extrachromosomal gene amplification in 
10% of metaphases counted (Briand et al., 1987). At the ultrastructural level, the 
monolayer of the epithelial cells are polarised and show microvilli on the apical 
surface whilst foldings and irregular projections decorate the basolateral surface 
(Briand et al., 1987).  The cells are maintained in a monolayer by well-developed 
desmosomes with associated bundles of intermediate filaments such as those 
characterised in MCF10A cells (Briand et al., 1987; Underwood et al., 2006). In 3D 
culture basement membrane assays, the HMT 3522 cells form acinar structures 
resembling normal MCF10A spheroids and breast tissue in vivo (Kenny et al., 2007; 
Underwood et al., 2006).  
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1.5.4 Growth medium of MCF10A cells 
Historically, the MCF10A cells have been cultured in complex medium to form 
epithelial monolayers (Soule et al., 1990). The growth medium consists of horse 
serum, EGF, insulin and cholera toxin as listed below: 
 
 Final 
concentration 
DMEM/ F12 100% 
Horse serum (HS) 5% 
EGF 20ng/ ml 
Insulin 0.01mg/ml 
Hydrocortisone 500ng/ml 
Cholera toxin 100ng/ml 
Table 1.1 Composition of MCF10A cell culture medium. Brooks and collegues 
used this recipe during the establishment of MCF10A cells (Soule et al., 1990). 
 
The additional supplements aid cell growth and proliferation via different signalling 
pathways. EGF and insulin are growth factors known to stimulate similar 
downstream signalling pathways such as the MAPK and PI3K pathways, which are 
implicated in cell survival, growth, proliferation, protein synthesis and cytoskeletal 
regulation (Engelman et al., 2009). EGF directly activates EGFR to propagate 
mitogenic pERK signals while insulin preferentially binds insulin receptor (IR) to 
relay pro-survival signals via the PI3K pathway (Boyer, 2008; Yarden and 
Sliwkowski, 2001; Siddle, 2011; Zielinski, 2009). In MCF10A cells, Boyer (2008) 
showed that EGF activated the MAPK (Mitogen activated protein kinase) and P70S6 
(Ribosomal protein S6 kinase, 70kDa polypeptide). EGF also activated pAKT to a 
lesser extent when compared to insulin stimulation. Both ligands activated the 
4EBP1 (eukaryotic initiation factor 4E binding protein) to a similar degree, indicating 
crosstalk downstream of the receptors. In HEK 293 and Swiss 3T3 cells, insulin and 
EGF synergise to enhance the mitogenic cue for proliferation (Borisov et al., 2009; 
Crouch et al., 2000). Together, this would explain the ability of MCF10A cells to 
proliferate without EGF, albeit at a slower growth rate (Soule et al., 1990).  
 
Hydrocortisone (glucocorticoid) binds to glucocorticoid receptors in the cytoplasm, 
which translocate into the nucleus to regulate gene expression (Kadmiel and 
Cidlowski, 2013). It is also a lactogenic stimulus in cultured mammary tissue 
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explants (Okamoto and Oka, 1984). Hydrocortisone acts in synergy with fetal bovine 
serum (FBS) to promote human mammary epithelial cell cluster attachment and 
colony formation (Gaffney and Pigott, 1978). The combination of hydrocortisone, 
insulin and prolactin is required for functional differentiation of mammary epithelia in 
culture (Okamoto and Oka, 1984). Cholera toxin is a virulent factor released by the 
pathogen, Vibrio cholerae (Serezani et al., 2008). This heterodimeric AB toxin binds 
to cell membranes using the B subunit to allow translocation of the A subunit into 
the target cells. In the cytoplasm, the A subunit catalyses the ADP ribosylation of 
Gαs subunits bound to GPCR (G protein coupled receptors). The ribosylated Gα 
subunit then binds and stimulate adenylyl cyclase that generates cyclic AMP 
(adenosine monophosphate) to regulate gene expression in many processes 
including cell growth. In the context of MCF10A cells, cAMP has since been shown 
to support the polarisation of acini, by promoting the clearance of luminal space in 
3D culture (Nedvetsky et al., 2012). Together, this cocktail of supplements support 
the growth and proliferation of MCF10A cells in laboratory culture. 
 
1.5.5 Isogenic cells derived from the MCF10A cell line 
Due to their relative genomic stability, the MCF10A cells provide an excellent 
system to generate isogenic cell panels (Soule et al., 1990; Vitolo et al., 2009). They 
are extensively used to model dynamic morphogenesis during mammary 
development and also progression of breast cancers (Pauley et al., 1993). Hence, 
Horizon Discovery Ltd. has systematically introduced EGFR related oncogenic 
mutations into these cells with the aim of developing a platform to screen for 
adjuvant synthetic lethal inhibitors (Table 1.2). 
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MCF10A 
cells 
Mutation  Effect of mutation 
Parental  None --- 
EGFR Heterozygous ΔE746-A750  EGFR activating mutation, in-frame 
deletion (exon 19), near ATP binding 
cleft, predicted to stabilise ATP or 
competitive ATP inhibitors binding to the 
EGFR (Imai and Takaoka, 2006). 
PI3K  Heterozygous H1047R  catalytic p110α subunit of the Class 1 
PI3K, activating mutation in the 
conserved kinase domain (exon 20). 
Heterozygous E545K catalytic p110α subunit of the Class 1 
PI3K, activating mutation in the 
conserved helical domain (exon 9). 
KRAS WT None  WT paired to KRAS G12V cells.  
KRAS 
G12V 
Heterozygous G12V  Ras activating mutation. 
PTEN WT None WT paired to PTEN null mutated cells. 
PTEN null Homozygous  PTEN knock out, loss of function 
mutation. 
Table 1.2 Oncogenic mutations engineered into MCF10A cells by Horizon 
Discovery Ltd. Mutations downstream of the EGFR signalling pathway were 
introduced into MCF10A cells using the recombinant adeno-associated virus (rAAV) 
technology (Introduction: 1.2.5 below). WT (Wild-type) cells represent cells that 
have undergone similar gene editing processes to be used as control for the 
matched isogenic mutated cells. Information in this table was gathered from 
datasheets and discussions with Horizon Discovery Ltd and literatures as stated. 
 
1.5.6 Recombinant adeno-associated virus (rAAV) based gene editing 
The isogenic MCF10A cells have the same genetic background as the parental cells 
except for the somatic mutations introduced via the recombinant adenovirus-
associated technology (rAAV) as listed in Table 1.2 (Di Nicolantonio et al., 2008). 
Recombinant AAV knock-in constructs were generated to introduce the specific 
mutation into the homologous alleles in the genome of MCF10A cells (Figure 1.8). 
Single stranded DNA (ssDNA) containing the mutation and an endogenous ssDNA  
were cloned between two AAV inverted terminal repeats (ITR) to make up the 
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Figure 1.8. Structure of AAV targeting construct. The  schematic represen-
tation show AAV vector carrying the EGFR ∆E746-A750 (EGFR*) oncogenic 
allele in the 5’ arm, used to introduce the mutation into MCF10A parental cells 
by homologous recombination. ITR, inverted terminal repeat; Neo, geneticin-
resistance gene; triangle, LoxP sites. AAV, adeno-associated virus. (Adapted 
from Di Nicolantonio et al., 2008).
AAV 
ITR
AAV 
ITR
LoxP LoxP LoxPEGFR* EGFR
Exon 19
 Neo
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recombination cassette. An antibiotic selection marker was placed in between the 
homology arms flanked by two LoxP sites, to enable Cre-recombinase mediated 
excision of the antibiotic cassette from the genome of the targeted cells after 
antibiotic selection. Only a small portion of the cassette with the relevant mutation 
remains in the genome of the cells, with minimal alteration in the length of genome. 
After targeted rAAV infection and antibiotic selection, resultant clones with the locus- 
specific integration of the targeted alleles were identified using a polymerase chain 
reaction (PCR) screen. Selected clones positive for the edited alleles were 
expanded and genomic DNA (gDNA) and RNA were extracted to confirm the 
presence and expression of the mutations introduced. 
 
This technology allows the mutated gene to be expressed under the control of its 
endogenous promoter instead of heterologous expression of transfected genes 
using viral promoters. The mutated isogenic cells can be used with matched 
controls, either the MCF10A parental cells or MCF10A wild-type (WT). The MCF10A 
parental cells are the original cells of which the isogenic cells are based on. 
MCF10A WT cells are parental cells that have undergone the rAAV gene editing but 
did not retain the introduced somatic mutations. Paired with the mutated isogenic 
cells, it is possible to screen for inhibitors based on the concept of synthetic lethality 
(Figure 1.9). Two genes are synthetic lethal if mutation of either one maintains cell 
viability but simultaneous inhibition of both genes confers cell death (Kaelin, 2005).  
 
NSCLC patients with the EGFR ΔE746-A750 have shown high sensitivity to the 
EGFR kinase inhibitor, Gefitinib (Fukuoka et al., 2003). However, drug resistance 
within a year of treatment has propelled the search for adjuvant therapies to delay or 
inhibit the occurrence of secondary mutations that cause the resistance (Yoshida et 
al., 2010). Comparing the viability of paired MCF10A parental and EGFR ΔE746-
A750 cells using drug compound libraries in a high-thoroughput manner may 
provide new targets for the design of adjunct therapies (Kaelin, 2005). In this setting, 
drug compounds that antagonise or kill cells in a genotype-specific manner can be 
identified and further validated in different biological contexts. 
 
Mutations in the PIK3CA (catalytic p110α subunit of the Class 1 PI3K) gene are 
commonly found in cancers. The PIK3CA mutation hotspots include E542K, E545K 
and H1047R (Karakas et al., 2006). Over-expression of cDNAs with these PIK3CA 
mutations promoted cellular transformation of chicken embryonic fibroblasts (Kang 
et al., 2005). The average mutational frequency of PIK3CA mutations from literature 
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Figure 1.9. A simplified scheme representing the concept of synthetic 
lethality.   In the example above, inactivation (red cross) of either gene invov-
led in survival processes (gene A, gene B) does not affect the viability of organ-
ism. Concurrent inactivation of both gene confers lethality. (Adapted from 
Nijman, 2011).
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mining is up to 25% in breast cancer, 26% in colon cancer and 36% in liver cancer 
(Karakas et al., 2006). However, variations exist within the same type of cancer, due 
to differences in geography, patient cohorts and methods of DNA testing and 
preservation.  
 
Inversely, PTEN (Phosphatase and Tensin homologue) acts to suppress the PI3K-
AKT signalling network that promotes cell growth and proliferation (Leslie and 
Brunton, 2013). Reduction or loss of PTEN, commonly found in human cancers, is 
mediated through the loss of heterozygosity and epigenetic silencing of the alleles 
(Leslie and Brunton, 2013; Vitolo et al., 2009). In 50-75% of breast cancer, loss of 
PTEN expression and acquisition of PIK3CA mutations relate to poor prognosis and 
resistance to chemotherapies, which highlight the importance of the PI3K pathway 
in breast cancer (Vitolo et al., 2009). In MCF10A cells, Bachman’s group showed 
that the heterozygous loss of PTEN was sufficient to sustain the activation of the 
PI3K-AKT pathway (Vitolo et al., 2009). Moreover, homozygous absence of PTEN 
expression further increased the sustained activation. PTEN deletion also allowed 
growth factor independent proliferation of MCF10A cells which conferred resistance 
to PI3K inhibitor (LY 294002) and MEK 1/2 inhibitor (UO126). This was 
accompanied by resistance to apoptosis even when the MCF10A PTEN null cells 
were starved in minimal media (1% charcoal stripped dextran treated FBS, 100 
units/ ml penicillin, streptomycin without growth factors) for up to 9 days. Therefore, 
the PTEN null isogenic MCF10A cells can be screened for using different drug 
compounds to find alternative inhibitors. The proteome of drug resistant PTEN null 
cells can also be compared to the isogenic PTEN WT cells to identify target proteins 
that confer resistance, allowing the rational design of combination therapy. 
 
1.6 Project summary 
In this thesis, I report that confluent monolayers of mammary epithelial cells are 
capable of drastic membrane reorganisation to form interdigitating structures 
prompted by EGF withdrawal (Figure 1.10). Downstream MAPK and PI3K signalling 
cascades synergistically aid the formation of digits. The formation of interdigitations 
is followed by elevated numbers of desmosomal junctions and related adaptor 
proteins. Ultrastructural analysis exhibited bundled actin cables emanating from the 
tips of these structures. Upon re-application of EGF, actin polymerisation and 
contraction is required to reverse such interdigitations. The functional outputs of 
interdigitations include immobility within confluent monolayers, impaired wound 
healing and enhanced mechanical stability. 
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Figure 1.10. Graphical abstract summarising the plasticity of mammary 
epithelial cells governed by EGF and actin cytoskeleton remodelling. 
Non-malignant mammary epithelial cells require EGF in their culture medium. 
Removal of EGF induces interdigitations in confluent monolayers. EGF and 
canonical downstream signaling cascades mediate formation of interdigitations 
over a relatively long period (>12 hours). Formation of digits is accompanied by 
the restricted mobility of cells within confluent monolayers and enhanced resis-
tance to mechanical and osmotic stress. Digits are reversed relatively rapidly 
(1 hour onwards) by EGFR specific ligands, (EGF & TGFα).  Reversal of digits 
requires actin polymerisation and actomyosin contraction based on inhibition 
when treated with actin depolymerising drugs, Latrunculin A, Cytochalasin D 
and myosin inhibitor, Blebbistatin. Reversal of digits restores ability of cells to 
move within confluent monolayers and yet maintain enhanced cell-cell adhe-
sion.
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2.1 Mammalian Cell Culture 
2.1.1 Cell culture inhibitors, reagents and antibodies 
Gefitinib, AZD6244, Lapatinib, Erlotinib, GDC0941, CP724714 were purchased from  
Stratech (Suffolk, UK); Cytochalasin D, Latrunculin A, Blebbistatin and EHop-016 
from Sigma (Dorset, UK); PI103, LY294002  from Calbiochem (Merck, Germany, 
UK), EHT1864 and NSC23766 from R&D Systems (Minneapolis, USA). IC50 and 
inhibitors’ concentration used are listed in Table 2.1. Culture media and 
supplements used were: Dulbecco’s modified Eagles’s medium (DMEM) F12 
GlutaMax and fetal bovine serum (FBS) (Invitrogen, Paisley, UK), HS (First Link, 
Birmingham, UK), recombinant human EGF, TGFα, NRG1 (PeproTech, London, 
UK), HGF (Genentech, California, USA) hydrocortisone, insulin, cholera toxin 
(Sigma). Primary and secondary antibodies used in protein biochemistry and 
microscopy are listed in Table 2.2 and 2.3. 
 
2.1.2 Two-dimensional (2D) culture 
MCF10A cells 
MCF10A parental and isogenic cell lines (Table 2.4) (Horizon Discovery, 
Cambridge, UK) were cultured at 37oC, in 5% CO2 in (DMEM)/F12 GlutaMax 
supplemented with 5% horse serum (HS) EGF (20ng/ml, PeproTech), 
hydrocortisone (500ng/ml), insulin (0.01mg/ml) and cholera toxin (100ng/ml, Sigma) 
referred to as ‘maintenance medium’ hereafter (Soule et al 1990). For maintenance, 
confluent monolayers of cells (75-95%) were split every two days at 1:5-1:8 dilutions 
as follows: Confluent monolayers were washed 3x with PBS, then incubated with 
0.5-1ml of 0.05% trypsin with EDTA (Gibco) for 10 minutes at 37oC. Cells were 
resuspended in 6ml of maintenance medium in either 25cm2or 75cm2canted neck, 
vented cap flasks (Corning, New York, USA) in the recommended volumes. 
MCF10A cells were seeded in six-well plates at densities shown in (Table 2.5). 
Medium was exchanged for complete medium with 10% FBS (‘growth medium’) 
instead of the HS, with or without 20ng/ml EGF. Different experimental 
configurations are summarised in Table 2.6. Conditioned medium was obtained by 
harvesting medium from cells cultured in parallel to the cells used for the 
experiment. Inhibitors were added directly to wells or together with fresh or 
conditioned medium. In the reversal experiments, growth factors were added 
directly to cells cultured in medium without EGF. 
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Table 2.1. Inhibitors and concentrations used. Chemical structures of inhibitors 
accessed from manufacturers’ websites are summarised in Appendices: Table2.1A.  
Inhibitor Target 
inhibition 
Source Catalogue 
# 
In vitro 
IC50 
[Lab 
Stock] 
[Final] 
Gefitinib EGFR 
ATPase 
binding 
pocket 
Stratech 
(Selleckchem) 
1025 7nM, 
37nM 
10mM 300nM 
Erlotinib 
hydrochloride 
 
EGFR Stratech 
(Selleckchem) 
S1023 
 
2nM 5mM 100nM 
Lapatinib 
ditosylate 
 
EGFR/ 
Her2 
Stratech 
(Selleckchem) 
S1028 
 
EGFR: 
10.2 nm  
Her2: 
9.8nM 
10mM 1µM 
CP724714 
 
Her2 Stratech 
(Selleckchem) 
 
1167 EGFR: 
6.4µM 
ErbB2 
kinase 
domain: 
32nM 
10mM 250nM 
AZD6244 
 
MEK  Stratech 
(Selleckchem) 
S1008 MEK1: 
14nM 
ERK1/2: 
<40nM 
10mM 300nM 
PI103 
 
Pan PI3K  Calbiochem 528100 
 
8-150nM 10mM 100nM 
LY294002 
 
Pan PI3K  Calbiochem 440202 
 
PI3K: 
1.4µM 
10mM 20µM 
GDC-0941 
 
PI3K I, II, III  
 
Stratech 
(Selleckchem) 
S1065 PI3Kα/ 
δ:3nM 
 
10mM 
 
500nM 
Cytochalasin 
D 
 
Actin 
polymerisat
ion 
Sigma 
 
C8273 
 
NIH3T3: 
0.104µM 
10mM 5µM 
Latrunculin A 
 
Actin 
polymerisat
ion 
Sigma 
 
L5163 
 
MDA-MB-
435: 
94.88 nM 
10mM 5µM 
 
Blebbistatin 
 
Myosin II 
 
Sigma 
 
B0560 
 
2µM 17.1m
M or 
23.2m
M 
 
25µM (3hrs) 
 
EHT1864 
 
Rac1 GTP 
displaceme
nt 
R&D systems 
(Tocris) 
 
3872 
 
Rac1 
40nM, 
Rac1b 
50nM, 
Rac2 60 
nM, Rac3 
250nM 
75mM 5µM 
EHop-016 Rac1/ Vav2 
interaction 
Sigma 
 
SML0526 1µM 5µM 23.2mM 
NSC 23766 
 
Rac1-
GEF(Trio/ 
Tiam1) 
inhibitor 
 
R&D systems 
(Tocris) 
 
2161 50µM 100m
M 
50µM 
Cycloheximide 
 
Protein 
translation 
Sigma 
 
C7698 
 
HeLa: 
532.5nM 
35.5m
M  
 
35.5µM(3hrs)
, 355nM 
(24hrs) 
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Antibody Target Epitope Source Output Block Incubation Dilution 
HECD1 E-
cadherin 
N-term CRUK IF, WB 5% goat 
serum 
5% Milk or 
5% BSA 
IF/WB 
1:1000 
EP700Y 
 
E-
cadherin 
N-term Abcam 
(#ab40772) 
IF 5% goat 
serum 
5% Milk or 
5% BSA 
IF 1:1000 
Desmopl-
akin 1&2 
 
Desmopla
-kin 
 
C-term David 
Garrod 
(#11-5F) 
IF, WB 5% goat 
serum 
5% BSA IF 1:200 
WB 1:30 
Desmogl-
ein 1 
 
Desmogle
-in 
 
Cytoplas-
mic 
repeat 
units of 
DSG 
David 
Garrod 
(#33-3D) 
IF, WB 5% goat 
serum 
5% BSA IF 1:100 
WB 1:100 
ZO1 
 
ZO1 
 
mid-
region 
Zymed 
(#40-2200) 
IF, WB 5% goat 
serum 
5% BSA IF 1:100 
WB 1:1000 
Claudin-1 
 
Claudin-1 
 
C-term Invitrogen 
(#51-9000) 
IF, WB 5% goat 
serum 
5% BSA IF 1:100 
WB 1:125 
Occludin 
 
Occludin 
 
C-term 
150aa 
(GST) 
Invitrogen 
(#33-1500) 
IF, WB 5% goat 
serum 
5% BSA IF 1:25 
WB 1:125 
pEGFR 
Y845 
 
pEGFR 
Y845 
 
c-Src 
phos. site 
Cell 
Signalling 
(#2231) 
 
WB N/A 5% BSA WB 1:1000 
pEGFR 
Y992 
 
pEGFR 
Y992 
 
PLCγ 
binding 
site 
Cell 
Signalling 
(#2235) 
 
WB N/A 5% BSA WB 1:1000 
pEGFR 
Y1045 
 
pEGFR 
Y1045 
 
c-Cbl 
docking 
site 
Cell 
Signalling 
(#2237) 
 
WB N/A 5% BSA WB 1:1000 
pEGFR 
Y1068 
 
pEGFR 
Y1068 
 
Grb2 
binding 
site 
Cell 
Signalling 
(#2234) 
 
WB N/A 5% BSA WB 1:1000 
EGFR R1 
 
Total 
EGFR 
Extracellu
-lar 
CRUK 
(#sc-101) 
IF 5% goat 
serum 
N/A IF 1:2000 
EGFR 
D38B1 
 
Total 
EGFR 
C-term Cell 
Signalling 
(#4267) 
 
WB N/A 5% BSA WB 1:1000 
pAKT  
 
pAKT  
 
Ser 473 Cell 
Signalling 
(#4060) 
 
WB N/A 5% BSA WB 1:2000 
AKT 
 
Total AKT 
 
C-term Cell 
Signalling 
(#9272) 
 
WB N/A 5% BSA WB 1:1000 
pERK 
 
pERK Thr 202, 
Thr 204 
 
Cell 
Signalling 
(#4370) 
WB N/A 5% BSA WB 1:2000 
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Table 2.2. Primary antibodies used for immunofluorescence and Western 
blotting. Abbreviations used include IF: immunofluorescence, WB: Western 
Blotting, C-term: C-terminus, hypervar. reg.: hypervariable region, phos: phospho-, 
aa: amino acid.  
Antibody Target Epitope Source Output Block Incubation Dilution 
EEA-1 
 
EEA-1 
 
 Ian Mills 
(#243/3) 
IF 5% goat 
serum 
N/A IF 1:1000 
rab11a 
 
rab11a 
 
C-term 
hypervar-. 
reg. 
Invitrogen 
(#71- 5300) 
IF 5% goat 
serum 
N/A IF 1:200 
tfr/ CD71 
 
Transferri
n 
aa461-
760 
Santa Cruz 
(#sc9099) 
IF 5% goat 
serum 
N/A IF 1:400 
VPS35 
 
VPS35 
 
C-term aa 
783-796 
Abcam 
(#ab10099) 
IF 5% BSA N/A IF 1:150 
Actin Actin 
 
DDDIAAL
VIDNGS
GK 
Abcam 
(#ab6276) 
WB N/A 5% BSA WB 1:10000 
pERM pERM aa around 
Thr567 of 
Ezrin 
Cell 
Signalling 
(#3141) 
 
WB N/A 5% BSA IF 1:1000 
alpha-
Tubulin 
DM1A 
alpha-
Tubulin 
 
C-term aa 
246-430 
Sigma 
(#T6199) 
IF 5% goat 
serum 
N/A IF 1:1000 
Rac1 Rac1  Cytoskeleto
n 
(#Arc03) 
 
WB N/A 5% BSA WB 1:500 
Cdc42 
 
Cdc42 
 
aa around 
Lys135 
Cell 
Signalling 
(#2462) 
 
WB N/A 5% BSA WB 1:1000 
PREX1 
 
PREX1 
 
Internal 
region 
peptide 
sequence 
CERSNL
PTDASTT
A 
Sigma 
(#SAB2501
302) 
WB N/A 5% BSA WB 1:500 
Vav2 
(C64H2) 
 
Vav2  Near C-
term 
Cell 
Signalling 
(#2848) 
 
WB N/A 5% BSA WB 1:1000 
Caveolin 
 
Caveolin 
 
aa1-97 BD 
(#610059) 
WB N/A 5% BSA WB 1:20000 
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Table 2.3. Secondary antibodies for Western Blotting and Immunofluorescence. 
 
 
 
Table 2.4 MCF10A isogenic cell panel licensed from Horizon Discovery Ltd. 
Isogenic cells with introduced mutations in the EGFR associated pathways are 
matched to MCF10A parental (BHP) or Wild Type (WT) unless indicated. WT cells 
have undergone gene editing processes as the mutants but did not retain mutations. 
BHP parental cells are the original MCF10A cells of which all the other cells have 
been based on. 
 
 
Secondary antibodies Source Application Dilution 
Donkey anti-mouse IRDye 800CW LICOR Biosciences 
(#926-32212) 
WB 1:15000 
Donkey anti-mouse IRDye 680CW LICOR Biosciences 
(#926-32222) 
WB 1:15000 
Donkey anti-rabbit IRDye 800CW LICOR Biosciences 
(#926-32213) 
WB 1:15000 
Donkey anti-rabbit IRDye 680CW LICOR Biosciences 
(#926-32223) 
WB 1:15000 
Donkey anti-rabbit AF488 Invitrogen 
(#A21206) 
IF 1:500 
Donkey anti-rabbit AF594 Invitrogen 
(#A21207) 
IF 1:500 
Donkey anti-mouse AF488 Invitrogen 
(#A21202) 
IF 1:500 
Donkey anti-rabbit AF594 Invitrogen 
(#A21203) 
IF 1:500 
Reference 
 
MCF10A Clones 
HD PAR-003 
 
Parental  BenHoPark (BHP), 245 
HD 101-010 
 
EGFR ∆E746-A750 8A5B1B7 
HD PAR-004 
 
K-Ras WT N/A:SNB: 00119 
HD 101-004 
 
K-Ras (+/G12V) 2 
HD 101-011 
 
PI3Kα (H1047R) 1, 22, 23  
(clone 22 & 23 matched to parental clone 245). 
HD 101-002 
 
PI3Kα (E545K)  10 
(matched to parental clone 245). 
HD PAR-021 
 
PTEN WT N/a:SNB: 00291 
HD 101-006 
 
PTEN null 10A5pc10 
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Table 2.5. Experimental seeding densities of MCF10A cells in 2D culture. 
Seeding numbers apply to cells seeded on plastic or glass coverslips in each well of 
6-well plate. 
 
HMT 3522 cells 
HMT 3522 S1 cells (ECACC, Salisbury, UK) were maintained at 37oC, in 5% CO2 
with serum free DMEM/F12 GlutaMax supplemented with insulin (250ng/ml), EGF 
(10ng/ml), transferrin (10µg/ml), Na-selenite (2.6ng/ml), 17β-Estradiol (27.2pg/ml), 
hydrocortisone (0.5µg/ml) and recombinant human prolactin (5µg/ml). Confluent 
monolayers (75-95%) were split every five days at 1:3-1:5 dilutions depending on 
the degree of confluence, with fresh medium exchange every 2 days. Cells were 
detached using 0.05% trypsin with EDTA (Gibco) for 10 minutes, resuspended in 
0.0125 % defined soybean trypsin inhibitor (Invitrogen) at a concentration ratio of 
1:1 to trypsin and up to 6 ml of HMT 3522 maintenance medium. HMT 3522 S1 cells 
were seeded in six-well plates at a density of 3.0 x 105cells/well (on glass 
coverslips). Complete growth medium was exchanged to medium lacking EGF 96 
hours after seeding, once cells were in a confluent monolayer. Cells were then left 
for another 166 hours in medium lacking EGF. In reversal experiments, EGF 
(20ng/ml) was added directly to cells that had been cultured in medium without 
EGF. 
 
2.1.3 Three-dimensional (3D) mammary morphogenesis assay 
MCF10A parental, PI3K H1047R, PTEN wildtype and PTEN null cells (Horizon 
Discovery, UK) were maintained as described in 2.1.2.The 3D morphogenesis 
assay was adapted from both Debnath et al (2003) and Lee et al (2007). Each well 
of a 8 well tissue culture treated glass slides (BD, Oxford, UK) was coated with 48µl 
of Matrigel [8.9mg/ml protein concentration] on ice, centrifuged for 10 minutes at 
MCF10A cells Per well 
6-well 
Per well 
6-well 
 +EGF -EGF 
Parental  1.0 x 105 1.5 x 105 
EGFR ∆E746- A750 3.0 x 105 5.0 x 105 
PI3K H1047R 1.3 x 105 1.8 x 105 
PI3K E545K 1.3 x 105 1.8 x 105 
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Table 2.6. 2D Experimental configurations 
of MCF10A cells. In the ‘forward’ experi-
ments, cells were cultured from subconflu-
ence whereas in the ‘induction’ experiments, 
interdigitations were induced in monolayers 
of MCF10A cells. This was done by 
exchange of growth medium to remove EGF. 
Interdigitated sheets in the ‘reversal’ experi-
ment were pre-cultured as the forward 
experiment. EGF was then added to reverse 
the interdigitations. 
FORWARD INDUCTION REVERSE
-EGF +EGF -EGF
Configuration
Starting
 condition
Timeline
Visibility of 
interdigitations 60+ hours 24hours
1-24 hours 
reversal
Seed
Exchange media
Add inhibitors/ growth factors
Exchange media
Fix
Chapter 2: Materials and Methods
D0 D1 D2 D3 D4D0 D1 D2 D3 D4 D0 D1 D2 D3 D4
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300g (RT) and left to solidify for 30 minutes at 37oC. For 3D culture maintenance 
and experiments, media were prepared according to the recipe in Table 2.7. 
Component Resuspension 
medium 
Assay 
medium  
[-EGF]  
Assay 
medium 
[+EGF]  
Refeeding 
medium 
[-EGF] 
Refeeding 
medium 
[+EGF] 
 DMEM/ F12 
Glutamax 
 
DMEM/ 
F12 
Glutamax 
 
DMEM/ 
F12 
Glutamax 
 
DMEM/ 
F12 
Glutamax 
 
DMEM/ 
F12 
Glutamax 
 
HS 20% 2% 2% 2% 2% 
EGF  --- --- 10ng/ml  --- 5ng/ml  
Hydrocortisone  --- 0.5µg/ml 0.5µg/ml 0.5µg/ml 0.5µg/ml 
Chlolera toxin  --- 100ng/ml 100ng/ml 100ng/ml 100ng/ml 
Insulin  --- 10µg/ml 10µg/ml 10µg/ml 10µg/ml 
Penicillin/ 
Streptomycin 
--- 100units/ml 100units/ml 100units/ml 100units/ml 
Matrigel --- --- --- 2.7% 2.7% 
Table 2.7. 3D culture media recipes. Recipes were adapted from Debnath et al., 
(2003) and Lee et al. (2007). 
 
Cells were trypsinised as previously described, and seeded in Assay medium 
[+EGF]. Every 4 days, medium was exchanged to Refeeding medium [+EGF] or  
[-EGF], with Matrigel added fresh. Gefitinib (300nM) was added daily from day 4 
onwards or as indicated. MCF10A spheroids were fixed on days 14 and 22. 
 
2.1.4 Small interfering RNA (siRNA) interference  
Cells were seeded at seeding densities show in Table 2.5. Just after seeding, cells 
were treated with RNAimax transfection reagent with 40nM ON-TARGET plus non-
targeting oligonucleotide (NT1) or SMARTpool human oligonucleotides targeting 
Vav2 (siVav2) or Rac1 (siRac1) (Thermo Fisher Scientific, Waltham, MA) at a 
volume ratio of 1:1. The pooled sequence of oligonucleotides are listed below. 
Oligonucleotides 
(item #) 
RNA targeting sequences 
siRac1 
#L-003560-00-0005 
 
GUGAUUUCAUAGCGAGUUU, GUAGUUCUCAGAUGCGUAA, 
AUGAAAGUGUCACGGGUAA, GAACUGCUAUUUCCUCUAA 
 
siVav2 
#L-005199-00-0005 
 
CUGAAAGUCUGCCACGAUA, UGGCAGCUGUCUUCAUUAA, 
GUGGGAGGGUCGUCUGGUA, GCCGCUGGCUCAUCGAUUG 
Table 2.8. RNA targeting sequences of siRNA oligonucleotides used. 
Oligonucleotides were made by Dharmacon and distributed by Thermo Fisher 
Scientific. 
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Medium was exchanged to FBS growth medium 5-6 hours later after the cells have 
attached on the same day. For the Rac1 pulldown experiments, cells were 
transfected again 48 hours later before GST-PBD beads pull-down of endogenous 
activated Rac-GTPase at 72 hours. 
 
2.2 Molecular Biology 
2.2.1 Plasmid transfection of MCF10A cells 
Medium was exchanged 5-8 hours post seeding, and cells were transfected 36-48 
hours later once they had reached a minimum of 50% confluence. MCF10A parental 
cells were transfected with pEGFP-C1 (Clontech), GFP-LifeAct, GFP-RacG12V or 
GFP-RacT17N (gifts of Laura Machesky, Beatson Institute, Glasgow), using the 
Lipofectamine LTX transfection reagent (Invitrogen) according to manufacturer’s 
instructions. Typical transfection efficiency obtained was approximately 20-30%. 
Transfection medium was replaced by complete medium with or without 20ng/ml 
EGF 5-6 hours after transfection. Transfected cells were visualised by time-lapse 
imaging or fixed with 4% PFA for immunofluorescence microscopy after 18-24 
hours. 
 
2.2.2 Bacterial transformation 
Plasmids were transformed as follows. 50µl of DH5α subcloning efficiency cells 
(Invitrogen) were thawed on ice and transferred to a polypropylene tube. Less than 
100ng of DNA were added to the cell suspension and cells were incubated on ice 
for 20 minutes. The cell suspension was then heat-shocked at 42oC in a water bath 
for 45 seconds and placed immediately on ice for 2 minutes. 200µl of SOC (Super 
Optimal Broth with Catabolite Repression, Invitrogen) medium was added to the cell 
suspension and the bacteria were incubated in a shaker at 250 rpm for 1 hour at 
37oC. Bacterial cells were then spread on selective Luria Bertani (LB, Lab M, Bury, 
UK) agar plates and incubated overnight at 37oC.  
 
2.2.3 Glycerol stock 
Glycerol stock was prepared from an overnight culture of transformed bacteria in LB 
broth. For this purpose, 5ml LB supplemented with either Kanamycin (25µg/ml) or 
Ampicillin (250µg/ml) were incubated in a rotating shaker at 37oC and 245 rpm 
overnight. The next morning, the bacteria were centrifuged at 4000 rpm for 15 
minutes. The supernatant was then discarded and the bacterial pellet resuspended 
in 40% glycerol in LB. The glycerol stock was catalogued and stored at -80oC. 
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2.2.4 Plasmid DNA Purification 
A single bacterial colony from the transformed bacteria grown on LB agar plates 
were cultured in 5ml LB broth selection media supplemented with Kanamycin 
(25µg/ml) or Ampicillin (250µg/ml) overnight, at 37oC and 245 rpm. For small scale 
preparations of DNA, Miniprep kits (Qiagen, Crawley, UK) were used and the 
procedures followed were according to manufacturers’ instructions. Bacteria were 
centrifuged, resuspended (Buffer P1, 50mM Tris-Cl, pH 8.0, 10mM EDTA, 
100ug/mL RNase A) and lysed in alkaline lysis buffer (Buffer P2, 200mM NaOH, 1% 
SDS). The lysates were neutralised (Buffer P3, 3.0M potassium acetate, pH 5.5) 
and spun at 14 000 rpm at RT (room temperature) for 10 minutes. The DNA 
containing aqueous phase supernatant was spun onto a filter  and eluted in Buffer 
PB (10mM Tris-Cl, pH 8.5). For large-scale preparation, HiSpeed Maxiprep kits 
(Qiagen) were used. Transformed DH5α cells were inoculated into 150ml LB broth 
in selection antibiotics and cultured overnight at 37oC and 245 rpm (as miniprep). 
Cells were harvested by centrifugation at 4500 rpm for 15 minutes and DNA isolated 
according to the manufacturers’ instructions. The concentration of the DNA was 
determined using the Nanodrop ND1000 Spectrophotometer. DNA plasmids were 
catalogued and aliquots were stored at -20oC.  
 
2.2.5 Agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA according to size and to 
verify the concentration of plasmid of interest before DNA sequencing. Agarose was 
diluted to the appropriate concentration in 1x TAE buffer (0.8%, 40mM Tris-acetate, 
1mM EDTA) and heated for 5 minutes in a microwave to dissolve the agarose. To 
stain the DNA, ethidium bromide (0.5%) was added to the dissolved agarose. 
Horizontal electrophoresis was performed in 1xTAE buffer. DNA bands were 
visualised using UV light  with a UVIdoc transilluminator (UVItec). 
 
2.2.6 DNA plasmid sequencing 
DNA plasmids:  pEGFP-Rac G12V and pEGFP-Rac T17N were sent to The DNA 
Sequencing Services, University of Dundee for sequencing. The Rac1 accession 
number used for sequence alignment was Homo sapiens NM_006908. The pEGFP-
C1 (Clontech) primer was used to sequence these plasmids. 
 
2.3 Microscopy 
2.3.1 Microscopy of 2D cell culture 
Cells on coverslips were rinsed twice with PBS (37°C, supplemented with 1mM 
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CaCl2, 1mM MgCl2), fixed in 4% paraformaldehyde (PFA) in PBS, permeabilised 
with 0.2% Triton-X-100 in PBS, blocked in 10% goat serum and incubated with 
primary and secondary antibodies in 5% goat serum in PBS (20 minutes each), all 
at RT. Alexa Fluor 488 or 594 conjugated secondary antibodies were incubated for 
20 minutes. Cells were washed 3x in PBS after each antibody incubation and finally 
dipped into sterile deionised water (dH2O) and mounted onto slides using Mowiol to 
which 0.5µg/ml of 4’,6-diamidino-2-phenylindole (DAPI) had been added. Phase 
contrast and immunofluorescence images were taken using a Nikon Eclipse Ti-E 
microscope (CFI Super Plan Fluor 20x/0.45 NA or CFI Plan Apochromat 40x/ 
0.45NA objective lens) and a digital camera (CoolSNAP EZ Turbo 1394; 
Photometrics). Confocal images were taken using a Leica SP2 microscope (HCX PL 
Apo 63x/ 1.40NA oil objective lens at 1.50 zoom).  The images were then processed 
using NIS-Elements Software (Nikon, Surrey, UK), Leica Confocal Software (Leica 
Microsystem, London, UK), Photoshop CS5 Version 12.0 x64 and annotated in 
Illustrator CS5 version 15.0.0 (Adobe). 
 
2.3.2 Microscopy of 3D spheroids 
The protocol for the fixation and staining of 3D cultures with the specified antibodies 
was adapted from Debnath et al 2003. Fixation and permeabilisation reagents were 
made in PBS buffer. 3D spheroids cultured in 8-well tissue culture treated slides 
were fixed immediately in 2% PFA for 20 minutes at 37oC. Spheroids were then 
permeabilised with 0.5% Triton-X100 for 20 minutes at RT. All further steps were 
conducted at RT. Chambers were rinsed with ‘Glycine rinse’ (130mM NaCl, 7mM 
Na2HPO4, 3.5mM NAH2PO4, 100mM glycine), 3x 10 minutes each. Each chamber 
was then incubated in blocking buffer (10% goat serum (GS), TBS-T {20mM Tris, 
137mM NaCl, pH7.6, 0.1% Tween 20}, 1% BSA) for 1 hour to block non-specific 
proteins binding sites. Spheroids were incubated with antibodies made in blocking 
buffer overnight. The next day, spheroids were rinsed with wash buffer (TBS-T, 1% 
BSA) for 3x 10 minutes. Spheroids were incubated in secondary antibodies and 
blocking buffer for 40 minutes. Spheroids were rinsed for 3x 10 minutes and 
mounted onto 24 x 60mm coverslips (thickness #1.5, Thermoscientific) with Mowiol 
and DAPI. Spheroids on coverslips were imaged using a Nikon Eclipse Ti-E 
microscope (CFI Plan Fluor DLL10x/0.3 NA), Leica SP2 microscope (HCX PL Apo 
63x/ 1.40NA oil immersion objective, at 1.50 zoom) and Marianas spinning disk 
confocal microscope (3i, Intelligent Imaging Innovations, Germany) (63 x 1.4NA oil 
immersion objective). For quantitation of the spheroids, individual outlines of the 
spheroids were traced using the Wacom Bamboo pen tablet and pixels threshold 
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(500 pixels and above) was set using Image J software. Values obtained were then 
plotted onto bar charts using the Microsoft Excel 2007 package. Images were 
processed as described for 2D experiments. 
 
2.3.3 Electron Microscopy (with Alison Beckett, Biomedical Electron Microscopy 
Unit, University of Liverpool) 
Confluent dishes of MCF10A cultured in ±EGF media were passed to Alison Beckett 
for further processing as described. Confluent monolayers were washed with 0.1M 
sodium cacodylate buffer pH7.4 before fixing with 2.5% (w/v) glutaraldehyde, 
1mg/ml Ruthenium Red in sodium cacodylate buffer at RT for 1 hour. Following 
rinses with 0.1M sodium cacodylate buffer, cells were post-fixed with 1% osmium 
tetroxide, 1mg/ml Ruthenium Red in 0.1M cacodylate buffer at RT for 2 hours. After 
rinsing with dH2O, cells were stained with 1% aqueous uranyl acetate (Agar) at RT 
for 1 hour and then dehydrated in a graded series of ethanol on ice. Cells were flat 
embedded using gelatine capsules in Epon and polymerised at 60°C for 2 days. 
Ultrathin serial sections (70-85nm) were cut longitudinally through the whole cell and 
stained with uranyl acetate and lead citrate before viewing at 100KV in a FEI Tecnai 
G2 Spirit transmission electron microscope (TEM). To quantify the number of 
junctions, a total of 33 micrographs were taken using AnalySIS (SIS, GmbH) with a 
final magnification of 16,500x for both ±EGF cells incorporating two biological 
repeats. 7 different grids from 6 separate resin capsules were used for -EGF and 4 
grids from 2 different resin capsules for +EGF conditions. Areas imaged were 
chosen at random where cells were observed to be adjacent and membranes close 
enough for cell-to-cell adhesion. Apposing membranes were measured using 
AnalySIS and junctions counted and expressed as the number of junctions per µm.  
 
2.4 Protein Biochemistry 
2.4.1 Cell lysis  
Monolayers of adherent cells on 6 well plates were placed on a pre-cooled metal 
plate, washed 3x with ice-cold PBS and lysed with RIPA lysis buffer (10mM Tris 
pH7.5, 150mM NaCl, 1% sodium deoxycholate, 50mM NaF, 1% Triton X-100, 0.1% 
SDS) supplemented with 1x PhosStop phosphatase inhibitor (Roche) and 1x 
mammalian protease inhibitor cocktails (Sigma) for 10 minutes. Cells were clarified 
of insoluble material by centrifugation at 20,000g and 4°C for 10 min.  
 
The protein concentration of the cell lysates was quantified using the BCA protein 
assay kit (Pierce, UK) according to the manufacturer’s instructions. Absorbance was 
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measured at 562nm using the Thermo Labsystems Multiskan Spectrum 
spectrophotometer. Lysates were diluted in 5x sample buffer (15% w/v SDS, 
312.5mM Tris HCl pH6.8, 50% glycerol, 16% Beta-mercaptoethanol) and adjusted 
to a final concentration of 0.5µg/µl in 1x sampler buffer.  
 
2.4.2 Western Blotting 
Protein samples were resolved on NuPAGE 4-12% pre-cast Bis-Tris polyacrylamide 
gels (Life Technologies), run at a constant voltage of 200V for 1 hour. Resolved 
proteins were transferred onto Protran nitrocellulose membrane (0.45µm, Geneflow) 
at 25V for an hour using a Genie Blotter (Idea Scientific, Minneapolis, USA) in either 
MOPS buffer (4-Morpholinepropanesulfonic acid) for standard proteins, and MES 
buffers (4-morpholineethanesulfonic acid) for proteins less than 30kDa.The 
transferred proteins were visualised by Ponceau-S stain (Sigma) and the stain was 
removed by washing with TBS-T. Membranes were blocked with 5% Marvel milk 
powder in TBS-T. Primary antibodies were incubated in either 5% bovine serum 
albumin (BSA) or 5% milk as indicated (Table 2.1). Membranes were washed for 3x 
4 minutes each using TBS-T, followed by incubation with fluorophore-conjugated 
secondary antibodies at RT for an hour (Table 2.2). Membranes were then washed 
once in TBS-T and 2x 4 minutes in TBS before acquisition of images on the LI-COR 
Odyssey Infrared Imaging system. 
 
2.4.3 Glutathione- Sepharose (GST) beads pull-down of activated Rac1 
GTP-bound forms of Rac1 were pulled down using bacterially expressed, purified 
GST-PBD (p21-binding domain of PAK, Cytoskeleton Inc, Denver, USA). This 
protocol was adapted from Pellegrin and Mellor 2008. Confluent monolayers of cells 
in 10cm dishes seeded at 9 x 105 cells (-EGF) were harvested on day 3. Cells were 
washed 3x with ice-cold PBS and lysed in RIPA lysis buffer (50mM Tris pH 7.2, 
500mM Nacl, 1% Triton X-100, 0.1% SDS w/v, 10mM MgCl2, 1x mammalian 
protease inhibitor (Sigma), 1x phosphatase inhibitor cocktails (Roche). The dishes 
were incubated on ice for 10 minutes. The lysates were transferred to 1.5ml 
eppendorf tubes and centrifuged at 20,000g, at 4°C for 10 minutes. Equal volumes 
of lysates (650µl) were incubated with 30 µg of purified GST-PBD beads 
(Cytoskeleton) at 4°C for 1 hour. 30µl of the remaining lysates were diluted in 7.5µl 
of 5x sample buffer, heated at 95oC for 10 minutes and stored in -20oC until later. 
The beads were centrifuged for 10 minutes, at 4oC and 8000g. The supernatant was 
removed and beads were washed 3x with Tris wash buffer (50 mM Tris- HCl pH 7.5, 
1%,Triton X-100, 150 mM NaCl, 10 mM MgCl2 and 1x mammalian protease inhibitor 
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cocktail (Sigma), for 30 seconds and then centrifuged at 8000g at 4oC. Proteins 
were eluted from the beads by adding 35µl of 2x sample buffer and centrifuged for 1 
minute at 20000g. Protein samples were heated for 10 minutes at 95oC. Samples 
were resolved on NuPAGE 4-12% pre-cast Bis-Tris polyacrylcamide gels with MES 
buffer (Life Technologies) and run at a constant voltage of 200V for 1 hour 
 
2.5 Functional Assays 
2.5.1 Wound healing assay 
MCF10A cells were grown to confluency in 6 well plates, in growth media with FBS 
±EGF for 71 hours. A scratch wound was made with a pipette tip (multichannel tip 
250µl; Anachem, Bedfordshire, UK). To remove dead cells the medium was 
exchanged for conditioned media taken from a prepared plate in parallel. Cells were 
then imaged as described below. 
 
2.5.2 Time-lapse microscopy 
Cells in 6 well plates were incubated in 5% CO2, at 37oC throughout the duration of 
time-lapse microscopy. Cells were imaged within 30-40 minutes of scratching for 3 
hours to record the basal condition of monolayers. Each well was imaged at 4 
different positions. Growth factors (20ng/ml EGF and HGF, 6ng/ml NRG1) or 
medium was exchanged to buffers of different osmolarities: hypotonic [35mM NaCl], 
[77mM NaCl] and isotonic [35mM NaCl] (Table 2.9). Buffers were made without 
HEPES as the microscope has CO2 flow and were adapted from Hyzinski-Garcia et 
al. (2011). Time-lapse microscopy movies captured images every 15 minutes for up 
to 24 hours, using a fully motorised Nikon Ti-E eclipse microscope (CFI Super Plan 
Fluor 20x/0.45 NA). Movies were processed using NIS-Elements software (Nikon), 
FijiIsJust ImageJ 1.48 (NIH) and MPEG Streamclip v1.9.2 (Squared5).  
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Table 2.9. Recipes for buffers of different osmolarity. Recipes were adapted 
from Hyzinksi-Garcia et al. (2011). [brackets] denote concentration. Highlighted in 
grey are the different concentrations of NaCl used to determine buffer osmolarity. 
 
2.5.3 Dispase dissociation assay 
MCF10A cells were seeded in 60mm diameter dishes (+EGF: 1.75 x 105 cells/dish 
and -EGF: 3.3 x 105 cells/dish). 93 hours after seeding, dishes were washed 3x in 
PBS and incubated in 2ml Dispase in PBS (2.4U/ml; Roche, West Sussex, UK) for 
30-40 minutes at 37oC. 5ml of PBS were added into each dish and dislodged cell 
sheets were centrifuged for 4 minutes at 200g. The supernatants were removed and 
cell sheets were resuspended up and down in 1ml PBS, using a 1ml Gilson Pipette 
for the indicated number of strokes, Monolayer fragments (clusters of more than 1 
cell) were counted using a haemocytometer. 
 
Buffer	  
	  
Recipe	   [Final]	  
Basal	  isotonic	  buffer	  [135mM	  NaCl]	  
Proposed	  by	  Hyzinski-­‐Garcia	  et	  al.	  (2011)	  
KCl	  
	  
3.8mM	  
MgSO4	  
	  
1.2mM	  
CaCl2	  
	  
1.3mM	  
KH2PO4	  
	  
1.2mM	  
D-­‐glucose	  
	  
10mM	  
HEPES	  
	  
10mM	  
NaCl	  
	  
135mM	  
Hypotonic	  buffer	  [77mM	  NaCl]	  
Contents	  of	  basal	  buffer	  above	  except	  for	  the	  [NaCl]	  
	  
NaCl	  
	  
77mM	  
Hypotonic	  buffer	  [35mM	  NaCl]	  
Contents	  of	  basal	  buffer	  above	  except	  for	  the	  [NaCl]	  
	  
NaCl	  
	  
35mM	  
Isotonic	  buffer	  [35mM	  NaCl]	  
Contents	  of	  basal	  buffer	  above	  except	  for	  the	  [NaCl]	  
and	  the	  addition	  of	  D-­‐mannitol	  
	  
	  
NaCl	  
	  
35mM	  
D-­‐mannitol	  
	  
200mM	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3.1 Introduction 
Initially I aimed to characterise the growth and morphology of the MCF10A panel of 
isogenic cell lines licensed from Horizon Discovery Ltd (Methods: Table 2.4). These 
would provide a platform of isogenic cells for synthetic lethal inhibitor screens as 
had been discussed in the original project plan. At that time, these cells had not 
been extensively used in our laboratory. The different clones of isogenic cells were 
also matched to different MCF10A parental and Wild type (WT) cells (Methods: 
Table 2.4). MCF10A parental cells provided the genetic background into which other 
mutations were homologously recombined (Introduction: 1.2.5, 1.2.6). These 
isogenic cell lines were generated by Horizon Discovery Ltd. at different stages of 
expansion. In the later phases, they generated mutated isogenic MCF10A cells with 
a common matched WT control. WT cells have undergone the same rAAV 
homologous recombination processes but with empty vectors and these provide a 
more accurate ‘control’ to the mutated cells.  
 
The original MCF10A cells have been routinely cultured in a complex medium 
(Methods: 2.1.2). The isogenic cells were separately cultured in different 
laboratories. Because they encoded mutations that are important for growth and 
survival, the culture medium recommended for the cells varied. Therefore, my initial 
aim was to establish the growth requirements of the cells by systematically varying 
the components of the growth medium. Subsequently, I worked towards 
standardising and optimising experimental protocols involving the MCF10A isogenic 
cell panel in 2D and 3D cultures (Table 3.1). The growth and morphology of the cells 
were visualised using bright field and immunofluorescence microscopy. Cells were 
stained with antibodies against E-cadherin and actin to visualise cell boundaries and 
the actin cytoskeleton respectively.  
 
Surprisingly, confluent monolayers of MCF10A cells grown in complete growth 
medium without EGF (in the presence of other supplements and FBS in the 
medium) showed an unusual phenotype. Neighbouring cells rearranged cell 
boundaries to form interdigitations. Previous studies have focused on the effect of 
EGF on MCF10A cell growth and proliferation using biochemical approaches (Park 
et al., 2004, Soule et al., 1990). MCF10A cells are also famously used in 3D 
Matrigel basement membrane cultures, especially to model mammary gland 
development and tumour progression. Here, I have briefly characterised the growth 
and morphology of the MCF10A isogenic cells in 3D culture. The optimisation of the 
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protocol includes the testing of Matrigel batches, growth conditions and antibody 
staining of the 3D spheroids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1. MCF10A isogenic cell panels tested in this thesis. The different clone 
names represent isogenic cells that were cultured and generated in different 
laboratories. Exp, experimental; BHP, cells from Ben Ho Park’s laboratory; 2D, two-
dimensional assay; 3D, three-dimensional assay. 
 
The initial characterisation of interdigitations is presented in this chapter. Based on 
this discovery, I realigned research effort towards elucidating mechanisms and the 
consequences of this membrane remodelling event as detailed in subsequent 
chapters. Although I preliminarily optimised the 3D experimental system, this assay 
was not pursued further as cells in the simpler 2D in vitro system provided a rational 
and simple assay to dissect the molecular mechanisms in detail.  
MCF10A cells Clone Exp. assay Chapter 3 Sections 
Parental BHP 2D & 3D 2D: 3.2.1,3.2.2, 3.2.3 
3D: 3.3.1, 3.3.2, 3.3.3, 3.3.4 
Parental 245 2D 3.2.2 
EGFR ∆E746-A750 8A5B1B7 2D 3.2.1, 3.2.3 
PI3Kα (H1047R) 22, 23 2D 3.2.2, 3.2.4 
PI3Kα (H1047R) 1 2D & 3D 2D: 3.2.2 
3D: 3.3.1, 3.3.2, 3.3.3 
PI3Kα (E545K) 10 2D 3.2.2, 3.2.4 
PTEN WT N/A 3D 3.3.1, 3.3.2, 3.3.3 
PTEN null 10A5pc10 3D 3.3.1, 3.3.2, 3.3.3 
72
Chapter 3: Morphological characterisation of MCF10A   
 
	  
Results 
 
3.2 Two-dimensional characterisation of MCF10A cells  
3.2.1 Morphological characterisation of MCF10A cells 
The traditional culture medium for MCF10A cells includes a cocktail of hormones 
and growth factors including EGF, insulin, hydrocortisone and cholera enterotoxin 
(Soule et al., 1990). To determine the necessity of the supplements in cell culture, 
each was removed from the culture medium. Cells were observed using brightfield 
and immunofluorescence microscopy at 62-70 hours after medium exchange.  
 
A qualitative evaluation of cell growth was undertaken of MCF10A parental cells 
seeded at 20,000 cells/ well of a 3.8cm2 well. MCF10A cells adopt a cobblestone-
like morphology when grown as confluent monolayers (Soule et al., 1990). Cells 
achieved near-confluence in complete growth medium after 72 hours (Figure 3.1). 
Growth was severely impaired, reaching only ~10-15% confluence when cultured 
without any supplements. Removal of EGF alone allowed growth of small cell 
‘islands’ that reached ~30% confluence. Removal of either insulin or cholera toxin 
did not adversely affect growth as cells still formed monolayers similarly to controls 
in complete growth medium. However, without hydrocortisone cells looked sick and 
did not form the characteristic cobblestone-like morphology (Figure 3.1). In 
comparison, isogenic MCF10A cells in which one allele of the endogenous EGFR 
gene has been engineered to express a constitutively active EGFR (∆E746-A750), 
cells showed similar subconfluent flattened morphology under all conditions except 
following the removal of cholera toxin. Here, cell confluence was qualitatively 
increased and cells exhibited a mesenchyme-like phenotype (Figure 3.1). 
 
Following these preliminary experiments, I adopted another protocol in which cells 
were seeded at a higher density in the presence of hydrocortisone (Methods: Table 
2.5). E-cadherin antibody stains the plasma membrane and illustrates the smooth 
boundaries between control cells in complete growth medium. When EGF was 
removed, MCF10A cells continued to grow but developed ‘finger-like’ interdigitations 
(Figures 3.2, 3.3, Movie 3.1). Interdigitations as described henceforth refer to these 
structures when seen in confluent monolayers under –EGF condition. Although EGF 
and insulin activate similar downstream signalling pathways, the removal of insulin 
did not phenocopy the removal of EGF (Borisov et al., 2009). Monolayers of EGFR 
E746-A750 isogenic cells did not interdigitate upon EGF withdrawal (Figure 3.2A). 
Together, this suggests that active EGFR suppresses interdigitations. Simultaneous 
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Figure 3.1. Growth requirements of subconfluent MCF10A cells. MCF10A 
parental and EGFR∆E746-A750 cells were cultured in complete growth 
medium and without supplements as annotated. Cells were seeded at 20,000 
cells/well of 12 well plates. Complete growth medium was exchanged for 
medium ±supplements (as annotated) 3.5 hours post seeding. After 72 hours, 
representative images of cells at 50% confluence or less were visualised using 
bright field microscopy at 20x magnification. Scale; 40µm.
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Figure 3.2. (A) EGF withdrawal induces interdigitations in MCF10A cells. 
Effect of removal of different supplements from growth media of MCF10A parental or 
isogenic cells expressing EGFR∆E746-A750. Control MCF10A cells organised into 
“cobblestone” monolayers. Interdigitations seen following EGF removal were not 
apparent in EGFR mutant cells. Complete growth medium was exchanged six hours 
post seeding for medium without supplements as annotated. After 72 hours, cover-
slips were fixed with 4% PFA and stained with E-cadherin. Cells were visualised 
using immunofluorescence microscopy at 20x magnification. Scale; 40µm.
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Figure 3.2. (B) Montage of z-stack showing the relative position of inter-
digitations in MCF10A cells. The montage shows MCF10A cells on cover-
slips at 2.25- 3.5µm thickness with interdigitations visible near the top of the 
cells. Subsequent z-stack images of cells were taken from the top to the 
bottom of the cells (left to right, continuously down each row of montage).  
Each z-stack image was taken at 0.25µm steps. MCF10A cells were cultured 
in ±EGF for 72 hours and immunostained with E-cadherin. Cells were fixed 
with 4% PFA and images were taken using confocal microscopy at 63x magni-
fication (zoom 2). Scale; 40µm.
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Figure 3.3. EGFR signalling suppresses interdigitation of MCF10A cells.  
Confluent monolayers of live cells on plastic dishes were imaged in growth 
medium with or without 20ng/ml EGF. More cells were seeded at 100,000-
150,000 cells/well of 6 well plate compared to Figure 3.1. Complete growth 
medium was exchanged for medium ±20ng/ml EGF six hours post seeding. 
After 72 hours, confluent monolayers were visualised using bright field micros-
copy at 20x magnification. Scale; 40µm.
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removal of cholera toxin together with EGF resulted in much fewer and shorter 
interdigitations. Using confocal microscopy, z-stack images of interdigitations were 
taken and assembled into a montage (Figure 3.2B). These images show that 
interdigitations are located near the top of cells at less than 3µm depth. Orthogonal 
sections of these images were not included as the cells were flat (up to 3µm in 
depth). Another independent clone of MCF10A parental cells (Clone 245) also 
showed interdigitations when cultured in medium lacking EGF (Figure 3.4).  
 
3.2.2 Morphological characterisation of MCF10A PIK3CA mutant cell clones 
When PIK3CA mutated clones were subjected to the same experimental 
procedures, the appearance of interdigitations in the -EGF condition was dependent 
on the clones (Figures 3.5, 3.6). Only the PI3K E545K (clone 10) showed 
interdigitations whereas PI3K H1047R (clone 23) exhibited mild interdigitations 
(Figure 3.5). H1047R clone 1 and clone 22 cells failed to interdigitate in the absence 
of EGF (Figures 3.5, 3.6). I observed two distinct populations of the H1047R (clone 
1) cells: cobblestone-like (E-cadherin stained) and mesenchyme-like (non E-
cadherin stained) (Figure 3.6).  
 
3.2.3 Optimisation of MCF10A cell lysis 
To obtain lysates of MCF10A cells for the initial biochemical analysis of EGFR 
status, I compared lysis buffers commonly used in this laboratory either with Triton 
X-100 or NP40 as detergent (Table 3.2). This was performed as initially I failed to 
harvest lysates that reproduced satisfactory signal strength when probed for EGFR. 
Cell lysates were probed for total EGFR and components of two downstream 
signalling signatures: pAKT and pERK. Actin was probed as loading control (Figure 
3.7). MCF10A parental cells were cultured in complete growth medium for 48 hours. 
Medium was then exchanged to complete growth medium or medium lacking FBS to 
serum starve the cells for 16 hours (Zhan et al., 2006). Growth medium ±EGF was 
exchanged to acutely stimulate cells for 10 minutes. The levels of proteins were 
compared to HeLa cell lysates obtained from a colleague, which had been serum 
starved overnight and acutely stimulated with 1ng/ml EGF for 5 minutes before lysis. 
Total EGFR levels were highest in MCF10A cells not acutely stimulated with EGF. 
The blots show a remarkably rapid reduction of EGFR within 10 minutes of 
stimulation although EGFR downregulation has been shown to take between 30 
minutes- 2 hours in other cells (Eden et al., 2009; Sorkin and Zastrow, 2002). The 
total EGFR reduction was similar to that observed in cells  cultured either with or 
without serum starvation for 65 hours (Figure 3.7 A, B). Duan et al. (2011) 
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Figure 3.4. Interdigitations observed in different clones of MCF10A paren-
tal cells. Cells were cultured in growth medium ±20ng/ml EGF for 68 hrs. Cov-
erslips were fixed with 4% PFA and stained with E-cadherin, F-actin and DAPI. 
Images of confluent areas were taken using immunofluorescence microscope 
at 40x magnification. Scale; 40µm. 
+E
G
F
E-cadherin Actin Merged
-E
G
F
+E
G
F
-E
G
F
M
C
F1
0A
 p
ar
- c
lo
ne
 B
H
P
M
C
F1
0A
 p
ar
- c
lo
ne
 2
45
79
M
C
F1
0A
P
ar
+EGF -EGF  
Figure 3.5. Variable E-cadherin staining and ability to form interdigitated 
structures in PIK3CA mutated MCF10A cells. MCF10A PI3K H1047R (clone 
23) and PI3K E545K (clone 10) showed characteristic cobblestones monolay-
ers in complete growth medium. Not all H1047R (clone 22) cells were 
E-cadherin stained. In medium lacking EGF, only E545K (clone 10) cells inter-
digitated. Cells were cultured in medium ±EGF for 47-68 hours. Coverslips 
were fixed with 4% PFA  and stained with E-cadherin. H1047R (clone 22) were 
grown in DMSO as control for another experiment. Areas of monolayers were 
visualised using immunofluorescence microscopy at 40x magnification. Scale; 
40µm.
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Figure 3.6. MCF10A PI3K H1047R (clone 1) cells of two distinct pheno-
types. MCF10A PI3K H1047R (clone 1) showed two populations of cells; 
fibroblast-like and cobblestones when cultured in growth medium ±EGF.  Cells 
were cultured in medium ±EGF for 69 hours. Coverslips were fixed with 4% 
PFA  and stained with E-cadherin (green) and F-actin (red). Cells were visual-
ised using (A) immunofluorescence or (B) bright field microscopy at 20x magni-
fication. Scale; 40µm.
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previously reported downregulation of EGFR with 100ng/ml EGF stimulation after 60 
minutes but they did not show levels of EGFR at 10 minutes. EGFR reduction may 
be due to effective downregulation via the endocytic pathway or a post-translational 
modification induced by EGF stimulation that masked the antibody recognition 
epitope.   
 
Most intense signals for EGFR, pERK and pAKT were obtained using NP40 lysis 
buffer 2 and TritonX lysis buffer 3 (Figure 3.7, Table 3.1). Levels of pAKT were 
slightly reduced after serum starvation but the band showed a slight upshift, 
characteristic of phosphorylation with the EGF stimulation seen using TritonX lysis 
buffer 1 and 3. In MCF10A cells, EGF stimulated the pERK pathway but its effect on 
pAKT was less clear as the different lysis buffers gave different results. 
Furthermore, the constant presence of insulin in the medium may explain the 
relatively high basal levels of pAKT observed. Henceforth, membranes show non-
serum starved MCF10A cells lysed with the TritonX lysis buffer 3 which provided 
intense signals for pERK and pAKT similar to EGF stimulated HeLa cells. 
 
I have also tested antibodies to probe for different phosphorylation sites on the 
EGFR comparing lysates of MCF10A parental and the constitutively activated 
EGFR∆E746-A750 cells (Figure 3.7). MCF10A cells cultured in medium with or 
without EGF for 65 hours were lysed without prior serum starvation. EGFR 
ubiquitylation acts as one of the internalisation signals upon EGF stimulation. This 
RTK is ubiquitylated by E3 ligase, Cbl after direct phosphorylation at Y1045 or 
indirectly via Grb2 adaptor proteins at phosphorylated Y1068 and Y1086 sites 
(Levkowitz et al., 1999; Motley et al., 2003; Roepstorff et al., 2008; Waterman et al., 
2002). Without EGF, the EGFR phosphorylation was reduced at pY1068 and 
pY1045 in MCF10A parental cells (Figure 3.7). Accordingly, these were 
accompanied by high expression of EGFR indicative of reduced degradation. In 
contrast, the signal for pY992 in the same milieu increased although this signal was 
very weak, evident from the high intensity scanned blot. This may reflect the higher 
levels of EGFR that remained under -EGF condition.  
 
Phosphorylation of EGFR at Y1045 of EGFR mutants was similar in ±EGF, although 
total EGFR reduced under +EGF condition. This indicates that EGFR activation is 
independent of EGFR expression levels. Direct binding of Cbl to the phosphorylated 
Y1045 site has been shown to be unnecessary for EGFR endocytosis while binding 
at Y1068 via Grb2 was needed for EGFR degradation (Grovdal et al., 2004; 
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Roepstorff et al., 2008). The slight 
increase of EGFR pY1068 in the 
absence of EGF suggest that the 
constant activation of EGFR in these 
cells may be conferred dominantly at 
this phospho-site that also mediates 
the EGF stimulated degradation. The 
negative control HeLa cells were not 
serum starved but acutely stimulated 
with 1ng/ml EGF (7 minutes). Total 
levels of EGFR remained high in 
these cells and  
pEGFR was only modestly increased 
compared to the MCF10A parental 
and EGFR  
mutant cells. Henceforth, pEGFR 
Y1068 and total EGFR (clone D38B1) 
antibodies have been used to probe 
subsequent membranes presented in 
this thesis.  
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2. Recipes of lysis buffers. 
3.2.4 EGFR associated signatures of MCF10A isogenic cells 
Next, I characterised the status of pEGFR and the associated effectors in the 
MCF10A parental and the isogenic cell panel: EGFR∆E746-A750, PI3K H1047R 
clone 1, clone 22, clone 23 and PI3K E545K cells. Initially, only 8µg of samples 
Lysis Buffer 1 
(0.1% TritonX lysis buffer) 
[Final] 
Tris pH 7.2 
 
10mM 
NaCl 
 
158mM 
EDTA 
 
1mM 
Triton X-100 
 
0.1% 
MPI Sigma  
 
1:250 
Phosphatase Cocktail inhibitor II  
 
1:100 
Lysis Buffer 2 
(NP40 lysis buffer) 
 
Tris pH 7.5 
 
25 mM 
NaCl 
 
100mM 
NaF 
 
50mM 
NP40 
 
0.5% 
MPI Sigma  
 
1:250 
Phosphatase Cocktail inhibitor II  
 
1:100 
Lysis Buffer 3 
(1% TritonX lysis buffer) 
 
Tris-HCL pH 7.5 
 
10mM 
NaCl 
 
150mM 
TritonX-100 
 
1% 
w/v SDS 
 
0.1% 
Sodium deoxycholate 
 
1% 
NaF 
 
50mM 
MPI Sigma  
 
1:250 
Phosphatase Cocktail inhibitor II  
 
1:100 
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Lysis Buffer
Figure 3.7. Optimisation of lysis buffers and EGFR antibodies for 
MCF10A cell lysates. (A) MCF10A cells were cultured in complete growth 
medium with EGF (48 hours) and medium was exchanged to medium ±FBS 
(16 hours). Second medium exchange to medium +EGF with FBS was to 
stimulate cells with EGF  (10 minutes). Lysates were lysed separately with 3 
different lysis buffers as detailed in Table 3.1. Positive control, HeLa cell lysates 
were acutely stimulated with 1ng/ml EGF (5 minutes) after overnight FBS star-
vation. (B) Phospho and total EGFR antibodies were tested on MCF10A cells 
cultured in complete growth medium for 65 hours without prior serum starve. 
HeLa cells were stimulated with 1ng/ml EGF (5 minutes) before lysis and did 
not undergo overnight serum starvation. 12.5µg of MCF10A cell lysates were 
loaded onto each lane. 
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were loaded into each lane. Levels of pEGFR Y1068 in -EGF condition were similar 
to +EGF control in MCF10A parental cells. This could be accounted for by the 
increased EGFR expression that may have masked the slight decrease of pY1068 
(Figure 3.8). The isogenic PI3K H1047R (clone 1) cells show reduced pY1068 and 
increased total EGFR in -EGF condition as previously seen with MCF10A parental 
cells (Figure 3.7, 3.8). The levels of EGFR remained similar across the MCF10A cell 
panel. Lysates for the EGFR mutant cells were re-loaded as a technical repeat, 
confirming previous results (Figure 3.7, 3.8).  
 
A biological repeat compared the EGFR profiles of different clones of MCF10A 
parental and PIK3CA mutants; H1047R and E545K cells at a higher concentration 
of lysates, 12.5µg (Figure 3.9). In +EGF culture, pEGFRY1068, pERK and pAKT 
signals were increased in comparison to –EGF (Figure 3.9). The accompanying total 
EGFR expression levels were reduced reflecting phospho-mediated degradation of 
EGFR. Total levels of ERK and AKT remained constant regardless of EGF 
stimulation, indicative of their protein half-lives that have been reported to be over 
27 hours (Schwanhaeusser et al., 2011). In general, the EGFR associated 
signatures showed similar trends across the MCF10A isogenic cells. The PIK3CA 
mutants with constitutively active PI3K; H1047R and E545K cells, showed increased 
activation of pAKT both in ±EGF conditions when compared to the parental cells.  
 
As seen in the graphs (Figure 3.8, 3.9) the phospho-EGFR in MCF10A isogenic 
cells show similar activity in basal ±EGF conditions. An exception is the EGFR 
∆E746-A750 mutant cells that have a higher basal pEGFR Y1068 signal due to the 
presence of constitutively active EGFR. Although pEGFR signal in these cells was 
reduced in –EGF, this remained higher than that seen in parental and H1047R cells 
(Figure 3.8). Incidentally, the EGFR mutant cells did not form digits when cultured in 
the absence of EGF (Figure 3.2). The PIK3CA mutants H1047R and E545K 
revealed differential abilities to form digits when cultured in –EGF despite showing 
similar phospho-EGFR fluctuations in ±EGF culture conditions (Figure 3.5, 3.9). This 
suggests that the different oncogenic potency of the PIK3CA mutations may 
contribute to the ability of cells to form digits. With E545K cells reported as less 
potent in inducing tumour in mouse xenograft models, these cells are likened to less 
malignant cells and thus may have retained the ability to form digits compared to 
their H1047R counterparts (Isakoff et al., 2005). Concordance of EGFR and Rac-
GTPase expression levels was good across the isogenic platform despite slight 
differences in overall protein concentrations due to inter-experimental variations. 
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Figure 3.8. EGFR profile of MCF10A parental, PI3K H1047R and EGFR 
∆E746-750 mutants. (A) MCF10A cells were cultured in complete growth 
medium ±EGF for 65-68.5 hrs. PI3K H1047R lysates duplicate lanes were 
technical repeats from the same experiment. EGFR∆E746-A750 lysates 
loaded were technical repeats of Figure 3.7B. 8µg of MCF10A cell lysates 
were loaded onto each lane. (B) The intensity of the bands quantified with the 
Odyssey software for pEGFR Y1068 were normalised to the total EGFR levels 
of each lane.
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Figure 3.9. EGFR associated profiles of MCF10A parental, PI3K H1047R 
and E545K mutants of different clones. (A) Duplicate lanes were biological 
repeats of the same cells. MCF10A cells were cultured in complete growth 
medium ±EGF for 65-72hrs. 12.5µg of MCF10A cell lysates were loaded onto 
each lane. (B) The intensity of the bands quantified with the Odyssey software 
for pEGFR Y1068 were normalised to the total EGFR levels of each lane.c, 
clone; par, parental.
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This indicates that the gain-of-function mutations of the isogenic cells do not affect 
EGFR and Rac expression levels.  
 
3.3 Three-dimensional characterisation of MCF10A cells 
3.3.1 Morphological characterisation of MCF10A cell acini in 3D culture 
MCF10A cells form acinar structures with a hollowed lumen when grown in 3D 
culture for at least 14 days (Debnath et al., 2003). Bright field microscopy images 
were used to visualise the general morphology and to quantify the cross sectional 
surface area (CSA) of the spheroids (Figure 3.10). Using confocal IF microscopy, 
Golgi apparatus (GM130), actin-membrane linker (p-ERM) and nuclear (DAPI) 
stains were used to visually dissect the acini in 3D culture (Figure 3.10). This 
experiment was done in parallel with a colleague, Rebecca Eccles to establish the 
3D morphology of these cells in the laboratory. Using bright field microscopy, the 
structure of MCF10A parental, PTEN WT, PTEN null acini showed similar 
spheroidal architecture and size (Figure 3.10). H1047R (clone 1) cells showed two 
populations of irregularly shaped acini: very large and very small in size. These cells 
were paired with the MCF10A parental cells as control. Similar homologously 
recombined WT control cells for this mutation were not available at the time of 
experiment.  
 
GM130 marks the cis-Golgi of cells which polarise towards the lumens of the 
MCF10A spheroids. pERM was used to mark the cell boundaries within the acini 
(Debnath et al., 2003; Debnath et al., 2005). On day 14, IF images of MCF10A 
parental acini showed organised cells in the outer layer. Lumens of acini were 
evident by the lack of DAPI stain. In contrast, the very large representative H1047R 
acinus was irregularly shaped, had an apically orientated Golgi apparatus and no 
visible lumen (Figure 3.10). The very small acinus consisted of tight clumps of cells. 
This correlated with the 2D microscopy results where two distinct populations of 
H1047R (clone 1) cells were previously seen (Figure 3.6). PTEN WT spheroids 
showed a thicker outer layer of cells with an organised GM130 stain. PTEN null 
acini had the thicker outer layer and the Golgi apparatus were disorganised. The 
lumens were also less evident compared to PTEN WT acini. 
 
3.3.2 Cross-sectional surface area (CSA) distribution of MCF10A isogenic 
acini 
The bright field images of MCF10A isogenic acini were analysed using Image J 
software. The outline of each spheroid was individually traced electronically and the 
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Parental PI3K H1047R (clone 1)
PTEN WT PTEN null
Figure 3.10. MCF10A spheroidal acinar structures. (A) Representative 
images of the MCF10A acinar structures in 3D culture. PI3K H1047R (clone 1) 
cells show distinct populations with very large and very small acini (second 
from left). PTEN null acini were larger than PTEN WT acini. (B) Parental and 
PTEN WT acinis show apical orientated cis-Golgi apparatus (red) and organ-
ised actin linker (green). Lumens of acini were hollowing out as seen from 
DAPI stains (blue). PI3K H1047R (clone 1) show distinct populations of con-
trasting sizes as seen in (A). Representative spheroids were visualised on day 
14 using (A) bright field microscopy at 10x magnification, scale; 75µm.  (B) 
Coverslips were fixed with 2% PFA  and stained with p-ERM (green), GM130 
(red) and DAPI (blue). Stained spheroids were visualised using confocal immu-
nofluorescence microscopy at 63x magnification, different zooms. Scale; 
40µm.
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Figure 3.11. Similar cross sectional area distributions of MCF10A paren-
tal and PI3K H1047R acini. Areas of acini were measured and compared on 
day 14 and day 22 using 10x bright field microscopy images and Image J. A 
total of 99-198 acini were counted for each cell type. 
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Figure 3.12. Cross sectional areas of MCF10A PTEN WT and PTEN null 
acini show similar distribution. Cross sectional areas of acini were mea-
sured and compared on day 14 and day 22 using 10x bright field microscopy 
images and Image J. A total of 144-220 acini were counted for each cell type. 
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CSA of each was translated from pixels to µm2. The MCF10A parental line showed 
a normal distribution with the majority of acini around 3000µm2- 5000µm2 when 
measured on day 14 and day 22 (Figure 3.11). The distinct populations of the 
isogenic PI3K H1047R (clone 1) acini varied in CSA from ≤1000µm2 (59-63%) and 
up to 50,000µm2 (37-51%). CSA quantitation of the MCF10A parental and H1047R 
(clone 1) acini revealed no obvious change in trend when left in culture for either 14 
or 22 days (Figure 3.11). 
 
The MCF10A PTEN null (-/-) acini, which were paired with the PTEN WT control 
acini showed similar spheroidal morphology albeit with less lumen clearance (Figure 
3.10). The overall CSA of PTEN WT speroids on day 14 and day 22 were 
comparable to that of MCF10A parentals (Figure 3.11, 3.12). Importantly, the 
majority of PTEN null acini were on average 28% and 44% larger in CSA compared 
to most PTEN WT acini controls on day 14 and 22.  
 
3.3.3 Effect of culture duration on the size distribution of MCF10A acini 
More than 90% of PTEN null mutant spheroids showed a CSA of ≥4000µm2 
compared to 43% of PTEN WT on day 14. On day 22, the majority of PTEN null 
spheroids were larger than 6000µm2 in CSA whilst PTEN WT spheroid were 
predominantly at 2000 µm2-6000µm2. Overall the MCF10A parental and PTEN WT 
spheroids showed comparable distributions of CSA on day 14 and day 22 (3000- 
6000µm2). The CSA distributions have also been compared to the biological repeat 
carried out separately by a colleague, Rebecca Eccles, which showed similar trends 
(not shown). 
 
3.3.4 MCF10A parental spheroids cultured ±EGF 
Previously in 2D culture, interdigitations between neighbouring cells were visible in a 
confluent monolayer. I have preliminarily tested the prevalence of this phenomenon  
in the 3D context. Spheroids were left to grow in complete growth medium for 4 
days before medium was exchanged to medium ±EGF (Figure 3.13). The majority of 
the spheroids in complete growth medium observed on day 8 and day 14 were 
qualitatively larger (Figure 3.13). Lumens were surrounded by an organised outer 
layer stained positive with E-cadherin and pERM. Despite being in complete growth 
medium for 4 days initially, most spheroids subsequently cultured in -EGF medium 
remained undeveloped when compared to the +EGF controls. The majority of the 
cells within the –EGF spheroids also appeared with less lumenal clearance on day 
14. According to the manufacturer’s datasheet, traces of EGF (<0.5ng/ml) remain in 
92
+EGF
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Figure 3.13. EGFR signalling  retards  growth of MCF10A acini. MCF10A parental acini were 
cultured in complete growth medium until day 4. Medium was exchanged on day 4 to medium with  or 
without 5ng/ml EGF (HS). Medium was refed every 4 days. Spheroids were fixed with 2% PFA and 
permeabilised on days indicated. Acini were co-stained with E-cadherin (green), pERM (red) and DAPI 
(blue). Images were visualised using spinning disk confocal immunofluorescence microscopy at 63x 
magnification.  Scale; 40µm. HS, horse serum assay medium. Medium recipes are listed in Methods: 
Table 2.7.
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the Matrigel although acini were cultured without EGF. This may have been 
sufficient to suppress formation of interdigitations in the 3D environment. 
 
3.4 Discussion 
Main chapter findings 
• EGF suppresses the formation of interdigitations in MCF10A cells in 2D culture. 
• This phenotype is recapitulated in another clone of MCF10A parental cells and 
MCF10A PI3K E545K mutant isogenic cells. 
• Interdigitations are visibly stained using E-cadherin in confluent monolayers, 
near the top of cells (less than 3µm depth of cells). 
 
3.4.1 Two-dimensional characterisation of MCF10A cells 
The removal of EGF but not insulin in confluent monolayers allowed the formation of 
interdigitations in MCF10A cells. This suggests that EGF suppresses the process of 
interdigitation. Most common signalling pathways associated with EGFR activation 
include the PI3K and the MAPK pathways which are differentially activated by both 
insulin and EGF (Borisov et al., 2009). Based on computational modelling, insulin 
and EGF signaling have been proposed to converge upstream of Ras, at the level of 
adaptor protein, Gab1 (Borisov et al 2009). One may deduce that regulators of the 
interdigitated phenotypes may lie above this postulated convergence point of the 
PI3K and MAPK signalling levels due to the inability of insulin removal to 
recapitulate this process. Interestingly, EGF treatment has been shown to inhibit 
mammary duct formation in vivo in pre-pubertal mouse (Coleman and Daniel, 1990). 
Unlike the MCF10A cells, the addition of EGF also reduced the proliferative abilities 
of the ductal epithelial cells. The authors suggested that the preference for EGF at 
different stages of mammary development varied and is tightly regulated in vivo, 
overlapping with the need for different hormones. Henceforth, further experiments 
were undertaken in complete growth medium with EGF as the only unique variable 
tested for its role in the further characterisation of interdigitation in MCF10A parental 
cells.  
 
Since the first characterisation of MCF10A cells in laboratory culture, many groups 
have assessed the relevance of culture medium components to the growth and 
proliferation (Ethier et al., 1993; Park et al., 2004; Soule et al., 1990). Consistently in 
serum free conditions, EGF, hydrocortisone and insulin provide the strongest stimuli 
for proliferation of non-tumorigenic human mammary epithelial cells in monolayer 
culture (McGrath and Soule, 1983; Park et al., 2004). In my hands, EGF removal did 
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slow the growth of subconfluent MCF10A cells in culture. Subconfluent MCF10A 
cells changed morphology adversely when hydrocortisone was removed from 
medium. Additionally, insulin and cholera toxin have been shown to promote 
differentiation into luminal human mammary epithelial cells on collagen (Ethier et al., 
1993). However, cell differentiation remains outside the scope of this thesis.  
 
Cholera toxin raises intracellular cyclic AMP (cAMP) concentrations to positively 
regulate the polarisation of outer cells and lumen clearance of MCF10A cells in 3D 
culture (Nedvetsky et al., 2012). Without cholera toxin, the subconfluent EGFR 
mutant cells exhibited a very mesenchyme-like phenotype compared to control. 
Presumably, the subconfluent culture of EGFR ∆E746-A750 allowed the cells to 
exhibit mesenchyme-like characteristic that resembles the epithelial-to-
mesenchymal (EMT) phenotype as the cells were not yet contact inhibited. In the 
presence of an EGFR activating mutation, cholera toxin appears to suppress EMT. 
EMT has been linked to increased risk of resistance to small molecule tyrosine 
kinase inhibitors of the EGFR, gefitinib and erlotinib in lung cancer cells that 
harbours the EGFR∆E746-A750 mutation (Suda et al., 2011). In contrast to my 
observations, inhibition of the PKA activity downstream of cAMP signalling pathway 
suppressed EMT in human lung adenocarcinoma A549 cells (Shaikh et al., 2010). 
 
In confluent monolayers, MCF10A parental and EGFR mutant cells remained 
cobblestone-like. Cholera toxin appears to mildly suppress EGF action as the 
combinatorial removal of EGF and cholera toxin presented a mild interdigitated 
phenotype. This reflects the tight regulation of cell morphology by different 
supplements in different spatial context. The role of cholera toxin and the 
downstream cAMP pathways in the plasticity of EGFR mutant cells although 
interesting, was not pursued further. Cholera toxin was kept in the medium to 
maintain a standard growth medium for both culture and experiments using the 
MCF10A isogenic cells.  
 
Morphological characterisation of MCF10A PIK3CA mutant cell clones 
The PIK3CA gain-of-function ‘hotspots’ at H1047R (kinase domain) and E545K 
(helical domain) result in constitutively active enzymes with differential oncogenic 
potential (Isakoff et al., 2005; Meyer et al., 2013). The latter has been reported to be 
less potent in inducing heterogenous mammary tumour in mouse xenograft models 
which sustained a longer tumour latency period. Accordingly, the E545K mutation is 
seen in only ~5% of human breast cancers compared to the more frequent H1047R 
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at ~15% (Meyer et al., 2013). Under control +EGF conditions, different clones of 
H1047R and E545K cells show characteristic cobblestone monolayers. Control 
treated WT cells for this mutant were not available. The recommended medium for 
the PIK3CA mutants (H1047R clone 1 and clone 23) is without EGF. However, in 
my hands, the PIK3CA clones exhibited varied phenotypes when cultured ±EGF. 
The H1047R clone 1, clone 22 and clone 23 did not interdigitate in -EGF. The 
E545K clone 10 showed interdigitations comparable to the MCF10A parental cells. 
The less-tumour inductive potency of the E545K mutation in MCF10A cells may 
have sustained the non-malignant ability to interdigitate in the absence of EGF 
better than the more oncogenic H1047R mutated cells. This would suggest that the 
ability to interdigitate in confluent monolayers remains within the remit of non 
malignant mammary epithelial cells. The increase in pAKT witnessed across the 
PIK3CA isogenic MCF10A cells remained independent of the levels of AKT, which is 
consistent with reports by other groups  (Wallin et al., 2012; Isakoff et al 2005).  
 
3.4.2 Three-dimensional characterisation of MCF10A cells 
Subsequently, the PIK3CA H1047R (clone 1) and PTEN null mutants were cultured 
in the 3D Matrigel assay. The phosphatase and tensin homolog (PTEN), a tumour 
suppressor antagonises PI3K-AKT signalling by dephosphorylation of 
phosphatidylinositol 3,4,5-triphosphate (PIP3) to phosphatidylinositol 4,5-
biphosphate (PIP2), the secondary messenger that is generated by PI3K (Leslie and 
Brunton, 2013; Wallin et al., 2012). Presumably, the PIK3CA H1047R and PTEN 
null acini may show similar morphologies in a 3D Matrigel assay. The MCF10A PI3K 
H1047R and PTEN null acini lacked lumen clearance when compared to the 
parental and PTEN WT spheroids. Other studies of similar MCF10A H1047R cells 
by Genentech Inc. and Horizon Discovery Ltd. show that these cells in short term (1-
2 days) Matrigel culture grew into ‘highly elongated network of branches’ suggestive 
of an invasive phenotype while PTEN null cells displayed minimally invasive 
behaviour (Wallin et al., 2012, Rigby et al., 2010 [poster]). This would support the 
subtler phenotype of the PTEN null acini when compared to the PI3K H1047R 
spheroids. In prolonged 3D culture, I saw two distinct populations of irregularly 
shaped PI3K H1047R (clone 1) acinar structures that were either very large or very 
small. This may correspond to the mixed epithelial and mesenchymal phenotype 
seen in 2D culture. Brugge’s team reported that stably transfected MCF10A PIK3CA 
(H1047R and E545K) mutant cells have abnormally proliferative acini that did not 
invade surrounding Matrigel basement membrane but grew in soft agar indicating 
transformation. They proposed that this is synonymous to pre-malignant, non-
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invasive mammary tumour growth (Isakoff et al., 2005). The loss of PTEN in PTEN 
null cells may have contributed to the enhanced survival of cells within the acinar 
lumen due to the constant activation of the AKT pathway (Vitolo et al., 2009).  
Notably, in my hands, most acini did not exhibit complete lumen clearance on day 
14. The low concentration of Matrigel used (8.9mg/ml) may have delayed this 
process. I also did not discriminate between acini that were embedded either fully or 
overlaying the surface of Matrigel. Overlaying acini may stain with fluorescent-
conjugated antibody more efficiently but may have developed quicker, limiting the 
cells’ ability to form a hollow lumen (Debnath et al., 2003). Due to time limitation, I 
did not characterise the EGFR signalling profiles within the 3D acini. The 
comparable CSA distribution of MCF10A parental, PTEN WT and PTEN null acini 
would allow subsequent experiments to be ended on day 14 to simplify the 
experimental protocol. However, if changes in CSA of the PTEN null acini are 
relevant outputs, the experiment may have to be extended to allow PTEN null cells 
to continue growing to show a more noticeable difference in CSA when compared to 
PTEN WT.  
 
The majority of MCF10A acini in prolonged culture without EGF were similar in size 
to the day 4 controls indicative of the lack of growth. Previously sialodectomised 
(removal of submandibular gland) pregnant mice have reduced the size and weight 
mammary gland that was reversed by EGF treatment (Okamoto and Oka, 1984). 
Indirectly, this infers that EGF can positively regulate the size and weight of 
mammary glands in vivo. The size and weight gain of the mammary gland may be 
due to EGF-stimulated ductal growth as seen in ovariectomised pubertal mice 
(Coleman et al., 1988). Technically, reduced growth factor Matrigel was used but 
residual EGF (<0.5ng/ml) listed in the manufacturer’s datasheet may have continued 
to suppress interdigitation in MCF10A cells even when cultured without EGF in the 
assay medium. This level of EGF is within the range found in human plasma at 0.2-
0.8 ng/ml (Hayashi and Sakamoto, 1987). The lack of lumen clearance in the -EGF 
MCF10A acini may indicate lack of cell polarisation and acini maturation. MCF10A 
cells incubated in medium lacking EGF in collagen cultures form horizontally spread 
cell sheets forming ‘duct-like’ structures as opposed to single cell clumps of control 
+EGF cells (Soule et al., 1990). Inversely, EGF treatment reduced the number of 
ducts per mammary gland in the highly proliferative glands of pubertal mice 
(Coleman and Daniel, 1990). These studies may highlight the role of EGF in 
suppressing the formation of ductal structures in collagen cultures and in vivo. 
Rationally, the MCF10A acini seen in Matrigel culture may not be the most optimal 
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assay to visualise the formation of mammary ducts. Further investigation of the 
interdigitated sheets of MCF10A cells in -EGF should be undertaken in more 
appropriate cultures such as the collagen cultures as published by Soule et al. 
(1990).  
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4.1 Introduction 
To further characterise the interdigitated phenotype previously described in 2D 
culture, I continue to optimise experimental protocols to induce the formation of 
interdigitations in MCF10A cells. Building on the knowledge that EGF suppresses 
interdigitations, the localisation of the EGF receptors was investigated in cells 
cultured with and without EGF. Further mechanism-related questions explored 
include:  
i) How long does it take to form interdigitations in a monolayer? 
ii) Which EGFR associated signalling cascades are involved? 
iii) Is the process of interdigitation reversible? 
iv) If so, which EGFR associated signals are involved in the reversible process? 
Small molecule inhibitors were used to inhibit canonical downstream integrators of 
the EGFR signals to delineate mechanisms involved in the formation and reversal of 
digits. Biochemical readouts of phosphorylated and total proteins were coupled with 
immunofluorescent outputs to establish a link between the interdigitated phenotype 
and the different signalling cascades. 
 
Previously, the formation of interdigitations required the cells to be cultured without 
EGF. One would expect that exchange to medium without EGF would fail to resolve 
digits of the confluent cells. Surprisingly, subsequent optimisation experiments led to 
the discovery that complete growth medium lacking EGF transiently reversed the 
interdigitations. This was investigated further by forming two separate hypotheses: i) 
Do the MCF10A cells secrete an autocrine factor that stabilises/ favours 
interdigitations? ii) Is there an exhaustible factor in FBS that transiently substitutes 
for EGF to resolve the interdigitations? These questions were tested in the reversal 
of interdigitation ±FBS and also by the use of conditioned medium.  
 
It is also possible that the reversal of interdigitations could be due to the presence of 
another factor in the FBS that may have overlapping effectors as the EGF. The 
EGFR can be activated by different ligands containing the EGF motif which includes 
EGF, transforming growth factor-α (TGFα), heparin-binding EGF-like growth factor 
(HB-EGF), betacellulin (BTC), amphiregulin (AREG), epiregulin (EREG), epigen 
(EPGN) and neuregulins (Schneider and Wolf, 2011). The ligands are differentially 
expressed depending on tissue type (Yarden and Sliwkowski, 2001).	  EGFR can also 
be transactivated by other signalling receptors such as Met receptor and insulin 
receptor both activated by non-ErbB family ligands, hepatocyte growth factor (HGF) 
and insulin to activate the PI3K-pAKT cascades downstream of EGFR (Borisov et 
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al., 2009; Boyer, 2008; Hammond et al., 2010; Zielinski et al., 2009). Therefore, I 
investigated if the reversal of interdigitations is specific to EGF or if it may be 
substituted by other EGF-like ligands that allow EGFR transactivation to relay 
overlapping downstream signalling. 
  
I have investigated if this phenomenon is applicable to other mammary epithelial 
cells. Breast cancer cells such as MCF7 maintain smooth boundaries between 
neighbouring cells and do not require EGF in the culture medium. Another non-
malignant mammary epithelial cell line, HMT3522 S1 was reported to form finger-
like interdigitations when cultured without EGF but had not been characterised 
further (Holm et al., 1993). Like MCF10A cells, they also require the presence of 
EGF in a complex cocktail of medium. Subsequently, I cultured and recapitulated 
this dynamic phenotype in these cells. 
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Results 
 
4.2 Formation of interdigitations in MCF10A cells 
4.2.1 EGFR distribution along interdigitations 
E-cadherin used as a plasma membrane marker illustrates the smooth boundaries 
between neighbouring cells within a monolayer cultured in routine growth medium. 
When EGF was removed, MCF10A cells continued to grow into monolayers but 
developed ‘finger-like’ protrusions between cells. EGFR is a transmembrane protein 
that is internalised into endosomal vesicles upon EGF stimulation (Roepstorff et al., 
2008). The EGFRs in control MCF10A (+EGF) cells were internalised. This is 
consistent with the findings of Duan et al. (2011) who reported EGFR internalisation 
in MCF10A cells acutely stimulated with EGF. In contrast, EGFRs remained on the 
membranes in -EGF condition and showed similar staining pattern to E-cadherin, 
along the folds of the interdigitations (Figure 4.1). Duan et al. (2011) did not record 
an interdigitated phenotype in their experiments most likely because their 
observations were limited to subconfluent cells grouped in small islands. Instead 
they reported that EGFR activation stimulated downstream actin regulators to 
remodel adherens junctions. Their observation supports the earlier phase contrast 
results of MCF10A cells in subconfluent culture that did not display the interdigitated 
phenotype (Figure 3.1). 
  
4.2.2 Timecourse of formation of interdigitations 
Initially I seeded 100,000–150,000 cells per well of a 6 well plate and left the 
MCF10A cells to proliferate in complete growth medium for 72 hours. Figure 4.1 
shows that interdigitations formed under -EGF condition. To determine the minimal 
time needed for the cells to form digits within the monolayer, I designed separate 
experimental configurations by asking: i) how long does it take for cells to 
interdigitate when seeded from a fully dissociated state at low density? ii) Can 
interdigitations be induced after cells have achieved confluent monolayers? In 
growth medium lacking EGF, the prominence of E-cadherin stained interdigitations 
increased from 38-70 hours, when cells were seeded from subconfluence and left to 
grow into a confluent monolayer (Figure 4.2). Control (+EGF) cells appeared smaller 
as the cells proliferated to become more crowded in the monolayer. Next, to 
circumvent the time needed for cells to proliferate and form a monolayer, 
interdigitations were induced by exchanging the medium after the MCF10A cells 
were confluent. With this experimental configuration, it took less than 22 hours to 
induce the interdigitations (Figure 4.2). Using time-lapse microscopy, this time frame 
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Figure 4.1. EGF Receptor, E-cadherin and actin stains along interdigi-
tated monolayers of MCF10A cells. Complete growth medium was 
exchanged to medium ±20ng/ml EGF six hours post seeding. After 72 hours, 
cells were fixed with 4% PFA and stained for (A) E-cadherin (green), (B) EGFR 
(green) and F-actin (red). EGFR remained along the interdigitations when 
cultured in growth medium without EGF. Cells were visualised using confocal 
microscopy at 63x magnification (zoom 1.5 and 1.9). Scale; 40µm.
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Figure 4.2. Timecourse for the formation of interdigitations. (A)The promi-
nence of E-cadherin stained interdigitations on the membrane of MCF10A 
parental cells gradually increased from 38-70 hours after medium exchange 
when seeded from subconfluence. Medium lacking EGF was replaced for com-
plete growth medium, 5 hours post seeding. (B) Interdigitations were induced 
in confluent MCF10A monolayers within 22 hours. Cells were cultured to con-
fluence in complete growth medium (67 hours) before EGF was removed by 
medium exchange (22 hours). Coverslips were fixed with 4% PFA  and stained 
with E-cadherin. Cells were visualised using immunofluorescence microscopy 
at 40x magnification. Scale; 40µm.
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was narrowed down to between 12-17 hours after medium exchange to remove 
EGF (Movie 4.1). It was also apparent that the cells became relatively immobile 
within a monolayer after interdigitations have been induced (Movie 4.1). 
 
4.2.3 The EGFR inhibitor, Gefitinib phenocopies the induction of 
interdigitations in the presence of EGF 
Next I tested if EGFR inhibition would recapitulate this phenotype. Previously, 
cultures of MCF10A cells with constitutively active EGFR (EGFR∆E746-A750) 
suppressed interdigitation in medium without EGF (Figure 3.2). Gefitinib inhibits 
EGFR by competitively binding to the ATP binding pocket of the kinase domain 
(Jain el al., 2005). Cells treated with Gefitinib recapitulated the formation of 
interdigitations (Figure 4.3) when cultured for 48 hours in complete growth medium 
(+EGF). However, using Gefitinib, confluent cells needed between 24-48 hours to 
form interdigitations in a monolayer. This was longer than required following the 
removal of EGF (12-17 hours). Subsequently, I asked if Gefitinib decayed in 
prolonged culture of up to 48 hours (Figure 4.3). When Gefitinib was only added 
once on seeding day (*) the levels of pEGFR Y1068, pAKT and pERK increased in 
+EGF condition in contrast to reduced expression when Gefitinib was added daily. 
When Gefitinib was added daily, the pEGFR Y1068 and p44 of pERK levels were 
reduced but remained higher than basal levels without EGF stimulation. The 
reduction of pY1068, pERK and pAKT by Gefitinib treatment was not absolute. Jain 
et al. (2005) found that Gefitinib treatment only reduced but did not inhibit tumour 
volume of prostate cancer xenograft in mice as the inhibitor binds only at a few key 
phosphorylation sites such as Y845 on the kinase domain of EGFR. They attributed 
the continued tumour growth to EGFR signals propagated via other tyrosine sites as 
EGFR can be phosphorylated at alternative tyrosine sites such as pY1068 (Guo et 
al., 2003; Jain et al., 2005). The residues of phosphorylated EGFR (Y1068), AKT 
and ERK seen in MCF10A cells treated with Gefitinib agree with this view (Figure 
4.3). 
 
The levels of pAKT were slightly reduced but remained fairly constant when cultured 
without EGF for 48 hours (Figure 4.3). In line with previous observations by Boyer, 
(2008), ERK and AKT levels remained constant, fitting with their extended half-lives 
of over 27 hours (Schwanhaeusser et al., 2011). As expected, the presence of EGF 
that stimulated phosphorylation of EGFR at Y1068 and reduced total levels of 
EGFR. 
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4.2.4 Effect of EGFR associated signalling pathway inhibitors in the induction 
of interdigitations 
Small molecule inhibitors were used to inhibit canonical signalling pathways 
downstream of EGFR, orchestrated by PI3K and MEK. Pan class 1A PI3K inhibitor, 
PI103 and MEK inhibitor, AZD6244 were applied to confluent MCF10A monolayers 
to suppress these pathways for 6 and 24 hours. IF images show that the application 
of these inhibitors for 24 hours failed to induce interdigitation  (Figure 4.4). Gefitinib 
only induced mild interdigitations in 24 hours as compared to the prominent digits 
seen in 48 hours (Figure 4.3, 4.4). Control cells demonstrated obvious 
interdigitations 24 hours after EGF was removed from the confluent monolayer as 
expected. The downstream effector pAKT was not reduced by PI103 in the 
presence of EGF. Basal pAKT levels remained similar regardless of EGF when 
cultured for 24 hours as seen previously (Figure 4.4, 4.5).  
 
AZD6244 is a MEK1/2 kinase inhibitor that selectively inactivates ERK1/2 
phosphorylation in sensitive cancer cell lines, HCT116, SW620 (colon cancers) and  
WM793 (melanoma) (Yang et al., 2010). In my hands, AZD6244 abrogated pEGFR 
and pERK levels better than Gefitinib at both timepoints (Figure 4.4). The reduction 
in pEGFR levels was surprising as this inhibitor functions to block downstream 
MEK1/2 at a unique pocket structure adjacent to the ATP binding site (Zhao et al., 
2014). At the time of writing, AZD6244 is still being evaluated in phase II clinical trial 
as adjuvant to Erlotinib, an EGFR inhibitor used in KRAS mutated non-small cell 
lung (NSCLC) cancer patients to mitigate resistance mechanisms (Zhao et al., 
2014). Previous experiments using Her2 and EGFR driven cancer cells, BT474 and 
HCC827 reported that the reduction of pERK signalling by AZD6244 treatment was 
compensated by the increase in phosphorylation of ErbB3 to stimulate the pro-
survival pAKT pathway (Turke et al., 2012). Such response illustrates the ability of 
tumorigenic cells to resist small molecule inhibition that remains a caveat to 
personalised medicine. To my knowledge, such experiments have not been 
conducted in non-malignant cells lacking hyper-activated EGFR. It appears that in 
non-malignant MCF10A cells, pEGFR at Y1068 is also reduced, and cells 
proliferated less. This could represent inhibition of a positive feedback loop on the 
EGFR by the MAPK, in contrast to the situation described for BRAF inhibitors in 
colon cancer cells (Prahallad et al., 2012). In my hands, pAKT expression remains 
unchanged, which speaks against the same positive feedback seen in Her2 and 
EGFR driven cancers.   
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Figure 4.3. Gefitinib induces interdigitations in the presence of EGF.  (A) 
Cells were treated with Gefitinib (300nM) from seeding and were fixed 48 
hours after medium exchange. Cells stained with E-cadherin were visualised 
using immunofluorescence microscopy at 20x magnification. Scale; 40µm. 
(B) Duplicate lanes of parental cells clone BHP were biological repeats. Cells 
were cultured in complete growth medium ±EGF for 46.5-49.5 hrs. EGF refers 
to the presence of EGF in growth medium. Gefitinib was added on seeding day 
only (*) or daily until lysis. 10µg of MCF10A cell lysates were loaded onto each 
lane. Expt, experiments repeated.
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Figure 4.4. Formation of digits independent of short-term inhibition of 
EGFR and canonical downstream targets. MCF10A cells were cultured in 
complete growth medium (+EGF) for 47 hours after seeding. Medium was then 
exchanged to include either Gefitinib (300nM, EGFR inhibitor), PI103 (100nM, 
PI3K inhibitor) or AZD6244 (300nM, MEK inhibitor) for 6 or 24 hours. (A) Cov-
erslips were fixed with 4% PFA and stained with E-cadherin. Cells were visual-
ised using immunofluorescence microscopy at 40x magnification. Scale; 
40µm. (B) 10µg of MCF10A cell lysates were loaded onto each lane. 
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On glass coverslips, AZD6244 treated cells failed to form a coherent monolayer and 
the larger cells observed indicated lower confluence. Only mild interdigitations were 
observed. Clearly, 24 hours was not sufficient to induce interdigitated monolayers of 
MCF10A cells using Gefitinib, PI103 and AZD6244.  
 
An alternative PI3K inhibitor, LY294002 was compared to PI103. There was a 
slightly better reduction in pAKT levels at 4 hours in the presence of EGF compared 
to PI103 treatment (Figure 4.5). In ZR-75-1 breast cancer cells, LY294002 
suppressed pAKT transiently but levels recovered within 24 hours although growth 
of cells was halved and they remained viable in culture for up to 6 days (Ripple et 
al., 2005). Although not formally tested, inhibitors may need to be added daily as 
Gefitinib (Figure 4.3). Thus, when inhibitors were added daily and in combination for 
longer (48 hours), digits were induced in confluent monolayers. Interdigitations 
provoked by Gefitinib treatment was less penetrant compared to the application of 
AZD6244 that produced more widespread interdigitating structures. This was further 
elaborated when used in combination with Gefitinib or LY294002 (Figure 4.5). 
Treatment with AZD6244 or LY294002 alone led to shorter fingers structures 
compared to the removal of EGF. However, combining all 3 inhibitors recapitulates 
the prominence of interdigitations seen with the removal of EGF. Thus EGF tonically 
suppresses interdigitations in confluent monolayers via the combined outputs of 
EGFR, PI3K and MAPK signalling pathways. It is possible that other downstream 
EGFR activated components are involved that remain to be determined. It is 
noteworthy that neither of the EGFR associated inhibitors impeded the induction of 
interdigitations in the absence of EGF. This demonstrates that neither pathways is 
critical to induce interdigitations. ?
?
Alternative EGFR, ErbB2 and PI3K small molecule inhibitors were also applied to 
induce interdigitations in MCF10A cells. Accordingly, daily addition of the EGFR 
inhibitors; Erlotinib and Gefitinib reduced pERK significantly at 48 hours (Figure 4.6). 
EGFR/ ErbB2 inhibitor; Lapatinib reduced pERK at 4 and 48 hours albeit to a lesser 
extent. All 3 ErbB inhibitors induced interdigitations in confluent monolayers of 
MCF10A cells (Figure 4.6). The PI3K inhibitor, GDC0941 significantly reduced pAKT 
levels at 4, 24 and 48 hours and induced more prominent interdigitations compared 
to the previously used PI103 and LY294002 inhibitors (Figure 4.4, 4.5, 4.6). Rac-
GEF(Trio/ Tiam1) inhibitor, NSC23766 did not affect pERK or pAKT levels as 
expected (Akbar et al., 2006).  
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Figure 4.5. Long-term inhibition of EGFR and canonical downstream targets 
recapitulates the phenotype induced by EGF removal.,Cells were  cultured in 
complete growth medium +EGF for 45.5-47 hours. Medium was exchanged to 
include the inhibitors as annotated for (A) 4, 20 hours and (B) inhibitors were added 
daily for 48 hours. (A) 10µg of MCF10A cell lysates were loaded onto each lane. * 
indicates presence of EGF in medium. (B) Combinations of Gefitinib (300nM), AZD 
6244 (300nM) and LY294002 (20µM) added to confluent MCF10A cells in the pres-
ence of EGF, induced highly developed interdigitations. Formation of fingers by EGF 
withdrawal was not impeded by the presence of the same inhibitors. Coverslips were 
fixed with 4% PFA and stained with E-cadherin. Cells were visualised using immuno-
fluorescence microscopy at 40x magnification. Scale; 40µm. 
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Figure 4.6. Alternative ErbB family and PI3K inhibitors induces interdigi-
tations at 48 hours. (A) Treatment with EGFR inhibitors, Gefitinib (300nM) 
and Erlotinib (100nM) reduced pERK levels at 48hrs. EGFR and ErbB2 inhibi-
tor, Lapatinib (1µM) only reduced pERK slightly. PI3K inhibitor, GDC0941 
(500nM) reduced pAKT. Rac-GEF inhibitor, NSC23766 (50µM) did not affect 
levels of EGFR signalling or Rac1 proteins. 10µg of MCF10A cell lysates were 
loaded onto each lane. All inhibitors were added in +EGF medium. MCF10A 
cells were cultured 48-54 hours before exchange of medium to include the 
inhibitors for (A) 4, 24 and (A & B) 48 hours. Inhibitors were added daily after 
cells have achieved confluence in the presence of EGF. (B) Coverslips were 
fixed with 4% PFA and stained with E-cadherin. Cells were visualised using 
immunofluorescence microscopy at 40x magnification. Scale; 40µm. 
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4.3 Resolution of interdigitations in MCF10A cells 
4.3.1 Interdigitations resolve upon exchange to medium containing EGF 
Knowing that interdigitations are inducible, naturally I wanted to investigate if these 
structures are reversible. MCF10A cells were cultured without EGF for up to 70 
hours to form interdigitated monolayers. Interdigitations in MCF10A resolved within 
24 hours in medium with EGF (Figure 4.7). Resolution of these structures was 
apparent in MCF10A cells within 1.5 hours after EGF administration, which was 
relatively rapid compared to the induction (Movie 4.2). Motility of the cells within a 
monolayer also increased following resolution of interdigitations, accompanied by 
ruffling on the cell membranes (Movie 4.2). The relatively rapid resolution of 
interdigitations compared to the induction hints at a separately regulated 
mechanism, which will be discussed later in this chapter. 
 
4.3.2 Experimental optimisation for the reversal of interdigitations 
Initially, I tested if the duration of the experiment can be reduced to 3 hours after 
exchange to medium containing EGF or addition of EGF as previous experiments 
resolved interdigitations from 1.5 hours onwards (Movie 4.2). The assumption is that 
EGF reverses the interdigitations. Unexpectedly, interdigitations also transiently 
reversed when exchanged to medium lacking EGF (Figure 4.8). At the extended 24 
hour time period, interdigitations reformed under these conditions in contrast to the 
+EGF condition. This led to the formulation of two potential explanations: i) If 
exchange to fresh medium without EGF transiently reverses interdigitations, do the 
cells secrete an autocrine factor that is required for maintenance and allows the re-
formation of interdigitations within 24 hours? ii) If exchange to fresh medium without 
EGF transiently reverses interdigitations, does the medium contain an exhaustible 
factor that transiently substitutes for EGF to supress interdigitations? (Figure 4.9). 
 
To test if cells secrete an autocrine factor, I have compared the exchange of fresh 
for conditioned medium using the resolution of interdigitations as a readout. 
Conditioned medium was derived from parallel dishes of cells cultured with ±EGF 
medium for 68 hours prior to being used. MCF10A cells were cultured to form 
confluent interdigitated monolayers and digit resolution was observed following 
medium exchange. Interdigitations remained in conditioned medium without EGF 
(Figure 4.10). In contrast, exchange to fresh medium without EGF transiently 
resolved the interdigitations as previously observed (Figure 4.8, 4.10). As expected, 
exchange to either fresh or conditioned medium containing EGF completely 
reversed the interdigitations. It is possible that conditioned medium may contain 
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Figure 4.7. Reversibility of interdigitations in MCF10A cells. Interdigi-
tations resolved within 24 hours when 20ng/ml EGF was readded to the  
MCF10A parental cells. Cells were cultured in medium lacking EGF for up 
to 70 hours. Medium was then exchanged to complete growth medium 
±EGF for another 24 hours. Coverslips were fixed with 4% PFA  and 
stained with E-cadherin. Cells were visualised using immunofluorescence 
microscopy at 40x magnification. Scale; 40µm.
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exchange regardless of EGF (1 hour, 3 hours). Interdigitations reformed 
within 24 hours in the absence of EGF. Direct addition of EGF resolved 
interdigitation at all points. Cells were cultured for 67 hours in -EGF 
medium before either addition of supplements or exchange to fresh 
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tive control. Coverslips were fixed with 4% PFA  and stained with 
E-cadherin. Cells were visualised using immunofluorescence microscopy 
at 40x magnification. Scale; 40µm.
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Figure 4.9. Hypotheses for the transient reversal of interdigitations. Flowcharts indicate the hypotheses and experiments 
undertaken with MCF10A cells to investigate the transient reversal of interdigitations seen in fresh medium exchange.
Hypothesis 1:
Factor x secreted by cells stabilise/ promote 
interdigitations?
(autocrine signal?)
Experiment:
Fresh medium vs Conditioned medium
If cells are secreting a positive factor that 
stabilises the interdigitations, then -EGF 
conditioned medium will maintain fingers.
Therefore, fingers will NOT reverse in 
conditioned medium exchange.
Hypothesis 2:
Fresh medium contains factor y that 
suppresses/ resolves interdigitations 
transiently?
Experiment:
+FBS medium vs -FBS medium
If FBS in the medium has factor y that 
suppresses/ resolves interdigitations,
then fresh +FBS medium will resolve fingers. 
factor y
Fresh 
medium
factor x
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Figure 4.10. Conditioned medium without EGF maintains interdigitations. 
Interdigitations resolved transiently upon fresh medium exchange regardless of 
EGF (1 hour, 3 hours) and reformed within 24 hours in the absence of EGF. 
MCF10A cells were cultured for 68 hours in -EGF medium to form interdigitated 
monolayers before exchange to fresh or conditioned medium ±20ng/ml EGF. 
Coverslips were fixed with 4% PFA  and stained with E-cadherin. Cells were 
visualised using immunofluorescence microscopy at 40x magnification. Scale; 
40µm.
-EGF
1 hr 3 hrs 24 hrs
+EGF
-E
G
F 
(6
8 
ho
ur
s)
 →
 M
ed
iu
m
 e
xc
ha
ng
e 
 +
E
G
F 
 -E
G
F 
 +
E
G
F 
 -E
G
F 
Fr
es
h 
m
ed
iu
m
 
C
on
di
tio
ne
d 
m
ed
iu
m
 
68
 h
ou
rs
Tr
an
si
en
t
 re
ve
rs
al
116
Chapter 4: Detailed characterisation of the interdigitated phenotype  
	  
secreted autocrine factor(s) that promotes interdigitations. Hence resolved 
interdigitations reform within 24 hours of exchange to fresh medium -EGF.  
 
To test if fresh medium contained an exhaustible factor, which transiently 
suppressed interdigitations, I compared medium ±FBS in their abilities to resolve 
interdigitations. It is in the FBS that many factors are introduced to the medium. In 
+FBS-EGF medium, interdigitations resolved transiently as previously seen with 
fresh medium exchange (Figures 4.8, 4.10, 4.11). In control medium, -FBS-EGF, 
interdigitations remained after exchange. Medium -FBS+EGF proceeded to resolve 
interdigitations although this was slightly delayed. Therefore, FBS or components in 
FBS temporarily substituted for EGF to suppress interdigitations. Henceforth, 
experiments investigating the resolution of interdigitations were performed with 
direct addition of EGF without medium exchange. This is to eliminate the effects of 
FBS, which may act synergistically to EGF to suppress interdigitations.  
  
4.3.3 Differential abilities of growth factors to reverse interdigitations 
To follow up further, I asked:  What factor in the FBS could account for the transient 
suppression of interdigitations? Ligands for various RTKs were added separately to 
monolayers of interdigitated MCF10A cells to mimic the presence of an ‘EGF-like’ 
factor present in the FBS (Figure 4.12).   
 
Common ligands implicated in cell signaling related to the ErbB and Met receptor 
families were tested in their abilities to oppose interdigitations. Insulin that was 
routinely present in growth medium did not suppress interdigitations (Figure 3.2). 
TGF-α, which activates EGFR transiently, suppressed the interdigitations at 3 hours, 
which reformed within 24 hours as seen with the exchange of medium containing 
FBS (Figure 4.11, 4.12). This correlated with the transient activation of pERK that 
increased upon TGF-α addition at 15 minutes, 1 hour and 3 hours but reduced to 
basal non-stimulated cell levels within 24 hours (Figure 4.12). EGFR was continually 
degraded with EGF but levels were restored within 24 hours of TGF-α stimulation. 
The downregulation of EGFR may be crucial for the complete resolution of the 
interdigitations. Here, Neuregulin 1 (NRG1), which binds to ErbB3 and ErbB4, did 
not resolve the interdigitations. The enhancement of pAKT was sustained 
throughout 24 hours of NRG1 stimulation as compared to the short-lived 
phosphorylation of AKT, which terminated at 3 hours after stimulation with EGF or 
TGF-α. Instead, the pERK levels only spiked within 15 minutes but were 
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Figure 4.11. FBS transiently resolves interdigitations. In the absence of 
EGF, interdigitations reversed transiently when medium was exchanged to  
+FBS-EGF medium. Interdigitations reversed completely when exchanged to  
+FBS+EGF medium. Reversal was slightly delayed when medium was 
exchanged to -FBS+EGF medium. MCF10A cells were cultured in -EGF 
medium for 66.5 hours to form interdigitated monolayers before exchange of 
medium containing DMSO. Coverslips were fixed with 4% PFA  and stained 
with E-cadherin. Cells were visualised using immunofluorescence microscopy 
at 40x magnification. Scale; 40µm.
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Figure 4.12. Differential abilities of ligands to reverse interdigitations. (A) Tran-
sient reversal of interdigitations in MCF10A cells (1-3 hours) when medium was 
exchanged to fresh +FBS-EGF medium. (B) Status of interdigitations at 1, 3 and 24 
hours after addition of ligands: EGF (20ng/ml), HGF (20ng/ml), NRG1 (6ng/ml) or 
TGFα (20ng/ml). Cells were fixed with 4% PFA, immuno-stained with antibody 
directed at the extracellular domain of E-cadherin before visualisation using immu-
nofluorescence confocal microscopy at 63x magnification, zoom 1.5. Scale; 40µm. 
(C) MCF10A cell lysates [8µg] following addition of ligands for the indicated times. 
Cells were cultured in growth medium lacking EGF for 69.5 hours before addition of 
ligands.
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immediately reduced to non-stimulated levels within an hour of NRG1 stimulation in 
contrast to the sustained pERK signals upon EGF stimulation.  
 
The hepatocyte growth factor (HGF), mediator of the ‘HGF-cell scattering’ 
programme failed to resolve the interdigitations at 3 hours despite shortening of the 
interdigitations apparent after 24hrs. The HGF cell–scattering programme is known 
to dissociate cell-cell contact when space is available (Birchmeier et al., 2003; Leroy 
et al., 2006). Western blots show that EGF and HGF elicit similar downstream 
activation of pERK of the MAPK pathway and pAKT of the PI3K pathway MCF10A 
cells at the timepoints tested (Figure 4.12). This observation agrees with the 
overlapping cell signalling networks reported in A549 lung adenocarcinoma cells 
(Hammond et al., 2010). The inability of NRG1 and HGF to completely resolve the 
interdigitations implies that this process is defined by a single cue, activation of 
EGFR.  In MCF10A cells, addition of EGF downregulated EGFR levels gradually 
over 24 hours. (Figure 4.12). The levels of pAKT gradually reduced over 24 hours 
regardless of ligand stimulation. Insulin in the medium may have been exhausted as 
cells were cultured in the same medium without replenishment of supplements for 
up to 93.5 hours.  
 
4.3.4 Effect of small molecule inhibitors in the resolution of interdigitations 
Previous experiments showed that the PI3K and the MAPK signalling pathways 
although not critical, acted synergistically in the formation of interdigitations (Figure 
4.5). Inversely, I investigated if this is true to maintain digits following application of 
EGFR, PI3K and MEK inhibitors. At 24 hours, Gefitinib (EGFR inhibitor), AZD6244 
(MEK1/2 inhibitor) and CP724214 (ErbB2 inhibitor) reduced pEGFR and pERK 
levels but failed to inhibit the resolution of interdigitations (Figure 4.13). AZD6244 
suppressed levels of pEGFR Y1068 and pERK significantly compared to other 
inhibitors as seen in Figure 4.4. The correlating IF image showed less crowded cells 
on the coverslips when interdigitations reversed in 24 hours (Figure 4.13). This 
confirms that the inhibition of EGFR, MEK and ErbB2 does not impede the reversal 
of interdigitations. The resolution of interdigitations induced by EGF was unaffected 
by treatment with either the PI3K inhibitor, LY294002 or MEK1/2 inhibitor, AZD 6244 
(Figure 4.14). This discounts the involvement of these canonical EGFR associated 
signalling pathways in the reversal process. Presumably, signalling cascades 
involved in the remodelling of the cell cytoskeleton are independent of the common 
pro-survival signal integrators downstream of the EGFR. This will be further 
explored in Chapter 5. 
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Figure 4.13. Resolution of interdigitations independent of ErbB family 
and MEK signaling pathways. (A) Reversal of interdigitations in the pres-
ence of EGFR inhibitor (300nM Gefitinib), ErbB2 inhibitor (250nM CP724714) 
and MEK inhibitor (300nM AZD6244). MCF10A cells were cultured in medium 
without EGF for 67-71 hours before addition of EGF and inhibitors as anno-
tated. (A) Coverslips were fixed with 4% PFA at the indicated times after EGF 
and inhibitor addition, immuno-stained with E-cadherin before visualisation 
using immunofluorescence confocal microscopy at 40x magnification. Scale; 
40µm. (B) Lysates were harvested at the times indicated after addition of EGF 
and inhibitors to resolve digits. 10µg MCF10A cell lysates were  loaded onto 
each lane, following addition of EGF and inhibitors at the indicated times.
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Figure 4.14. Resolution of interdigitations independent of PI3K and MEK 
signalling pathways. Dissolution of interdigitation proceeded normally in the 
presence of MEK (300nM AZD6244) and PI3K (20µM LY294002) inhibitors in 
the presence of EGF. Coverslips were fixed with 4% PFA, immuno-stained with 
E-cadherin before visualisation using immunofluorescence microscopy at 40x 
magnification at the time points indicated. Scale; 40µm. 
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4.4 HMT 3522 cells interdigitate reversibly dependent on status of EGFR 
activation  
When a separate non-malignant mammary cell line, HMT 3522 S1, was cultured 
from confluence without EGF, the ability to interdigitate was recapitulated (Figure 
4.15). This mimicked the interdigitations seen in MCF10A cells and confirmed a 
previous report in the literature (Holm et al., 1993). However, the process took 
longer in these cells (70 hours onwards) that are routinely cultured in serum free 
medium that are heavily supplemented with other growth factors (Briand et al., 
1987; Methods: 2.1.2). Accordingly, cells proliferated in the presence of EGF and 
became more crowded as compared to the less proliferative cells under -EGF 
conditions (Figure 4.15). In reverse, addition of EGF resolved most interdigitations 
within 24 hours resembling the process seen in MCF10A cells (Figure 4.15, 4.12).  
 
4.5 Discussion 
 
In this chapter, I have presented a detailed characterisation of the dramatic 
reversible changes in epithelial cell boundaries within a confluent monolayer that is 
elicited with a single defined cue, EGF. To my knowledge, the formation of the 
interdigitated MCF10A monolayers upon EGF removal has not been characterised 
elsewhere. I have recapitulated this reversible phenomenon in an independent clone 
of MCF10A cells and also in another non-malignant mammary epithelial cell line, 
HMT 3522 S1. Collectively, these results illustrate that non-malignant mammary 
epithelial cells in culture are able to form reversible interdigitation defined by the 
status of EGFR activation. In contrast, this ability is abrogated in EGFR∆E746-A750 
cells with oncogenic activation of EGFR that continually suppress the formation of 
digits in the absence of EGF.  
 
The assembly of interdigitations in the absence of EGF is slow (>12 hours) when 
compared to the relatively rapid reversal (1-3 hours). Formation of the 
interdigitations may reflect the requirement for an altered cellular transcriptome and 
proteome following EGF withdrawal. One hypothesis could be that cells have to alter 
transcription and expression of proteins downstream of the EGFR to assemble the 
interdigitations. To approach this hypothesis, genome wide mRNA expression 
profiles of confluent MCF10A and EGFR mutant cells in ±EGF conditions can be 
screened using next-generation sequencing technology (RNAseq). The induction of 
finger-like protrusions using inhibitors of the EGFR, PI3K and MEK pathways 
confirms that EGFR signalling mediated by these pathways suppress digits 
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Figure 4.15. Reversibility of interdigitations in non-malignant mam-
mary epithelial HMT 3522 S1 cells. HMT 3522 S1 cells were grown to 
confluence in complete growth medium (10ng/ml EGF) for 96 hours and 
interdigitations were induced by exchange to medium lacking EGF for a 
further 70-166 hours. (A) Induction of interdigitations from confluent 
monolayers of HMT3522 cells. (B) Reversal of digits upon addition of 
EGF. 20ng/ml EGF was either added or not for another 24 hours. Cover-
slips were fixed at the indicated times with 4% PFA  and stained with 
E-cadherin. Cells were visualised using immunofluorescence microscopy 
at 40x magnification. Scale; 40µm.
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formation. The tonic suppression of interdigitations requires the combined outputs of 
the PI3K and MAPK pathways but these are not essential to form digits when EGF 
is removed. 
 
The resolution of interdigitations is specific to ligands that bind to the EGFR, leading 
to their downregulation. It was shown that TGF-α transiently mimics EGF in the 
ability to resolve interdigitations. This can be explained with the transient binding of 
TGF-α to the EGFR that preferentially dissociates from the receptor due to the pH 
changes in the endosome. Thus, EGFR is recycled rather than degraded when 
compared to EGF stimulation (Roepstorff et al., 2009; Lax et al., 1988). In my 
studies, I have not disproved the possibility that cells may secrete positive autocrine 
factors that transiently suppress interdigitations. Previous groups have reported the 
presence of TGF-α in serum and also in secretions from MCF10A cells (Ciardello et 
al., 1990; Moskal et al., 1995). The secretome of cells in conditioned medium can be 
compared to fresh medium to identify EGF sensitive secretion that may contribute to 
the suppression of interdigitated phenotype. However, this falls outside the scope of 
this thesis. Stimulation of ErbB3 and c-Met by NRG1 and HGF respectively failed to 
resolve interdigitations. This is accompanied by the observation that interdigitated 
cells remain shackled with minimal mobility within a monolayer. The mechanical 
implications will be explored further in Chapter 5.  
 
Although independent of the PI3K and MAPK signalling outputs, the time course for 
digits reversal following EGF application (initiated within1.5 hours) is consistent with 
altered post-translational modifications such as phosphorylation (Amit et al., 2007; 
Avraham and Yarden., 2011; Tarcic et al., 2012). Non-biased systematic phospho- 
proteome and proteome analysis using SILAC (Stable Isotope labelling by amino 
acids in culture) based quantitative proteomics can be applied in the future. This 
would allow understanding of proteins downstream of the EGFR that could mediate 
the resolution of interdigitations to restore their motility within monolayers. Together, 
these data would allow unbiased clustering of relevant components to molecularly 
dissect the mechanisms involved in this reversible phenomenon. A more direct but 
biased approach would be to investigate the involvement of junctional profiles and 
the actin cytoskeleton in both processes. This will be further explored in Chapter 5. 
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5.1 Introduction 
In this chapter, the characterisation of the interdigitated monolayers is extended to 
explore the ultrastructure, cytoskeleton and junctions associated with the 
interdigitated phenotype. Transmission electron microscopy (TEM) work was 
undertaken to visualise the interdigitations at the ultrastructural level. Filaments 
resembling actin cables were observed projecting into the tips of the interdigitations. 
Subsequently, I have evaluated the need for actin polymerisation and actomyosin 
contractility by treating the cells with relevant inhibitors. The morphology of cells in 
confluent monolayers was observed using IF microscopy as an assay to determine 
the role of the actin cytoskeleton in the dynamic reversible action of interdigitations. 
 
In relation to the signal regulation at the actin cytoskeleton, the role of Rac1 GTPase 
in the formation and reversal of interdigitations was investigated. Rac1 signalling 
has been associated with actin nucleation and polymerisation via downstream actin 
regulators within the lamellipodia at the leading edge of mobile cells (Ridley, 2011). 
In addition, hyperactivation and overexpression of Rac1 have been implicated in 
breast cancer progression (Wertheimer et al., 2012). Hence, I have evaluated the 
activity of endogenous Rac1 in MCF10A cells using Glutathione-sepharose beads 
conjugated to the Rac1/CDC42 p21 binding domain of human p21 activated kinase 
1 (GST-PBD) in pull down experiments (Pellegrin and Mellor, 2008). 
 
Observations using the TEM also revealed an increase in desmosomal junctions 
along the interdigitations. Desmosomal junctions are normally assembled after 
adherens junctions to strengthen the integrity of cell-cell contact (Garrod, 2010; 
Chapter 1: Figure 1.8). Biochemical studies were also undertaken. This observation 
led to two conflicting hypotheses concerning their role in interdigitations: i) Do 
desmosomal proteins undergo increased clathrin mediated or non-clathrin mediated 
endocytosis in monolayers of cells with smooth boundaries? ii) Does the synthesis 
of desmosomal proteins increase during the formation of interdigitations? Both 
scenarios were explored via co-localisation IF microscopy using relevant antibodies. 
 
Together, these observations raised more questions as to the mechanical function 
of actin and desmosomal rich interdigitations. In other studies, actin rich lamellipodia 
have been implicated to aid mobility of cells across substrates while desmosomal 
junctions have been shown to strengthen cellular sheets of keratinocytes (Garrod, 
2010; Kimura et al., 2007; Ridley, 2011).  I have proceeded to use a wound-healing 
assay to compare the ability of control and interdigitated cells to roam and seal a 
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scratched region in confluent monolayers. The strength of cell-cell adhesion was 
measured using the dispase-based mechanical assay. Fragments obtained were 
quantified to indirectly assess resistance to external shear stresses. Preliminary 
time-lapse imaging recorded the capacity of interdigitated monolayers to withstand 
induced osmotic stress. Combined, these assays inform on the physiological 
functions of interdigitations. 
 
Results 
5.2 Ultrastructural and cytoskeletal characterisation: Formation and 
maintenance of interdigitations 
5.2.1 Actin cables project to digit tips 
Seeing the dramatic architectural changes upon EGF removal, I hypothesised that 
actin may be structurally remodelled in this process. When MCF10A monolayers 
were transiently transfected with GFP-Actin (GFP-LifeAct), interdigitations were 
seen to contain actin (Figure 5.1). This was also previously seen when boundaries 
of MCF10A cells were co-stained with E-cadherin and actin (Chapter 4: Figure 4.1). 
Actin drugs were used to assess the roles of actin polymerisation and actomyosin 
contraction in the reversible phenomenon of digit-formation. This will be discussed 
later in this chapter.  
 
To elucidate the ultrastructure of the interdigitations, we collaborated with the 
Transmission Electron Microscope (TEM) Unit at the University of Liverpool. Plasma 
membranes of MCF10A cells within monolayers were stained with Ruthenium Red 
to enhance visibility as described by Deneka et al., (2007). Remnants of 
interdigitations survived the fixation and presented as protrusions into neighbouring 
cells that were absent in cells cultured with EGF (Figure 5.1). To note, the presence 
of interdigitations were only captured at the top of the cells (~2-3µm) and not 
elsewhere. Transverse sections showed prominent actin cables that projected from 
the electron dense digit tips. This resembles actin bundles seen in the filopodia of 
Dictyostelium cells (Medalia et al., 2007; David Garrod [personal communication]).  
 
5.2.2 Formation of interdigitations is independent of actomyosin contraction 
The presence of actin filaments in the digits prompted the next question: Is  
actomyosin contraction required to induce interdigitations? Myosin II motor protein 
isoforms crosslink actin filaments of the cell cortex to regulate cell stiffness and 
actomyosin contracts to confer force allowing cells to attach to the substratum in 
culture (Even-Ram et al., 2007; Stevenson et al., 2012). Blebbistatin inhibits the 
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Figure 5.1. Ultrastructural and confocal evidence that show interdigita-
tions contain actin. (A) Complete growth medium was exchanged for medium 
±20ng/ml EGF six hours post seeding. After 72 hours, cells were transfected 
with GFP-LifeAct and counter-stained for E-cadherin. Cells were visualised 
using confocal microscopy at 63x magnification. Scale; 40µm.(B) Control 
MCF10A cells (left) show smooth membranes between adjacent cells com-
pared to the cells grown in medium lacking EGF (right), which show residual 
finger-like structures. Actin cables project from tips of the protrusions. Cells 
were cultured in medium ±EGF and fixed 62 hours later. Scale 2µm and 0.5µm 
(inset). 
+EGF
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magnesium dependent ATPase activity of non-muscle Myosin II thereby uncoupling 
it from the actin cytoskeleton (Limouze et al., 2004). I undertook a time-lapse 
imaging experiment to approach this question. Confluent monolayers in complete 
growth medium were subjected to medium exchange to remove EGF. After 16 
hours, cells were treated with Blebbistatin (Myosin II inhibitor) just before 
interdigitations form. By applying the drug at this timepoint, I was able to determine 
if actomyosin contraction affects the formation of interdigitations. In control 
monolayers continually cultured with EGF, blebbistatin treatment gradually induced 
‘blebbing’ of cells and eventually monolayers were disrupted (Figure 5.2, Movie 5.1). 
In contrast, monolayers in –EGF were maintained and interdigitations were induced 
within the 8 hours of imaging. Induction of interdigitations is independent of 
actomyosin contractility and overrides the need to maintain actomyosin-associated 
attachment of monolayers to substratum.  
 
5.2.3 Maintenance of interdigitated monolayers is independent of actin 
polymerisation and actomyosin contractility 
Once formed, interdigitations were maintained over 1.5 hours when treated with 
actin depolymerising agents, Cytochalasin D and Latrunculin A (Figure 5.3). Effects 
of these inhibitors on the induction of interdigitations were not assessed due to their 
toxicity within the time frame required for this process (>12 hours). Blebbistatin, 
which did not impede the induction of digits also failed to disrupt the pre-formed 
interdigitated monolayers for up to 3 hours (Figure 5.3). To further investigate the 
relevance of the actin cytoskeleton in this process, I have probed for actin-
associated proteins, ERM (actin-plasma membrane linker), Abi1 (actin 
polymerisation regulator) and ArpC2 p34 (actin nucleator) as these have been 
reported to organise membrane domains via the regulation of actin cytoskeleton 
(Fehon et al., 2010; Ridley, 2006). The levels of these proteins remained unchanged 
along with actin in ±EGF condition (Figure 5.4). Subcellular localisation of these 
proteins has not been explored due to time restriction but may provide visual clues 
as to their involvement in the formation and maintenance of interdigitated 
monolayers. 
 
5.2.4 Activated Rac1 oppose interdigitations 
Organisation of the actin cytoskeleton to form lamellipodia and membrane ruffles 
requires signals relayed by Rac1 to co-ordinate the actin cytoskeleton regulators 
(Ridley, 2006; Ridley, 2011; Wertheimer et al., 2012). EGF can activate Rac1 by 
conveying signals to the guanine nucleotide exchange factors (Rac-GEFs) which 
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Figure 5.2. Interdigitations are independent of actomyosin contractility. (A) MCF10A cells 
were cultured in complete growth medium for 50 hours before medium exchange to ±20ng/ml  
EGF. Blebbistatin (25µM) was added 16 hours after medium exchange before digits were 
induced. Cells were imaged every 10 minutes for 8 hours after addition of Blebbistatin using 
bright field time-lapse microscopy at 20x magnification. (B) Control cells treated with DMSO 
vehicle cultured under the same conditions, are included in the next page. These are still 
images from Movie 5.1.
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Figure 5.2. Interdigitations are independent of actomyosin contractility. (B) MCF10A cells 
were cultured in complete growth medium for 50 hours before medium exchange to ±20ng/ml  
EGF. DMSO vehicle was added as control to (A) 16 hours after medium exchange before digits 
were induced. Cells were imaged every 10 minutes for 8 hours after addition of Blebbistatin 
using bright field time-lapse microscopy at 20x magnification. These are still images from Movie 
5.1.
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Figure 5.3. Maintenance of interdigitation does not require actin polymer-
sation or contraction. MCF10A cells were cultured in growth medium lacking 
EGF for 67 hours before treatment with vehicle (DMSO) (A) Cytochalasin D 
(5µM), Latrunculin A (5µM) or (B) 25 µM Blebbistatin. Cover slips were fixed 
with 4% PFA at indicated times and stained for E-cadherin, F-actin and with 
DAPI. Cells were visualised using immunofluorescence microscopy at 40x 
magnification. Scale; 40µm.
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Figure 5.4. Levels of select actin associated proteins independent of EGF 
withdrawal. Immunoblot analysis of 10µg of MCF10A cell lysates harvested 
from 2 independent experiments, where MCF10A cells were cultured in growth 
medium lacking EGF for 65-67 hours before lysis with RIPA buffer. Lysates 
were probed for pEGFR Y1068, pERK and actin associated proteins. ERM, 
Ezrin, Radixin, Moesin; Abi1, Abl interactor 1; and ArpC2 p34, Actin-related 
protein 2/3 complex, subunit 2, 34kDa; Expt, experiment.
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promote the exchange of Rac-GDP to Rac-GTP (Ridley, 2011; Schmidt and Hall, 
1998; Wertheimer et al., 2012). Expression of constitutively active Rac1 (pEGFP-
RacV12) in preformed interdigitated monolayers of MCF10A opposed the digit 
formation (Figure 5.5). In interdigitated monolayers, 33-35% of the cells that were 
successfully transfected with GFP-RacN17 (Rac1 negative mutant) and pEGFPC1 
control vector showed interdigitations. None of the constitutively active Rac1-
GTPase cells showed interdigitations (Figure 5.5).   
 
Conversely, I used different Rac1 GEF inhibitors to ascertain if the inhibition of Rac 
activity may induces interdigitations as previously seen with Gefitinib (EGFR 
inhibitor) in this configuration (Figure 4.3, Figure 5.6). Treatment with EHop-016 
(Vav2 GEF-Rac1 interaction inhibitor) and Gefitinib failed to induce interdigitations 
over 48 hours (Figure 5.6). Inhibitors may bind to serum proteins and become 
limiting in the prolonged treatment (Hickman et al., 2004). In these experiments, I 
have only added them once rather than twice within the 48 hours (in contrast to 
experiments described in Chapter 4).  Rac1 inhibition via EHT1864 induced a mild 
interdigitated phenotype but was accompanied by anomalously shaped nuclei that 
resemble nuclear blebs (Figure 5.6). Digits remained indifferent to the Rac1 
inhibitors added after their formation. Treatment with the NSC23766 (RacGEFs: 
Tiam/Trio inhibitor) caused cell death in the absence of EGF (Figure 5.6). 
Experiments with these inhibitors need to be repeated and have been included here 
as a record for future reference.  
 
In addition, I have also checked the activation status of Rac1 in MCF10A 
monolayers under ±EGF conditions with or without prior serum starvation (Figure 
5.7). Previous literature has measured Rac1 GTPase activation of growth factor 
starved MCF10A cells acutely stimulated with 100ng/ml EGF in intervals for up to 90 
minutes (Duan et al., 2011). Active endogenous Rac1 and CDC42 were pulled down 
using GST-PBD beads (Methods: Section 2.4.3). Under basal conditions, 
monolayers cultured ±EGF with serum showed similar residual Rac1 activity (Figure 
5.7). Stimulation with EGF (3 minutes) following serum starvation induced Rac1 and 
to a lesser degree CDC42 activity. Duan et al. (2011) also reported the increase in 
Rac1 activity in growth factor starved (72 hours) subconfluent MCF10A cells 
stimulated with 100ng/ml EGF (10 minutes). The activation of Rac1 in the EGF 
mediated resolution of interdigitations will be explored later in this chapter. 
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Figure 5.5. Transient transfection of constitutively active GFP-RacG12V 
negates the interdigitations invoked by EGF withdrawal. MCF10A cells 
were cultured in the absence of EGF for 48 hours then transfected for 18 hours 
[0.5µg DNA+ 0.5µg pBlueScript vector]. Coverslips were fixed with 4% PFA 
and stained with E-cadherin. GFP-labelled cells were counted in the -EGF con-
dition and scored for interdigitations. Cells were visualised using immunofluo-
rescence microscopy at 40x magnification. Scale; 40µm.
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Figure 5.6. Induction of interdigitations independent of Rac1 inhibition. 
MCF10A cells were grown to confluence for 43 hours before exchange of 
medium to include the inhibitors at these  concentrations: Gefitinib (300nM), 
EHop-016 (5µM), EHT1864 (5µM) and NSC23766 (50µM). The inset shows 
the nuclear ‘blebs’ seen. Panel without images indicate cell death. Confluent 
cells were treated with the inhibitor for 48 hours before coverslips were fixed 
with 4% PFA and stained with E-cadherin and DAPI. Images were taken using 
the immunofluorescence microscope at 40x magnification. Scale; 40µm. 
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Figure 5.7. EGF activates Rac1. MCF10A cells were cultured in
±EGF medium for 45 hours. Serum starved cells were cultured in -FBS-EGF 
medium for 24 hours. Cells were stimulated with 20ng/ml EGF for 3 minutes. 
Cells were lysed and endogenous active Rac1 was pulled-down using GST-
PAK beads. Input lanes were loaded with 4.6% input of total lysates and each 
pull down lane was loaded with material from 30µg GST-PAK beads.
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5.3 Cytoskeletal characterisation: Resolution of interdigitations 
5.3.1 Resolution of interdigitations requires actin polymerisation and 
actomyosin contractility 
In tandem, I investigated if the actin cytoskeleton is required in the reversal of digits. 
As this process is relatively rapid (1.5 hour onwards, Figure 5.8), it is receptive to 
actin depolymerising agents, Cytochalasin D and Latrunculin A. In interdigitated 
monolayers, addition of either inhibitor with EGF impeded the ability of cells to 
resolve digits within 1.5 hours (Figure 5.8). Blebbistatin (Myosin II inhibitor) similarly 
inhibited the resolution of interdigitations in the presence of EGF. Note that from 1.5 
hours onwards, cells started to detach and die owing to the toxicity of the drugs. 
 
5.3.2 Residual pool of Rac1 resolves interdigitations 
Rac1 activation relays signals to reorganise the actin cytoskeleton during the 
formation of lamellipodia in cells (Ridley, 2011). The previous thread of evidence 
showing that EGF stimulates Rac1 activity (Figure 5.7) was further investigated in 
the context of digit reversal to smooth membrane boundaries between neighbouring 
MCF10A cells. Rac1 activity was measured as described previously using GST-
PBD beads after fully interdigitated monolayers were stimulated with EGF (3 
minutes). Activity of Rac1 increased while that of another small G protein, CDC42 
remained indifferent to EGF stimulation (Figure 5.9). One would suspect that Rac1 
activation correlates with the reversal of digits. However, inhibition of Rac1 activity 
using inhibitors; EHT1864 (Rac1 inhibitor), NSC23766 (RacGEFs: Tiam1/Trio 
inhibitor) and EHop-016 (RacGEF Vav2-Rac1 inhibitor) failed to maintain the 
interdigitated monolayers upon addition of EGF (Gao et al., 2004; Montalvo-Ortiz et 
al., 2012; Shutes et al., 2007). Control, pre-formed interdigitated monolayers 
remained unperturbed in the presence of these inhibitors (Figure 5.10).  
 
These results indicate that the induction and resolution of interdigitations is 
independent of small molecule inhibition of Rac1, Tiam1/ Trio and the Vav2-Rac1 
interaction. When tested, EHT1864 but not NSC23766 treated cells showed 
reduced Rac1 activity under EGF stimulation (Figure 5.11). Although EHT1864 is 
supposed to displace guanine nucleotide association in vitro, a low level of Rac  
activity remains in the MCF10A cells treated with this inhibitor (Shutes et al., 2007). 
This could be because EHT 1864 only binds at high affinity to Rac1 but does not 
induce nucleotide loss from Rac2 and Rac3, allowing the latter two to relay basal 
Rac activity detected by the PAK-PBD beads (Shutes et al., 2007). On the other 
hand, the lesser reduction of Rac activity by NSC23766 can be explained as this 
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Figure 5.8. Resolution of interdigitations requires actin polymerisation 
and actomyosin contraction. MCF10A cells were cultured in the absence of 
EGF for 66 hours before treatment with vehicle control (DMSO) and (A) 5µM 
Cytochalasin D or 5µM Latrunculin A or (B) 25µM Blebbistatin. Coverslips were 
fixed at indicated time points when significant reversal of interdigitation is 
evident in control cells, but not those which have been drug treated. Cells were 
fixed with 4% PFA and stained for E-cadherin, F-actin and visualised using 
immunofluorescence microscopy at 40x magnification. Scale; 40µm.
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Figure 5.9. EGF activates Rac1 but not CDC42. (A) MCF10A cells were 
cultured without EGF for 62 hours then stimulated for 3 minutes with 20ng/ml 
EGF. Lysates were probed with anti-Rac1, anti-CDC42 and anti pY1068 
EGFR. Lanes were loaded with 4.6% input of total lysates and with material 
from 30µg GST-PAK beads in each pull down lane. (B) Intensity of the bands 
were normalised within the same antibody. Intensity of the top bands of Rac1 
and CDC42 were quantified using the Odyssey software.
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Figure 5.10. Maintenance and reversal of interdigitations indepen-
dent of Rac1 inhibition. (A) MCF10A cells were cultured without EGF for 
66 hours and pretreated with inhibitors for 30 mins at these concentra-
tions; Gefitinib (300nM),  EHT1864 (5µM), NSC23755 (50µM) and 
EHop-016 (5µM). Coverslips were PFA fixed 1 and 3  hours after addition 
of of 20ng/ml EGF or 0.5mg/ml BSA (control) and stained for E-cadherin.  
IF images were taken using immunofluorescence microscopy at 40x 
magnification. Scale; 40μm. Inh, inhibitor.  
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Figure 5.11. Rac1 activity reduced by inhibitors and RacGEF knock-
down. (A) MCF10A cells were cultured without EGF for 70 hours and 
pretreated with inhibitors for 30 mins at these concentrations;  EHT1864 
(5µM) and NSC23766 (50µM). Cells were transfected with pooled siVav2 
oligonucleotides on seeding day and on the second day. Cells were then 
stimulated for 3 minutes with 20ng/ml EGF. Lysates were probed with 
anti-pY1068 EGFR, anti-Rac1 and anti-GST. Lanes were loaded with 
4.6% input of total lysates and with material from 30µg GST-PAK beads 
in each pull down lane. DKD, double siRNA knockdown; GEF, guanine 
nucleotide exchange factor.
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inhibitor only binds the RacGEF recognition grove that is specific to Tiam1 and Trio. 
Therefore, other members of the GEF family such as Vav can still stimulate Rac1 
activity in MCF10A cells (Gao et al., 2004; Sosa et al., 2010). The double siRNA 
knockdown (DKD) of Vav2 in MCF10A cells reduced Rac1 activity most efficiently 
when compared to EHT1864 and NSC23766 treatment possibly because Vav2 is an 
abundant GEF in MCF10A cells (Figure 5.11; Sosa et al., 2010).  
 
Subsequently, I targeted Rac1 using siRac1 (Methods: Section 2.1.4) 
oligonucleotides and asked if this would affect interdigitations in monolayers. Firstly, 
MCF10A cells were cultured and transfected with pooled siRac1 oligonucleotides 
once in 48, 65 hours and twice in 65 hours in complete growth medium (Figure 
5.12). The expression of Rac1 was only slightly reduced in this configuration 
(Induction). Double knockdown of Rac1 over 67 hours did not affect the ability of 
cells to form interdigitations upon removal of EGF (Figure 5.13). To test if siRac1 
would antagonise the ability of cells to resolve digits, EGF was added to preformed 
interdigitated monolayers transfected with the oligonucleotides. Rac1 levels were 
adequately reduced by siRac1 in this configuration (Figure 5.12- Reversal) yet digits 
continued to reverse within 24 hours (Figure 5.13). The induction and reversal of 
digits remained indifferent to the partial reduction of Rac1 levels 
 
As an alternative approach, I used pooled siVav2 oligonucleotides as others have 
shown reduced Rac1 activation via this GEF that is dominant in MCF10A cells 
(Duan et al., 2011; Sosa et al., 2010). Knockdown of Vav2 in MCF10A cells showed 
significant reduction of endogenously active Rac1 (Figure 5.14). Then, I investigated 
if the reduced Rac1 activity would disable the resolution of interdigitations. 
Interdigitations continued to resolve even though Vav2-knockdown reduced Rac1 
activity. Together, although actin polymerisation and actomyosin contractility are 
required to dissolve interdigitations, reduction in Rac1 activity is insufficient to 
override this cytoskeletal remodelling process. This was unexpected as Rac1 
activation co-ordinates the organisation of the actin cytoskeleton during lamellipodia 
formation (Ridley, 2006; Ridley, 2011). 
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Figure 5.12. Optimisation of Rac1 knockdown in the induction and 
reversal of interdigitations. MCF10A cells were cultured in complete 
growth medium (48 hours and 65 hours) transfected with pooled siRac1 
oligonucleotides once. Medium was exchanged to -EGF and transfected 
with  pooled siRac1 oligonucleotides again to induce interdigitations for 17 
hours. 20 ng/ml of EGF was added to reverse pre-formed interdigitations 
(65+ hours) for 1, 3 and 24 hours. Each lane was loaded with 10µg lysates. 
Lysates were probed with anti-pY1068 EGFR, anti-pAKT, anti-pERK, anti-
Rac1 and anti-CDC42. KD, knockdown by siRNA oliguonucleotides.
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Figure 5.13. Reversal of interdigitations independent of Rac1 knock-
down. MCF10A cells were cultured in complete growth medium (48 hours) and 
transfected with pooled siRac1 oligonucleotides on seeding day. Medium was 
exchanged to -EGF and cells were transfected again with pooled siRac1 oligo-
nucleotides to induce interdigitations for 17 hours. 20 ng/ml of EGF was added 
to reverse interdigitations at 1, 3 and 24 hours. Cells on coverslips were fixed 
with 4% PFA and stained with E-cadherin. Images were visualised using immu-
nofluorescence microscopy at 40x magnification. Scale; 40µm. Induction and 
Reversal refers to the configurations of experiment as denoted in Methods:
Table 2.6.
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Figure 5.14. Vav2 activated Rac1 is not required for reversal of interdigi-
tations. (A) Rac1 activity is substantially reduced by Vav2 depletion. MCF10A 
cells were cultured in -EGF growth medium (68 hours) and transfected with 
40nM siRNA specific for Vav2 on seeding day and day 2. 20 ng/ml of EGF was 
added  (3 mins). Lysates were probed with anti-Y1068 EGFR, anti-Vav2 and 
anti-Rac1. Lanes were loaded with 4.6% input of total lysates and with mate-
rial from 30µg GST-PBD beads in each pull down lane. (B) Intensity of the 
bands pulled down by GST-PBD beads were normalised to input. Band inten-
sities of Rac1 was quantified using the Odyssey software. (C) Reversal of 
interdigitation is unaffected by Vav2 depletion. Cells were cultured in growth 
medium lacking EGF for 67 hours to induce interdigitations and treated as (A) 
and incubated with EGF for the indicated times. Coverslips were fixed after 1 
hour, 3 hours and 24 hours with 4% PFA and stained with E-cadherin. Cells 
were visualised using immunofluorescence microscopy at 40x magnification. 
Scale; 40µm.
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5.4 Ultrastructural and junctional characterisation: Formation of            
interdigitations 
5.4.1 Interdigitations display increased desmosome numbers 
From TEM micrographs, we observed the accumulation of electron dense regions 
along the folds of protrusions in interdigitated monolayers (Figure 5.15). In TEM 
micrographs, adherens junction may form electron dense areas due to the 
interaction of E-cadherin molecules on the surface of adjacent cells (Kobielak and 
Fuchs, 2004). These junctions are normally connected to the polarised actin 
network across epithelial sheets (Figure 1.4). Paired electron dense strips on 
apposing membranes seen were distinctly surrounded by a haze of intermediate 
filaments, analogous to desmosomal plaques (Figure 5.15 inset; Green and Gaudry, 
2000). Intermediate filaments present in cells are persistently shorter at 0.5µm 
compared to actin filaments, 13.5µm that allows intermediate filaments to confer 
more flexibility in cells (Fletcher and Mullins, 2010). This shorter length and the lack 
of polarity of intermediate filaments are characteristically viewed as a ‘haze’ in TEM 
micrographs (Figure 5.15 inset). Desmosomes succeed adherens junctions during 
the assembly of cell-cell adhesion to strengthen the mechanical integrity of cell 
layers (Garrod, 2010; Green and Gaudry, 2000). These ‘spot welds’ are commonly 
associated to epithelia and other stress bearing tissues and are tethered to the 
plasma membranes via intermediate filaments. Intriguingly, desmosomal proteins 
are often mutated or silenced in invasive and/or metastatic breast cancer specimens 
(Oshiro et al., 2005, Klus et al., 2001) 
 
Quantification of desmosomes per unit length of plasma membrane revealed a 10-
fold increase in EGF starved cells. In agreement, expression of the desmosomal 
protein, Desmoglein and the adaptor molecule, Desmoplakin showed notable 
increases in MCF10A cells that formed interdigitated monolayers (Figure 5.15). In 
contrast, levels of Desmoplakin in constitutively active EGFR mutant cells remained 
indifferent to the presence of EGF in the medium (Figure 5.15). No changes in E-
cadherin or selected tight junction markers (ZO-1, Claudin-1) were seen in the 
MCF10A parental and EGFR mutant monolayers. In the absence of EGF, 
Desmoplakin continued to stain close to E-cadherin along digits, redolent of the 
interdigitating cell processes described in another non-malignant breast epithelial 
cell line, HMT 3522 (Figure 5.16, Holm et al., 1993).  
 
5.4.2 Co-localisation of Desmoplakin with Early Endosomal auto-Antigen 1 
(EEA1) 
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Figure 5.15. Interdigitations are accompanied by an increase in the 
number of desmosomes. (A) MCF10A cells were cultured in ±EGF growth 
medium and fixed 62 hours later for TEM as Figure 5.1B. Quantification of the 
number of desmosomes per unit length of plasma membrane indicates ten fold 
more junctions in cells cultured in medium without EGF. Data are aggregated 
from 33 micrographs per condition (~500µm) as described in Methods:2.3.3. 
(B) Immunoblot analysis of 12.5µg of MCF10A cell lysates from parental and 
EGFR∆E746-A750 cells cultured in medium with or without EGF for 65 hours 
and probed for desmosomal markers (Desmoplakin 1 & 2, Desmoglein 2),  tight 
junction markers (ZO-1. Claudin-1) and adherens junction marker 
(E-cadherin). Asterisk indicates a non-specific band. MCF10A parental cells 
but not the EGFR mutants show increased expression of desmosomal proteins 
when cultured in medium lacking EGF.
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Figure 5.16. Interdigitated cell processes decorated with Desmoplakin. Com-
plete growth medium was exchanged for medium ±20ng/ml EGF six hours post 
seeding. After 72 hours, cells were fixed with 4% PFA and stained for E-cadherin 
and Desmoplakin. Cells were visualised using confocal microscopoy at 63x mag-
nification. Scale; 40µm.
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Figure 5.17. Co-localisation of Desmoplakin and early endosomal 
marker, EEA1. MCF10A cells showed diffuse EEA1 stain in -EGF and partially 
localised with Desmoplakin in both ±EGF conditions. Cells were cultured in 
growth medium ±EGF for 66.5 hours and coverslips were fixed with ice cold 
methanol. Cells were stained with Desmoplakin and Early endosomal auto-
Antigen 1, EEA1. Images of monolayers were taken using confocal micros-
copy at 63x magnification (zoom 1.5). Scale; 40µm.
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The relative increase in desmosomal proteins in cells cultured without EGF 
prompted the next question: do Desmoplakins internalise under the influence of 
EGF from the cell surface leading to their reduction? I approached this question by 
co-staining desmoplakin with the early endocytic marker (EEA1) to visualise their 
co-localisation in ±EGF (Figure 5.17). Note the -EGF monolayers previously seen 
with increased protein expression showed more cells with internalised desmoplakin 
compared to control (+EGF) cells. In both ±EGF conditions, desmoplakin remained 
on the borders of cells and showed partial co-localisation with EEA1. No 
quantification was attempted. Independently, Bo Van Deurs and colleagues reported 
Desmoplakin endocytosis upon cell dissociation provoked by calcium depletion, 
which required actin polymerisation but was independent of clathrin-mediated 
endocytosis in non-malignant mammary epithelial cells, HMT-3522 (Holm et al., 
1993). 
 
5.4.3 Co-localisation of desmoplakin with Caveolin-1 
As a side observation, the TEM micrograph showed fortuitously recovered 
caveolae-like invaginations prevalent in digits under the -EGF condition (Figure 
5.18; Parton and Simons, 2007). Without positive leads in the canonical endocytic 
pathway, I wondered whether clathrin-independent, caveolin-dependent endocytosis 
would contribute to this phenotype. Monolayers of MCF10A cells were cultured 
±EGF and stained with a caveolae marker, caveolin-1 (Figure 5.18). Caveolin-1 
under -EGF condition appeared dispersed in the cytoplasm and on the membrane, 
often resembling the outline of interdigitations. In control (+EGF) condition, caveolin-
1 localised either in perinuclear pools, along borders of cells or at both locations 
simultaneously (Figure 5.18, Figure 5.19). These locations reflect the transport of 
caveolin from the endoplasmic reticulum, to Golgi complex and its subsequent 
assembly into lipid rafts near plasma membrane (Parton and Simons, 2007; Pol et 
al., 2005).  
 
5.4.4 Organisation of Golgi markers and microtubules induced by EGF 
removal 
Due to the likeness of caveolin-1 stain to the perinuclear Golgi apparatus and the 
drastic reorganisation of caveolin-1 to the cell boundaries, I was intrigued if the 
organisation of Golgi apparatus would be disrupted in the absence of EGF 
signalling. To visualise the Golgi apparatus, I co-stained caveolin-1 with either 
GM130 (cis-Golgi marker) or p230 (trans-Golgi marker) (Figure 5.19). Although 
there was minimal overlap in these stains, there was a distinct rearrangement of the 
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Figure 5.18. Subcellular localisation of caveolin-1 in MCF10A cells. (A) 
Control cells (+EGF) show smooth boundaries between neighbouring cells. 
This image is the same as Figure 5.1. The caveolae-like structures observed in 
digits (-EGF) are boxed and enlarged on the right.  Cells were cultured in 
medium ±EGF and fixed 62 hours later for TEM processing. Scale bar, 5 µm 
and 2µm. (B) MCF10A cells were cultured in ±EGF growth medium and fixed 
63 hours later. Coverslips were stained with E-cadherin, caveolin-1 and DAPI. 
Images were taken using confocal microscopy at 63x magnification, zoom 1.5. 
Scale; 40µm.
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Figure 5.19. Subcellular localisation of caveolin-1, Golgi markers and 
mictrotubules. MCF10A cells were cultured in ±EGF growth medium and 
fixed 65-67 hours later. Coverslips were stained with DAPI, caveolin-1 and 
Golgi markers;(A) GM130, (B) p230 and (C) microtubule marker: α-tubulin 
(DM1A). Coverslips were fixed with (A,B) 4% PFA or (C) ice cold methanol. 
Images were taken using immunofluorescence microscopy at 40x magnifica-
tion. Scale; 40µm. 154
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Figure 5.20. Cycloheximide treatment impedes induction of interdigita-
tions. (A) MCF10A cells were cultured in +EGF growth medium to achieve 
confluence at 48 hours before exchange to medium without EGF for 19-24 
hours. Cells were treated with either water or 100ng/ml cycloheximide after the 
medium exchange. Coverslips were fixed with 4% PFA and stained with 
E-cadherin. Images were taken using immunofluorescence microscopy at 40x 
magnification. Scale; 40µm. (B) Cells were treated as (A) but lysed and probed 
for Desmoplakin, EGFR and actin. Each lane was loaded with 10µg of MCF10A 
cell lysates. Bleb, Blebbistatin; CHX, Cycloheximide; DMSO, vehicle dimethyl 
sulfoxide; Expt, Experiment.
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Golgi apparatus from perinuclear in control (+EGF) cells to dispersed Golgi stacks in 
the -EGF condition. The Golgi apparatus in mammalian cells is normally positioned 
near perinuclear microtubule organising centres and this positioning is a dynamic 
process for which the mechanisms involved are still relatively uncharacterised 
(Yadav and  and Linstedt, 2011). The scattered Golgi apparatus under -EGF 
conditions may indicate a lack of cell polarisation and/or inactive secretory pathway 
as the Golgi and microtubules are known to realign with the leading edge of moving 
cells to facilitate secretion of proteins that direct cell movement (Yadav and 
Lindstedt, 2011). This disrupted Golgi localisation may be linked to the reduced 
mobility of -EGF monolayers when compared to the control (+EGF) monolayers 
seen in Movie 3.1. Related to this, the polarisation of the Golgi apparatus towards 
the lumen of MCF10A acini was reported to facilitated rotational movement of cells 
during acini morphogenesis (Wang et al., 2013). 
 
Golgi stack dispersal has been linked to the disruption of microtubules in Hela cells 
(Cole et al., 1996). Disruption of microtubules also inhibits the secretion of milk 
protein, casein in lactating mouse mammary cells (Rennison et al., 1992). Hence, I 
investigated if the microtubules that organises Golgi positioning would be 
remodelled upon EGF withdrawal. Fitting with the Golgi dispersal seen under -EGF 
conditions, microtubules rearranged from a perinuclear localisation (+EGF) to 
cytoplasmic stains that mimicked the inter-cell protrusions seen with the E-cadherin 
stained MCF10A cells (Figure 5.19, Figure 4.1). Collectively, these results hints at 
an EGF induced mechanism that leads to microtubule reorganisation and changes 
in Golgi apparatus positioning, which may redirect secretory pathway and 
redistribute caveolin-1. Moreover, the disruption of microtubules has been reported 
to dephosphorylate EGFR in oesophageal carcinoma cells, rendering microtubules 
a promising target for cancer therapy (Wu et al., 2013). The involvement of these 
components in EGF induced membrane remodelling of mammary epithelial cells 
may provide intriguing mechanisms to be pursued further.  
 
5.4.5 Protein synthesis during the induction of interdigitations 
Next, I asked if monolayers of cells need to synthesise additional proteins over at 
least 12-17 hours to enable the formation of interdigitations? To approach this 
question, cell monolayers were cultured in complete growth medium for 48 hours. 
Medium was exchanged to medium ±EGF with or without protein synthesis inhibitor, 
cycloheximide (CHX) (Figure 5.20, Movie 5.2; Schneider-Poetsch et al., 2010). 
Overnight treatment of EGF-starved monolayers with CHX failed to induce 
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interdigitations. However, it is possible that the induction is merely delayed as I did 
not extend the experiment further at the time.  
 
If inhibition of protein synthesis impaired digits induction, would desmoplakin be a 
one of the newly synthesised proteins required for interdigitations? MCF10A cells 
were treated with cycloheximide (CHX) for 19 and 24 hours in ±EGF conditions and 
cells were lysed to probe for Desmoplakin. The levels of Desmoplakin seen after 19 
and 24 hours of EGF removal remained unaffected by 24 hours of CHX treatment 
although digits failed to form under –EGF condition (Figure 5.20). This indicates that 
Formation of digits is not dependent on increased Desmoplakin as the digits formed 
within 24 hours of EGF removal without changing levels of Desmoplakin. It has been 
reported that a stable pool of Desmoplakin exists in confluent cells with a half-life of 
72 hours which may reflect the lack of changes in levels within 19 and 24 hours that 
have been tested here (Pasdar and Nelson, 1988). This observation with CHX 
warrants further investigation, as it is possible that synthesis of other proteins that 
are as yet unidentified is required to induce the digits. 
 
5.5 Junctional Characterisation: Resolution of interdigitations 
5.5.1 Increase of desmoplakin levels downstream of interdigitation formation 
In prolonged culture of MCF10A cells without EGF (60+ hours) expression of the 
desmosomal adaptor protein, Desmoplakin increased (Figure 5.15, Figure 5.21, 
Figure 5.22). Conversely, elevated levels of Desmoplakin remained at cell 
boundaries after interdigitations had been resolved (Figure 5.21, 5.22). Consistent 
with the unaltered levels of Desmoplakin during the induction of digits (19 & 24 
hours, Figures 5.20, 5.21, 5.22), the unchanged levels of Desmoplakin after digits 
reversal supports the notion that interdigitation itself is unlikely to be caused by 
desmosomes. Although Desmoplakin levels did not change in within 24 hours of 
digits induction and reversal, it would be possible for this desmosome adaptor 
protein to be internalised and relocated within cells to increase or decrease the 
assembly of desmosomal plaques (Garrod, 2010). To test this possibility, 
quantitative TEM can be undertaken to compare the numbers of electron-dense 
desmosomal plaques in the different configurations of induction and reversal of 
digits that can be induced at different time frames (Methods: Table 2.6). 
 
5.6 Mechanical and cell dynamic outputs of interdigitations 
5.6.1 Reduced wound healing ability of interdigitated monolayers  
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Figure 5.21. Desmoplakin levels remain elevated after resolution of inter-
digitations. (A) MCF10A cell lysates were prepared from cells incubated for 68 
hours in growth medium ±EGF. Other cells were subsequently treated for 1 
hour, 3 hours and 24 hours with EGF before lysis. (B) Immunofluoresence 
images for cells treated as in (A) showing Desmoplakin retention at the cell 
boundaries during dissolution of interdigitations. Single confocal sections at 
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Figure 5.22. Desmoplakin levels remain basal after interdigitation are 
induced. (A) MCF10A cell were cultured in ± EGF medium for 67 hours. 
Medium was exchanged to -EGF for 24 hours to induce interdigitations. In the 
reversal experiment, 20ng/ml EGF was added to interdigitated monolayers for 
7 hours. Each lane was loaded with 10µg lysates. Lysates were probed for 
levels of Desmoplakin, Y1068 EGFR, pERK and actin.
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Figure 5.23. Minimal closure of scratch wounds without ligand stimula-
tion. A) MCF10A cell were cultured in ± EGF medium for 72 hours. Wound was 
scratched into confluent monolayers of each well. Preconditioned medium was 
exchanged into wells to remove debris before phase contrast time-lapse imag-
ing. Area of wounds were imaged every 15 minutes for 24 hours at 10x magnifi-
cation.
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To build on the structural and junctional characteristics, I asked if the interdigitations 
confer mechanical force and functions in monolayers. Previous observations of 
interdigitated cells showed restricted mobility within monolayers (Movie 3.1). So, I 
tested the ability of the interdigitated monolayers to migrate into artificially induced 
wounds. A pipette tip was used to scratch a wound in each well of the confluent 
monolayers of MCF10A cells cultured in ±EGF for 72 hours. Without acute ligand 
stimulation, the scratched wounds failed to fully close (Figure 5.23). However, at the 
end of imaging (24 hours), the presence EGF in control growth medium allowed the 
wound to narrow more effectively than the -EGF interdigitated monolayers.  
 
To investigate if the resolution of interdigitations permits the closure of wounds, I 
added ligands of different receptors (as Figure 4.12) to pre-formed interdigitated 
monolayers. IF microscopy revealed the inability of the non-EGFR ligands to resolve 
interdigitations as was previously seen (Figure 5.24, Figure 4.12, Movie 5.3). As 
expected, acute addition of EGF, HGF and NRG1 all stimulated the phosphorylation 
of ERK and AKT as previously shown (Figure 5.25, Figure 4.12). HGF and NRG1 
did not phosphorylate EGFR at Y1068 as these bind to the c-Met receptor and 
ErbB3 receptors respectively (Citri et al., 2006; Birchmeier et al., 2003). In parallel, 
time-lapse imaging revealed that MCF10A cells were unable to seal induced 
wounds after HGF and NRG1 stimulation (Figure 5.25, Movie 5.3). In contrast, only 
EGF stimulation allowed effective wound closure within 19 hours by which time 
interdigitations would have been resolved. This is in agreement with Band and 
colleagues who observed wound closure within MCF10A monolayers stimulated by 
EGF (Duan et al., 2011).  
 
5.6.2 Increased resistance to external sheer stresses 
If interdigitated cells move less than the control (+EGF) monolayers, do  
interdigitations confer additional adhesive strength between cells in monolayers? I 
hypothesised that the interdigitated cells (-EGF) may resist external mechanical 
shear stresses better than the monolayers with smooth boundaries (+EGF). 
Typically, confluent sheets of cells were lifted using the dispase enzyme and 
subjected to shear stress by repeated pipetting (Ishii et al., 2005). The protease, 
dispase cleaves ECM proteins but preserves molecules of cell-cell adhesions (Lorch 
et al., 2004). The number of fragments obtained was counted. ‘Fragments’ allude to 
more than one cell that remains attached to each other. Less fragments were 
generated from the interdigitated monolayers (-EGF) even when exposed to the 
same external shear stress as the control (+EGF) monolayers (Figure 5.26). It is 
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Figure 5.24. Resolution of interdigitation is specific to EGF. MCF10A cells 
were cultured in - EGF medium for 69 hours before addition of growth factors. 
Coverslips were fixed at the indicated times after ligand addition, with 4% PFA 
and stained for E-cadherin. Images were taken using immunofluorescence 
microscopy at 40x magnification. Scale; 40µm. 
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Figure 5.25. Differential cell migration into scratch wounds. (A) MCF10A 
cells were treated as in Figure 5.24 prior to lysis. Each lane was loaded with 
10µg of lysates. Lysates were probed for Y1068 EGFR, pAKT, pERK and Actin. 
(B) Time lapse imaging recorded the ability of monolayers to close wounds 
when incubated with EGF (20ng/ml), HGF (20ng/ml) and NRG1 (6ng/ml). 
MCF10A cells were cultured in -EGF medium for 69-72 hours. A wound was 
scratched onto each well of interdigated monolayers 30-40 minutes prior to 
phase contrast time-lapse imaging at 10x magnification. 
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Figure 5.26 Interdigitated cells resist mechanical shear stress. (A) 
MCF10A cells  cultured in ±EGF growth medium for 93 hours were sub-
jected to dispase mechanical dissociation assay in triplicates. The number 
of fragments was assessed sequentially after 30, 45 and 60 pipetting 
strokes. ‘Fragments’ refer to more than one cell that remains attached to 
each other. Left: Shown are the relative fractions of fragments for cells 
grown ±EGF (average of two independent experiments, error bars indicate 
range). Right: Cumulative number of fragments of a representative experi-
ment. (B) Cells from these experimental configurations were subjected to 
the dispase mechanical assay as described above at 30x pipetting strokes. 
Total cell fragments were counted. Forward (Cells cultured ±EGF for 67 
hours); Induction (Cells were cultured +EGF (44 hours)→ ±EGF (24 
hours)); Reverse (Cells were cultured -EGF (67hours) → +EGF (7hours). 
The timelines for the experiments of different configurations, Forward, 
Induction and Reverse are as denoted in Methods: Table 2.6. 
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also noteworthy that increasing pipetting shears increased the number of single 
cells seen in control (+EGF) condition but less was seen in –EGF. Although these 
single cells were not counted, this suggests that digits protect cell sheets from 
induced fragmentation. In addition, the monolayers of +EGF sheets continued to 
fragment with increased shearing but total fragments from interdigitated sheets 
remained unaltered (Figure 5.26).    
 
I also undertook a preliminary experiment comparing the resistance to shear 
stresses of the monolayers obtained from different experimental configurations as 
previously described (Methods: Table 2.6); digits formation from subconfluence 
(termed ‘Forward), digit reversal (termed ‘Reverse’) and induction from confluent 
monolayers (termed ‘Induction’). Regardless of whether the cells were cultured in  
-EGF for 24 (‘Induction’) or 67 hours (‘Forward’), the interdigitated monolayers were 
more resistant to the pipetting shears (Figure 5.26). This would indicate that the 
increased adhesive strength witnessed in interdigitated cells (-EGF) occurs 
independent of the levels of adaptor protein, Desmoplakin which are only increased 
in the ‘Forward’ configuration (Figure 5.26, compare Figure 5.15 and Figure 5.20). 
 
After reversal of digits for 24 hours (‘Reverse), the resistance to fragmentation 
remained unaffected, corresponding well to the unchanged levels of Desmoplakin 
observed (Figure 5.26, Figure 5.22). The levels of Desmoplakin in this experimental 
configuration (‘Reverse’) resembled the increased Desmoplakin levels in prolonged 
culture without EGF (‘Forward’) (Figure 5.22). As discussed earlier (Section 5.5.1), 
levels of the adaptor protein, Desmoplakin do not inform on the number of 
assembled desmosomes in cells (Green and Gaudry, 2000). Desmoplakin can be 
internalised and remain detached from desmosomal plaques. Whether the number 
of desmosomes contributes to the increased resistance to fragmentation observed 
in monolayers of MCF10A remains to be determined at the ultrastructural level. 
 
5.6.3 Protection against hypotonic osmotic stress 
Previous observation that a caveolae marker (caveolin-1) redistributed from a 
perinuclear to a generally cytoplasmic localisation upon EGF withdrawal prompted 
further investigation into the functional relevance of this redistribution (Figure 5.19). 
Caveolae in cell culture disassemble from the plasma membrane in response to 
acute mechanical stress such as cell osmotic swelling (Sinha et al., 2012). The 
interdigitated cells (-EGF) presumably have a higher surface to volume ratio 
compared to the control (+EGF) cobblestones monolayer (Figure 4.1). Therefore, I 
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Figure 5.27. Interdigitated cells withstand hypo-osmotic stress. (A) MCF10A cells were 
cultured in growth medium ±EGF for 48 hours before medium exchange to hypotonic buffer 
[35mM NaCl]. (B) Control cells were exchanged to isotonic buffers at 35mM NaCl shown on the 
next page. Recipes of buffers are listed in Methods: Table 2.9. Cells were imaged every 5 min-
utes for 8+ hours after exchange to buffers, using phase contrast time-lapse microscopy at 20x 
magnification. These are still images from Movie 5.4.
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Figure 5.27. Interdigitated cells withstand hypo-osmotic stress. (B) MCF10A cells were 
cultured in growth medium ±EGF for 48 hours before medium exchange to isotonic buffer 
[35mM NaCl]. These images show control treatment to Figure 5.27A. Recipes of buffers are 
listed in Methods: Table 2.9. Cells were imaged every 5 minutes for 8+ hours after exchange to 
buffers, using phase contrast time-lapse microscopy at 20x magnification. These are still 
images from Movie 5.4.
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wondered whether the caveolae seen in digits (-EGF) would allow monolayers to 
withstand changes in osmolarity more effectively than smooth (+EGF) monolayers? 
To answer this, I observed the morphology of cells using time-lapse imaging at 5 
minute intervals after applying buffers of different osmolarity onto pre-formed 
monolayers (Movie 5.4, Figure 5.27).  
 
The buffers of different osmolarities tested were hypotonic [35mM NaCl], [77mM 
NaCl] and isotonic [35mM NaCl] (Methods: Table 2.9). Osmolarity of buffers reflects 
the concentration of solutes including each ionic species derived from salts (Gold et 
al., 1987). The osmolarity of isotonic buffer was controlled by the addition of 200mM 
D-mannitol to mimic iso-osmotic concentrations at 135mM NaCl (Hyzinski-Garcia et 
al., 2011; Methods: Table 2.9). This provides a control for any effects of ionic 
strength rather than changes in osmolarity. At the end of the time-lapse imaging 
experiment, interdigitated monolayers (-EGF) survived better than control 
monolayers (+EGF) with smooth boundaries in hypotonic buffer [35mM NaCl]. 
MCF10A monolayers were able to withstand hypotonicity at [77mM NaCl].  
 
5.7 Discussion 
5.7.1 Actin requirement and functional outputs of digits 
In this chapter, I have provided evidence that actin polymerisation and actomyosin 
contraction is required to resolve interdigitations in confluent monolayers. The EGF 
induced resolution manifests mechanically to allow closure of wounded monolayers. 
Rac1 is activated upon EGF stimulation in this process but reduced activation of 
Rac1 failed to impair digit reversal. Yarden and colleagues have demonstrated that 
acute stimulation with EGF induced migration of MCF10A cells across Transwell 
chambers, which is consistent with my observation that EGF prompted cells to move 
and close scratch wound (Tarcic et al., 2012). They reported the synthesis of EGR1 
(Early Growth Response 1) downstream of the EGF induced ERF (E Twenty Six 
protein family repressor) to sustain migratory ability of cells. It is possible that actin 
related proteins are also synthesised upon EGF stimulation but they only focused on 
transcription factors activated downstream of the EGFR signalling. Therefore, EGF 
dependent adaptors of the actin cytoskeleton remodelling system remain to be 
explored especially in the rapid reversal of the interdigitations. 
 
The formation and maintenance of the interdigitated state is independent of actin 
polymerisation and actomyosin contraction. However, data presented in the 
previous chapter (Chapter 4) have shown that the combined outputs of the PI3K and 
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MAPK signalling cascades are essential to induce digits in monolayers. 
Mechanically, the interdigitated monolayers have been shown to remain shackled 
with restricted ability to close artificially induced wounds in cell culture. In addition, 
these structures provide superior resistance to external shear stresses by reducing 
the risk of fragmentation within the monolayers. Interdigitations also allowed cells to 
remain attached within monolayers when actomyosin contraction was perturbed. 
The enhanced protection of interdigitated monolayers against physical stresses may 
reflect its physiological relevance in mammary tissues. For example, mammary 
glands have to adapt to significant mechanical stresses and volume changes during 
the menstrual cycle (Nazario et al., 1994).  
5.7.2 Increased desmosomal numbers as a consequence of digit formation 
The number of desmosomal plaques and levels of desmosomal proteins increased 
in prolonged culture without EGF (60+hours). However, two strands of evidence 
suggest that desmosomal adaptor proteins, Desmoplakin do not cause 
interdigitation: i) Digit induction for 24 hours is not accompanied by an increase in 
the expression of Desmoplakin, ii) Desmoplakin levels remained elevated after the 
resolution of digits. However, Desmoplakin can be internalised and detach from 
desmosomal junctions upon calcium removal (Holm et al., 1993, Garrod, 2010). 
TEM quantification of the numbers of desmosomal plaques in both the induction and 
reversal of digits should be compared to establish if assembled desmosomes are 
required in these processes.  
 
5.7.3 Reorganisation of microtubules, Golgi apparatus and caveolae in the 
absence of EGF 
Surprisingly, monolayers cultured without EGF showed a remarkable reorganisation 
of β-tubulin (microtubule marker), GM130/p230 (Golgi apparatus marker) and 
caveolin-1 (caveolae marker). Perinuclear positioning of microtubules, Golgi 
apparatus and caveolae in control (+EGF) cells was disrupted when cells were 
cultured without EGF. It is possible that secretion of cargos to the plasma 
membrane is altered in these cells to induce digits (Yadav and Lindstedt, 2011). The 
preliminary observation of an increased number of caveolae under -EGF condition 
in TEM micrographs may relate to the ability of cells to withstand osmotic stresses. 
However, the link between microtubule, Golgi apparatus, caveolae redistribution and 
the formation of digits needs to be investigated further by perturbing the 
microtubules with agents such as Nocodazole to test if this would impair the 
membrane remodelling witnessed upon EGF withdrawal. Ultrastructural examination 
to quantify caveolae numbers would establish if there are differences between 
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smooth and interdigitated membranes. Collectively, these may provide exciting 
insights into an EGF-dependent mechanism of the dynamic Golgi organisation and 
membrane remodelling in mammary epithelial cells. 
 
5.7.4 Protein synthesis required for the induction of interdigitations 
Inhibition of protein synthesis by CHX impaired the ability of monolayers to induce 
digits upon removal or interdigitations. This area would warrant further investigation 
using a more systematic approach to elucidate the EGF-dependent mechanisms 
involved in the formation of interdigitations. Tarcic et al. (2012) had reported that de 
novo protein synthesis occurs to sustain EGF induced migration of MCF10A cells 
based on mRNA microarray hybridisation studies. Hence it is rational to assume that 
cells would have to synthesise a different set of proteins to induce interdigitations 
and restrict mobility. Changes in the proteome and phospho-proteome can be 
analysed using stable isotope labelling of amino acids (SILAC) in cell culture to 
compare the ±EGF conditions. Using this technology, it is possible to systematically 
unravel the disparate mechanisms and post-translational modifications involved in 
both the formation and reversal of interdigitations (Hammond et al., 2010, Tarcic et 
al., 2012).  
 
5.7.5 Biological perspectives 
The enhanced protection against mechanical and osmotic stress and the increased 
cell-cell adhesion of interdigitated monolayers indicates that these structures may 
be biologically relevant in non-malignant mammary epithelial cells (Chapter 1: 
Section 1.5). This study provides a simplified in vitro system to methodically 
delineate the mechanisms associated with interdigitations that is widespread in 
stratified animal tissues. Further investigation is warranted to investigate the 
involvement of actin associated proteins especially in the rapid resolution of 
interdigitations. Moreover, the paradoxical requirements for actin remodelling in the 
reversal but not the formation of digits further indicates that both processes are 
separately regulated via EGF dependent signalling pathways that are yet to be 
identified.  
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Chapter 6: Discussion  
6.1 Reversibility of interdigitations accompanied by phenotypic and 
mechanical outcomes 
In this thesis, I have characterised in detail the remarkable changes in non-
malignant mammary epithelial cell boundaries within a confluent monolayer, elicited 
by a single defined cue, EGF (Chapter 1: Figure 1.10).  EGFR signalling in this 
context serves to suppress the ability of confluent MCF10A cell sheets to 
interdigitate. Confluent monolayers and the absence of EGF are prerequisites to the 
assembly of interdigitations (>12 hours). This process is recapitulated but requires a 
longer duration with EGFR, PI3K and MAPK inhibitors (24-48 hours). Interdigitations 
are inducible from cells seeded in subconfluence or from confluent monolayers with 
differing time scales at 24-36 hours and 12-17 hours respectively. The appearance 
of these finger-like protrusions is accompanied by a 10x increase in the number of 
desmosomes assessed by quantitative electron microscopy and levels of 
desmosomal proteins, whilst markers of adherens and tight junction proteins remain 
unchanged. The induction and maintenance of digits in a confluent monolayer does 
not require actomyosin contraction with actin polymerisation unnecessary in the 
latter. In monolayers of interdigitated cells, other phenotypic manifestations include 
dispersed Golgi apparatus with rearrangement of microtubules. This resembles loss 
of cell polarity congruent with the lack of directional movement within the 
interdigitated monolayers. As a consequence, interdigitated cells are unable to close 
an artificially induced wound but display increased cell-cell adhesive strength, 
resistance to fragmentation and osmotic pressures.  
 
Interdigitations are dynamically resolved upon application of EGF by a relatively 
rapid process (1-3 hours). Noteworthy is that dissolution is specific to EGF and not 
amenable to ligands of other RTK receptors, c-MET and ErbB3 despite the strong 
overlap in downstream signals (Citri and Yarden, 2006; Hammond et al., 2010). 
Instead reversal is dependent on actin polymerisation and actomyosin contractile 
forces. Counter-intuitively, this process is independent of the PI3K and MAPK 
signalling although these are required for the formation. Together, these imply the 
involvement of signalling pathways unique to EGFR that regulate actin dynamics. 
Rho GTPases are well known to regulate remodelling of the actin cytoskeleton 
(Ridley, 2006). Rac1 has been shown to be activated upon EGF stimulation and 
induce membrane protrusions known as lamellipodia by stimulating actin 
polymerisation (Duan et al., 2011; Machesky and Hall, 1996; Ridley 2006). In my 
hands, overexpression of constitutively active pEGFP-RacV12 opposes 
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interdigitations by forming membrane ruffles. This is consistent with other findings 
which have shown that hyper-activation of RacV12 oppresses cellular protrusions 
such as invadopodia in rat mammary adenocarcinoma cells and filopodia in  
Dictyostelium to impair the migratory ability of these cells (Dumontier et al., 2000; 
Moshfegh et al., 2014). Although membrane ruffling structures such as lamellipodia 
are known to facilitate movement of cells across substrates, the ruffling cells with 
constitutively active Rac remain confined to their interdigitating neighbours under  
-EGF condition (Ridley, 2011). Rac1 overexpression has been found in breast 
tumours to promote lamellipodia formation allowing oncogenic cells to metastasise 
(Small et al., 2002; Sahai and Marshall, 2002). Therefore, by elucidating the 
mechanisms that regulate the formation and maintenance of interdigitations, it may 
become possible to introduce this phenomenon into malignant breast tissues, to 
oppose ruffling, metastatic cells.  
 
However, reduction of Rac1 activity via the Rac-GEF, Vav2 is insufficient to 
maintain interdigitations. One possibility is that the residual pool of Rac1 is sufficient 
to remains to be explored. The molecular comparisons of interdigitations with other 
existing subcellular structures such as filopodia and invadopodia may provide 
additional insights to the mechanism governing the formation and reversal of 
interdigitations. The activation of CDC42 has been shown to impair EGFR 
degradation, which reduced the motility of breast cancer cells in culture (Hirsch et 
al., 2006; Wu et al., 2003). This situation may be synonymous with the formation of 
interdigitations in MCF10A cells when cultured without EGF that prevents cell 
movement within confluent monolayers.  
 
Cables of actin filaments seen in the digits resemble filopodia with parallel actin 
bundles (Ridley, 2006; Stevenson et al., 2012). CDC42 is known to promote the 
formation of filopodia by binding and stimulating actin nucleating and bundling 
protein families including diaphanous related formins (DRF), Ena/ VASP proteins 
and fascin (Ridley, 2006; Stevenson et al., 2012). The actin bundling protein, Fascin 
has been shown to be highly expressed at the invasive front of epithelia tumours 
whereas a variant of Mena have been reported to be overexpressed in breast 
cancer (Machesky and Li, 2010; Di Modugno., 2004). In my hands, actin 
polymerisation has been shown to be necessary for the reversal of interdigitations. 
One may hypothesise that Rho-GTPases and clusters of actin bundling proteins 
such as those mentioned above may alter localisation during digit reversal to allow 
remodelling of the cytoskeleton. 
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In future work, we propose to investigate the effects of constitutively active CDC42 
as well as its inhibition in the formation of digits. This will be possible by transfecting 
the cells under -EGF condition with constitutively active CDC42 constructs or using 
siRNA to knockdown CDC42 or it’s related GEFs. It will also be insightful to identify 
the location of the different actin regulators mentioned above especially in the 
reversal of digits and to draw comparisons with the actin components known in 
other types of cellular protrusions. The turnover of actin can also be visualised by 
transfecting cells with GFP-LifeAct and tracing the dynamic turnover of actin using 
fluorescence recovery after photobleaching (FRAP) microscopy. The rate of 
turnover of actin in both the formation and reversal of digits may provide clues as to 
the stability and modulation of actin polymerisation in these processes.  
 
Desmosomes have been seen to intermingle between interdigitating mammary 
epithelial cells in 2D and 3D cultures (Ewald et al., 2012; Holm et al., 1993). This 
supports the TEM quantification that showed increased desmosomal numbers under 
-EGF condition when cells interdigitate. However, the induction of interdigitations 
within confluent monolayers appears to form prior to the increase in desmosomal 
adaptor protein, Desmoplakin. Cells that interdigitated within 24 hours of –EGF 
culture did not show an increase in Desmoplakin when compared to cells that were 
in prolonged -EGF culture (60+ hours). Other studies in keratinocytes reported that 
the levels of desmosomal components did not correlate with the adhesive 
capabilities of cells in confluent monolayers (Kimura et al., 2007; Mattey and 
Garrod, 1986). Consistently, separate pools of cytoplasmic or intermediate filament 
attached Desmoplakin have been reported in cells (Pasdar and Nelson, 1988). This 
suggests that the number of desmosomes may change even when level of the 
adaptor protein, Desmoplakin remain stable in the induction and reversal of 
interdigitations. Therefore, we propose to evaluate and compare the number of 
electron dense desmosomal plaques by TEM in interdigitated monolayers before 
and after the resolution of interdigitation to assess if there is a change in the number 
of desmosomes in these processes. 
 
6.2 Physiological relevance of interdigitations in mammary glands 
Mammary gland tissues are subjected to remarkable changes in architecture to 
accommodate mechanical stresses and volume changes due to fluid and cell 
transports during physiological events that spans decades in humans (Gjorevski and 
Nelson, 2011; Nazario et al., 1994). Ultrastructural studies reported interdigitations 
between cells in i) luminal-like epithelial cells isolated from human post-weaning 
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fluid (Russo et al., 1975) ii) in the apical portion of human mammary gland alveolar 
cells in the secretory phase of the menstrual cycle (Nazario et al., 1994). The 
luminal-like epithelial cells of post-weaning fluid were cultured into confluent 
interdigitated monolayers without EGF as the MCF10A cells in this report. The 
interdigitated cells were proposed to line mammary ducts and be removed from the 
gland during involution (Russo et al., 1975). As discussed earlier in Chapter 5, the 
interdigitated state confers extra adhesion between cells. Counter-intuitively one 
would deduce that in vivo these cells would be less likely to detach and be removed 
from the ducts. However, it is possible that digits reverse in the ductal lumen due to 
the high concentration of EGF (>100ng/ml) found in mammary ductal lumens 
(Carpenter and Cohen 1979; Roepstorff et al., 2008). These detached epithelial 
cells could then re-form digits when cultured into monolayers without EGF. In an 
ultrastructure study of human non-malignant fibroadenomatous tissue, the authors 
reported interdigitations in the apical portion of the mammary alveolar cells 
especially in the secretory phase of the menstrual cycle accompanied by 
desmosomal junctions (Nazario et al., 1994).  
 
Ultrastructural studies of organotypic culture of primary pubertal mouse ductal 
epithelial cells on Matrigel revealed transient interdigitated ‘interior’ cells between 
the lumen and basement membrane upon FGF2 stimulation (Ewald et al., 2012). 
Using time-lapse microscopy, the authors elegantly demonstrated that these digits 
only appear transiently during the active branching process by which multilayer 
epithelia transition into simple bilayered epithelia lining. Cell protrusions allow the 
cells to move and polarize within the confines of the lumen and basement 
membrane without dispersion into the extracellular matrix (ECM). It may be possible 
that the non-branching MCF10A acini do not have cells that interdigitate within the 
spheroids. Alternatively, Brooks and colleagues reported well-organised duct-like 
structures when MCF10A cells were cultured without EGF in collagen as opposed to 
single-cell radiation from clumps when cultured with EGF (Soule et al., 1990). 
Although they did not report seeing interdigitations, it would be of interest to 
visualise MCF10A cells in this context as it was previously viewed at low 
magnification. Furthermore, collagen culture not only facilitates organisation of 
mammary acini but also monolayers and ductal structures, providing a more 
relevant surrogate for in vivo mammary morphogenetic processes (Dhimolea et al., 
2010). 
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Interestingly, Holm et al. (1993) noted that a non-tumorigenic HMT 3522 cell line 
form interdigitations remarkably similar to those described here, in medium without 
EGF. I have recapitulated and reversed this phenotype in these cells. The tonic 
application of EGF in culture may be similar to the activation of the EGFR observed 
during the pubertal mammary gland development and paradoxically also in 
mammary tumours in which EGFR is overexpressed (Yarden and Pines, 2012; 
Watson and Khaled., 2008). During pubertal development, collective migration may 
facilitate mammary gland branching (Gjorevski and Nelson, 2011). Prominent 
interdigitated structures have been observed in intraductal carcinomas, suggesting 
the possible subversion of this developmental process in cancer (Goldenberg et al., 
1969). Therefore, the inability of isogenic ∆E746-A750 cells expressing 
constitutively active EGFR to interdigitate seen here may lead to enhanced 
capabilities to detach from monolayers  and contribute to metastatic cell migration.  
 
6.3 Physiological relevance of interdigitations in non-tumorigenic systems 
The phenomena of interdigitations in MCF10A monolayers provides a simple in vitro 
system to examine a phenomenon that has been described in stratified animal 
tissues (Introduction: 1.5). Digits that resist shear stresses may reflect a key aspect 
of its physiological function. The molecular mechanisms governing interdigitations in 
vivo remains obscure although interdigitations are increasingly reported both in vivo 
and in laboratory culture. Other reports of interdigitations very rarely indicate the 
need or specificity of growth factor signalling (Baluk et al., 2007; Hoelzle and 
Svitkina, 2012; Russo et al., 1975). Rather, they have been reported in these non-
malignant systems as basal phenomena regardless of growth factor stimulation or 
withdrawal. Interestingly, the interdigitated endothelial cells lining the initial 
lymphatic vessels function to allow the flow of fluids and cells in developmental and 
immunogenic instances (Baluk et al., 2007; Yao and McDonald, 2014). This may 
provide a hint as to the plausible role of interdigitated cells in the ductal structures of 
mammary gland that have to withstand shear forces of fluid flow and transport of 
milk proteins necessary during lactation (Gjorevski and Nelson, 2011).  
 
6.4 Interdigitated phenotype as an in vitro screening tool 
The integration of phenotypic screens and systematic pathway profiling has been 
increasingly used to aid the concurrent discovery of disease biomarkers and also as 
pre-clinical drug evaluation in biological contexts (Carragher et al., 2012). With this 
multi-dimensional approach, it is now possible to pre-empt drug resistance and 
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allow a more robust pre-clinical testing to maximise the chances of a developmental 
drug to benefit patients in the most cost effective manner. A distinguishing feature of 
the system described here is that interdigitation can be invoked within a pre-formed 
coherent monolayer. Validation studies of EGFR small molecule inhibitors are 
currently performed in growth or invasion assays where cells are subconfluent or 
dispersed. This does not reflect the complex multi-layered cells found in tissues 
(Ewald et al., 2012). Selected inhibitors once developed often fail in the penultimate 
or final clinical testing stages, with high attrition rates incurring huge financial losses 
to the parties involved (Carragher et al., 2012). Therefore, this in vitro system may 
be advantageous to screen for the efficacy of EGFR inhibitors in a more relevant in 
vitro context, ie cell confluency mimicking the multi-layer epithelia strata in vivo.  
 
Collectively, the tonic suppression of interdigitation by EGF and the rapid dissolution 
of established interdigitations by acute addition represent distinct pathways. 
Previously, other groups have used EGF induced migratory ability of MCF10A cells 
as an assay to undertake systematic large scale wound healing, proteomic and 
transcriptomic screens (Simpson et al., 2008; Tarcic et al., 2012). Inversely, 
systematic proteomic and transcriptomic profiling of the reduced migration of these 
interdigitated cells when cultured without EGF may offer mechanistic insights in a 
non-tumorigenic setting. EGF associated components can be validated and cross-
referenced to the targets found previously and to allow identification of therapeutic 
targets in the context of cancer.  With the complexity of signalling networks, it is 
unlikely that one protein downstream of EGFR would dominate this phenotype. 
Rather, like signal transduction cascades, it will be possible to identify and 
manipulate clusters of protein or pathway hubs that may be implicated in this EGF 
defined membrane-remodelling phenomenon. 
 
6.5 Mammary morphogenesis linked to mammary oncogenesis 
This remarkable plasticity of mammary boundaries is reserved in non-tumorigenic 
mammary epithelial cells. The MCF10A and HMT 3522 S1 cells used are distinct 
from the commonly used breast cancer cells lines, which form smooth boundaries in 
cultures without EGF (eg. MCF7). Most such cell lines are maintained in simpler 
media without EGF supplementation. The accompanying physical manifestation of 
the digits is the shackling of the cells to a fixed position within a confluent 
monolayer. Tension generated from cell-cell adhesion between mammary luminal 
epithelial cells has been shown to maintain cell polarisation and facilitate collective 
cell migration (Ewald et al., 2012; Fata et al., 2007; Gjorevski and Nelson, 2011). 
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This is important to sort luminal epithelial cells into either the luminal ducts or 
terminal end buds for correct mammary patterning during pubertal development 
(Lanigan et al., 2007). One may envision that this also have implications in the 
initiation, metastasis and invasion of cancers. 
 
6.6 Future perspectives  
We have established here an in vitro cell system that recapitulates cellular 
interdigitation in adult non-malignant mammary epithelial cells. This system provides 
a simple setting to allow the systematic analysis of molecular mechanisms related to 
this phenotype and also the downstream migration capability in response to 
prolonged EGF withdrawal. Analyses of the transcriptomic and proteomic profiles 
associated to this reversible phenomenon may provide the first step to elucidate this 
tightly regulated yet dynamic restructuring of the cell cytoskeleton. Identification of 
the clusters of actin regulating proteins and signalling hubs associated to 
interdigitations can be extrapolated to genetically engineered isogenic cells with 
cancer-relevant mutations to validate their function and relevance in cancer. 
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Table 2.1A Chemical structures of inhibitors used. Structures of inhibitors 
were obtained from the respective manufacturers’ websites. The inhibitors are 
listed in alphabetical order based on the drug names listed in Methods: Table 
2.1.
AZD6244 Blebbistatin CP724714
Cycloheximide Cytochalasin D EHop-016
EHT1864 Erlotinib GDC0941
Gefitinib Lapatinib Latrunculin A
204
Table 2.1A (continued) Chemical structures of inhibitors used. Structures 
of inhibitors were obtained from the respective manufacturers’ websites. The 
inhibitors are listed in alphabetical order based on the drug names listed in 
Methods: Table 2.1.
LY294002 NSC23766 PI103
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In Brief
Tang et al. describe a dramatic reconfigu-
ration of confluent mammary MCF10A
cells controlled by EGF signaling. With-
drawal of EGF leads to wide-scale inter-
digitation of cells and increased desmo-
some number. Cells thereby become
locked into position and unable to
migrate within a monolayer. These inter-
digitations can be rapidly dissolved by re-
application of EGF, through a process
that requires actin polymerization and
myosin II activity. These convenient
phenotypic assays offer a platform for
detailed dissection of relevant effector
pathways.207
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SUMMARY
Defined signals that dictate the architecture of
cellular boundaries in confluent cultures are poorly
characterized. Here, we report dramatic remodel-
ing, invoked by long-term epidermal growth factor
(EGF) withdrawal from mammary-derived MCF10A
cells. Such intervention generates an interdigitated,
desmosome-rich monolayer, wherein cells project
actin-containing protrusions deep into neighboring
cells. These changes protect cellular sheets from
mechanical disruption and dramatically restrict the
freedom of cells to roam within the monolayer.
Ectopic expression of activated Rac counteracts
interdigitation and induces membrane ruffling, but
cells remain confined by their interdigitated neigh-
bors. Interdigitations are rapidly dissolved by acute
EGF application in a process that is sensitive to actin
depolymerization and myosin II inhibition. These
assays for formation and dissolution of interdigita-
tions provide a platform for the dissection of novel
signaling pathways that are highly specific to EGF
receptor (EGFR) activation.
INTRODUCTION
In a physiological setting, boundaries between cells can be
smooth or highly interdigitated, such as the visceral epithelia po-
docytes of the kidney (Mundel and Kriz, 1995). Early morpholog-
ical studies of mammary epithelial cells isolated from human
donor after weaning breast fluids described ‘‘a well developed
system of cytoplasmic interdigitation and numerous desmo-
somes’’ (Russo et al., 1975). During early embryonic develop-
ment and puberty, the elongated tips of mammary buds form
multilayered epithelia, and cells within the interior layers show
prominent interdigitation and high levels of desmosomes (Ewald
et al., 2012; Nazario et al., 1994). Interdigitated structures are
also prominent in intraductal carcinomas, suggesting that they
may have acquired characteristics of the normal developmental
program (Goldenberg et al., 1969). In keratinocyte and endothe-
lial cell cultures, interdigitated structures are observed as inter-
mediates in the formation of stable cell-cell contacts (Hoelzle
and Svitkina, 2012; Vasioukhin et al., 2000). However, defined
molecular pathways that can control the decision between
smooth or interdigitated cell boundaries have not been substan-
tively dissected in vitro.
The epidermal growth factor receptor (EGFR) is the founding
member of the ErbB family of receptor tyrosine kinases that
together coordinate complex signaling systems that underpin
organogenesis and differentiation of several cell lineages (Citri
and Yarden, 2006). Mutation and other mechanisms constitu-
tively activate the network in a variety of carcinomas, rendering
it a major target for pharmaceutical intervention. Epidermal
growth factor (EGF) stimulation initiates multiple signaling
cascades, including the PtdIns3-kinase pathway and several
mitogen-activated protein kinase (MAPK) pathways, of which
the ERK pathway is best understood (Katz et al., 2007). From a
cell biological perspective, the key EGF-mediated responses,
so far defined, are mitogenic and motogenic.
MCF10A cells are an immortal nontumorigenic epithelial cell
line that arose spontaneously from mortal diploid mammary
epithelial cells of extended lifespan (Soule et al., 1990). They
have found widespread use in epithelial cell biological studies
and are a favored model for the generation of isogenic cell line
panels. They form organized monolayers in cell culture, present-
ing a characteristic ‘‘cobblestone’’ appearance. EGF stimulates
invasive properties of these cells but is not required for growth
(Tarcic et al., 2012).
The most radical change in cellular adhesive properties oc-
curs during epithelial-to-mesenchymal transition that is impor-
tant to development, wound healing, and cancer cell metastasis
(Kalluri and Weinberg, 2009). For many cancer cell types, this
can be promoted by activation of receptor tyrosine kinases
such as EGFR and MET. Adherens junctions (AJ) and desmo-
somes constitute sites of cellular adhesion that link adhesive
Cadherin proteins to actin and intermediate filaments (IF),
respectively. Together, they contribute synergistically to deter-
mine the strength of adhesion between cells (Huen et al.,
2002). Desmosomes appear as paired electron dense plaques
that align between neighboring cells and contain two types of
Cadherin family proteins, Desmogleins and Desmocollins (Du-
bash and Green, 2011). At both types of adhesive junctions,
the armadillo family of proteins connect Cadherins with adaptor
proteins, which link to the cytoskeleton. One such, Plakoglobin
(PG), is a constituent of both AJ and desmosomes. Another,
Desmoplakin (DP), is specific to desmosomes and is required
for strong cellular adhesion and integrity of epithelia in vitro
and in vivo.
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Here, we show that MCF10A cells within a confluent mono-
layer setting are capable of major rearrangements to form
highly developed interdigitating structures prompted by EGF
withdrawal. Our ultrastructural analysis reveals actin cables
projecting from the tips of these structures. Such interdigita-
tions can be rapidly reversed by reapplication of EGF in a
process that requires dynamic polymerization of actin and
cytoskeletal contractility. The presence of interdigitating struc-
tures is associated with immobility within confluent mono-
layers, impaired wound healing, and enhanced mechanical
stability.
Figure 1. EGFR Signaling Suppresses Ac-
tin-Containing Interdigitations between
MCF10A Cells
(A) Effect of removal of EGF or insulin from growth
media of MCF10A cells (top row) or isogenic cells
expressing EGFR DE746-A750 (bottom row).
Control MCF10A cells organize in a confluent
monolayer with ‘‘cobblestone’’ morphology. In-
terdigitations seen following EGF removal are not
apparent in EGFR mutant cells.
(B) Phenocopy of the ‘‘finger-like’’ structures when
cells are cultured in the presence of EGF and the
EGFR inhibitor, Gefitinib. Medium was exchanged
6 hr post seeding in complete growth medium
(10% FBS ± EGF, insulin), fixed with 4% PFA 72
(A) or 48 (B) hr later, and immunostained with
antibody directed at the extracellular domain of
E-cadherin.
(C–E) Complete growth medium was exchanged
for medium ± 20 ng/ml EGF 6 hr postseeding (C).
After 72 hr, cells were fixed with 4% PFA and
stained for E-cadherin (green), and F-actin (red),
(D) cells transfected with GFP-LifeAct and coun-
terstained for E-cadherin (red), (E) live cell
monolayer grown on a plastic dish. Cells were
visualized using conventional immunofluores-
cence microscopy at 203 magnification (A and
B), confocal immunofluorescence microscopy at
633 magnification (C and D), and phase-contrast
microscopy at 203 magnification (E). Scale bar,
40 mm.
RESULTS
EGFR Signaling Suppresses
Interdigitation of MCF10A Cells
The widely accepted culture conditions
for MCF10A cells suggest supplementa-
tion of the medium with a cocktail of
hormones and other factors (EGF, insulin,
hydrocortisone, and cholera enterotoxin)
together with horse serum (Soule et al.,
1990). Our first step was to determine
if all these components are necessary
for cell growth. In our hands, 2D cell
growth was not influenced by insulin or
cholera toxin, diminished by EGF with-
drawal, and most profoundly impaired
by hydrocortisone loss. For the ensuing
experiments, cells were routinely cultured with all of these com-
ponents ±EGF.
Under normal culture conditions, E-cadherin provides a uni-
form plasma membrane staining, which highlights the smooth
boundaries between neighboring cells. However, we noticed a
remarkable reorganization upon culturing cells in the absence
of EGF. Under these conditions, cells form long finger-like
projections into the body of neighboring cells, creating a
regular pattern of interdigitation (Figure 1A). Two lines of evi-
dence indicate that EGFR tyrosine kinase activity is required
for the suppression of this interdigitated state: (1) isogenic
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MCF10A cells, in which one allele of the endogenous EGFR
gene has been engineered to express a constitutively active
EGFR (DE746-A750), do not respond to EGF withdrawal
(Figure 1A), and (2) application of the EGFR inhibitor
Gefitinib induces interdigitation in the presence of EGF
(Figure 1B).
Actin Cables Project to Digit Tips and Desmosome
Numbers Increase
Interdigitations contain actin and can be observed in cells ex-
pressing GFP-Actin (Life-Act) or simply by phase-contrast light
microscopy (Figures 1C–1E; Movie S1). Once formed, they are
maintained over 1.5 hr in the presence of the actin-depolyme-
rizing agent Cytochalasin D (Figure S1A). The myosin II inhibi-
tor, Blebbistatin, also fails to disrupt interdigitation (Figure S1B).
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Figure 2. Ultrastructural and Confocal
Visualization of Interdigitations and an
Accompanying Increase in the Number of
Desmosomes
(A) Control MCF10A cells (left) show smooth
membranes between adjacent cells compared
to the cells grown in medium lacking EGF
(right), which show residual finger-like struc-
tures. Actin cables project from tips of the
protrusions. Cells were cultured in medium
±EGF and fixed 62 hr later. Scale bar, 2 mm and
0.5 mm (insets).
(B) Quantification of the number of desmosomes
per unit length of plasma membrane indicates
10-fold more junctions in cells cultured in medium
without EGF. Data are aggregated from 33 micro-
graphs per condition (500 mm) as described in
Experimental Procedures.
(C) Immunoblot analysis of 12.5 mg of MCF10A
cell lysates from parental and EGFRDE746-A750
cells cultured in medium with or without EGF for
65 hr and probed for Desmoplakin 1 and 2 and
Desmoglein 2. Asterisk indicates a nonspecific
band. Parental cells, but not EGFRDE746-
A750 cells, show increased expression of
desmosomal proteins when cultured in medium
lacking EGF.
(D) Confocal immunofluorescence images showing
staining patterns of desmoplakin and E-cadherin.
Cells were cultured in medium ± EGF and fixed with
methanol after 70 hr.
Scale bar, 40 mm.
We were not able to assess the effects
of these drugs on digit formation itself,
owing to their toxicity within the time
frame required for this process (>12 hr,
see below). We undertook a transmission
electron microscopic (TEM) analysis of
the cellular morphology induced by EGF
withdrawal, using ruthenium red to
enhance the plasma membrane staining,
as described by Deneka et al. (Deneka
et al., 2007). Remnants of interdigitations
survive the fixation and present as rough
projections into the neighboring cell that are entirely absent in
cells cultured with EGF (Figure 2A). In transverse sections,
prominent actin cables are observed which project from a
dense structure at the digit tip (inset, Figure 2A). Also striking
is the accumulation of electron dense desmosomal plaques in
cells deprived of EGF. These are recognized as paired elec-
tron-dense regions associated with both membranes of neigh-
boring cells and by the intermediate filaments, which project
from them (inset, Figure 2B). Desmosomes provide a system
of ‘‘spot welds,’’ which contribute to the mechanical properties
of cell layers. These adhesive structures maintain the mechan-
ical integrity of epithelial and other stress-bearing tissues by
tethering intermediate filaments to the plasma membrane.
Desmosomal proteins are often mutated or silenced in breast
cancer (Klus et al., 2001; Oshiro et al., 2005). EGF withdrawal
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leads to a 10-fold increase in desmosomes per unit length of
plasma membrane (Figure 2B). This is accompanied by a
notable increase in expression of the transmembrane desmo-
somal protein Desmoglein and the adaptor molecule Desmo-
plakin (Figure 2C,D), while no changes in E-cadherin levels or
of selected tight junctional markers (ZO-1, Claudin) are seen
(Figure S2A).
A
E
-c
ad
he
rin +
E
G
F
-E
G
F
24 hrs 38 hrs 46 hrs 62 hrs 70 hrs
0-5 hrs 24 hrs 38 hrs 46 hrs 62 hrs
0
70 hrs
B
M
C
F1
0A
 P
ar
-EGF
→24hrs -EGF
-EGF
→ 24hrs +EGF
Seeding
Medium exchange
Fix and stain
D
DMSO Cytoc. D
Basal
-EGF
-E
G
F→
+E
G
F+
 in
hi
bi
to
r (
1.
5h
rs
)
E
-c
ad
he
rin
A
ct
in
1 hr 3 hrs 3 hrs
E
-c
ad
he
rin
A
ct
in
DMSOBlebbistatin
-E
G
F 
(6
6h
rs
) →
  +
E
G
F+
 In
hi
bi
to
rE
H
M
T 
35
22
 S
1
-EGF
→24hrs -EGF
-EGF
→ 24hrs +EGF
C
Figure 3. Time Course of Interdigitation,
Reversibility, and the Requirement of Actin
Polymerization
(A) The prominence of E-cadherin stained in-
terdigitations on the membrane of MCF10A
parental cells gradually increased from 38 to 70 hr
after medium exchange. Medium lacking EGF re-
placed the complete growth medium 5 hr post-
seeding, and cells were fixed with 4% PFA at times
indicated after medium exchange (timeline).
(B and C) Interdigitations resolved within 24 hr
when 20ng/ml EGF was restored to the MCF10A
parental cells or HMT 3522 S1 cells. MCF10A cell
coverslips were treated as in (A) up to 70 hr, and
medium was then exchanged and left for a further
24 hr ± EGF. HMT 3522 were grown to confluence
in full medium containing 10 ng/ml EGF for 96 hr
followed by EGF withdrawal for 166 hr, which es-
tablished interdigitations. Cells were then treated
for a final 24 hr ±EGF.
(D and E) Actin polymerization and actomyosin
contractility is required for the reversal of in-
terdigitations. Cells were cultured in growth me-
dium lacking EGF for 67 hr before treatment with
vehicle control (DMSO) and 5 mM Cytochalasin D
(D) or 25 mM blebbistatin (E; left 1 hr; middle and
right, 3 hr). Coverslips were fixed at indicated time
points when significant reversal of interdigitation is
evident in control cells, but not those that have
been drug treated. Cells were stained for E-cad-
herin and F-actin and visualized using immunoflu-
orescence microscopy at 403 magnification.
Scale bar, 40 mm.
Differing Time Scales of Formation
and Dissolution of Interdigitations
Reflect Different Signaling
Cascades
Interdigitations can be seen forming
24–38 hr after withdrawal of EGF from
newly seeded cells and elaborate over
the next day or so (Figure 3A). They can
also be induced within an already estab-
lished confluent monolayer by acute
removal of EGF, under which circum-
stances they become apparent after 12–
16 hr (Movie S2). This is accompanied by
a remarkable stabilization of cellular posi-
tion and neighbor associations within a
monolayer and loss of all roaming capa-
bility (Movies S1 and S2). Ectopic expres-
sion of the constitutively active form (V12)
of the small GTPase Rac1 (tagged with
GFP), which regulates cytoskeletal dynamics and cell motility,
suppresses the interdigitation with neighboring cells. However,
such isolated cells are held in place by a cordon of interdigitating
neighbors (Figure S3; Movie S3).
Importantly, interdigitating structures are reversible; smooth
boundaries between cells and mobility within the monolayer
are re-established upon addition of medium containing EGF
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(Figure 3B; Movie S4). Reversal of fingers is apparent within 1 hr
after EGF administration. Another ‘‘near-normal’’ breast cell
line, HMT-3522, forms similar interdigitations following EGF
withdrawal, and these too are dissolved by application of EGF
(Figure 3C; Holm et al., 1993). Remarkably, this reversal process
requires actin polymerization, as treatment with the actin depo-
lymerizing agent cytochalasin D inhibits the acute loss of inter-
digitations (Figure 3D). Uncoupling of myosin II from actin by
applying Blebbistatin similarly inhibited the dissolution of inter-
digitations (Figure 3E). Although there are some intriguing obser-
vations reported, linking desmosomal proteins (Plakophilin 1,
Desmoglein 3) to actin organization and dynamics (Hatzfeld
et al., 2000; Tsang et al., 2012), we propose that interdigitation
itself, is unlikely to be caused by increased desmosome number.
Desmosomal proteins of mouse keratinocytes and oral squa-
mous carcinoma cells are similarly sensitive to EGF, but no inter-
digitating structures were reported in these studies (Lorch et al.,
2004; Yin et al., 2005). Furthermore, following acute application
of EGF, interdigitations dissolve and the cells recover motile
properties, but desmosomal proteins remain elevated and
distributed at the plasma membrane (Movie S4; Figures S2B
and S2C).
Interdigitations readily form if EGF is withdrawn shortly after
seeding or after cells have reached full confluency. The first
configuration is not amenable to analyzing the effects of drugs,
which severely inhibit cell growth, but responds clearly to Gefiti-
nib (Figure 1). However, when starting with established confluent
monolayers, the induction of interdigitations by Gefitinib treat-
ment is less penetrant. In fact, under these conditions, the
mitogen-activated protein kinase/extracellular signal-regulated
kinase 1 inhibitor AZD6244 produced more widespread interdig-
itating structures, which can be further elaborated by combining
with the PtdIns3-kinase inhibitor LY294002. Treatment with
LY294002 alone leads to some short finger structures. In both
these cases, the finger structures are less fine than those pro-
duced by EGF withdrawal, shorter and fatter i.e., stubby.
Combining all 3 inhibitors recapitulates the effects of EGF with-
drawal at high penetrance (Figure S4A). Thus in confluent cell
monolayers the tonic suppression of interdigitation by EGF,
requires the combined outputs of PtdIns3-kinase and MAPK
pathways, as well as further EGFR-dependent factors. A corol-
lary of these experiments is the finding that the active process
of interdigitation induced by EGF withdrawal is not negatively
influenced by inhibition of either PtdIns3-kinase or MAPK path-
ways (Figure S4A).
We noted that simply exchanging the culture medium for fresh
medium containing 10% bovine serum, but no added EGF, tran-
siently reversed the interdigitated phenotype (Figure 4A). This
implies that bovine serum must contain an exhaustible factor
capable of mimicking the effect of EGF. We tested a number
of other growth factors for their ability to suppress the mainte-
nance of interdigitations. First of all, insulin, which is routinely
included in the culture medium, has no effect (Figure 1). Trans-
forming growth factor alpha (TGF-a), which also activates
EGFR directly, transiently suppresses interdigitations similar to
the effect of fresh serum. However, neuregulin 1 (NRG1), which
specifically activates other ErbB family members (ErbB3 and
ErbB4), had no effect (Figure 4B). The hepatocyte growth factor
(HGF) showed no effect after 3 hr, when the process is essen-
tially complete in EGF-treated cells. Some shortening of fingers
is evident after 24 hr (Figure 4B), which may be an indirect
consequence of the ‘‘HGF-cell scattering’’ program, which leads
to cell-cell dissociation when space is available (Birchmeier
et al., 2003). Receptor tyrosine kinases (RTKs) elicit highly over-
lapping cell signaling networks, which for EGF and HGF have
been directly compared in A549 lung adenocarcinoma cells
(Hammond et al., 2010). In line with these observations, we
see that HGF and EGF elicit similar levels of activation of surro-
gate markers of the MAPK pathway (pERK) and the class 1
PtdIns3-kinase pathway (pAkt) in MCF10A cells over a 3 hr
time point (Figure 4C). Accordingly, this process of dissolution
is insensitive to inhibitors of these pathways (LY294002 and
AZD6244) (Figure S4B).
Rac1 is rapidly activated following EGF application toMCF10A
cells (Figure S5A). This can be strongly suppressed by depletion
of the guanine nucleotide exchange factor, Vav2, in accordance
with previous findings (Duan et al., 2011) (Figure S5B). However,
such depletion does not impede the rapid dissolution of interdig-
itations provoked by acute EGF (Figure S5C). Thus, while
expression of constitutively activated Rac1 can act to suppress
interdigitation (Figure S3), the rapid reversal process appears
to be largely independent of the major pool of EGF-activated
Rac1.
Resistance to Shear Stresses and Wound Healing
We have tested if the interdigitated state provides a resistance
to disruption by shear stresses. Confluent sheets of cells were
lifted by treatment with the enzyme dispase and subjected to
shear stress by repeated pipetting. Cell sheets cultured with
EGF readily fragment, whereas interdigitated/high desmosome
sheets culturedwithout EGF are highly resistant to fragmentation
(Figure 5A).
As a corollary of our findings that interdigitations impede the
freedom of individual cells to roam within confluent monolayers
(Movies S1 and S2), we looked at the ability to close a wound
in the confluent monolayer induced by a scratch made with a
pipette tip. Cells cultured in the absence of EGF, and hence high-
ly interdigitated, are unable to close such a wound unless EGF is
applied to dissolve the interdigitations. Neither HGF nor NRG1
can substitute for this effect, despite being powerful motogenic
stimuli in other cell systems (Figure 5B; Movie S5) (Birchmeier
et al., 2003; Ritch et al., 2003).
DISCUSSION
In this study, we provide a detailed characterization of a dramatic
reversible change in the architecture of epithelial cell boundaries
within a confluent monolayer that can be elicited with a single
defined cue. Suppression of interdigitations represents a mani-
festation of EGFR signaling in nontumorigenic breast epithelial
cells. Assembly of interdigitations in the absence of EGF is
slow (>12 hr), while dissolution following application of EGF is
relatively fast (1–3 hr). Formation is likely to reflect long-term ad-
justments to the cellular proteome following EGF withdrawal,
while dissolution is driven by actin-myosin contractile forces
associated with acute EGF application. The rapid dissolution
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process requires actin polymerization and contractility but is
independent of PtdIns3-kinase and MAPK pathways. This dis-
tinguishes it from the tonic suppression of interdigitation by
EGF, for which we provide evidence of the involvement of both
these signaling pathways. It is also striking that dissolution is
particular to EGF and cannot be recapitulated by ligands for
other RTK receptors, MET and ErbB3, despite the strong overlap
in downstream signals (Hammond et al., 2010). Our work there-
fore indicates the involvement of a signaling pathway unique to
EGFR.
We have characterized a simple in vitro system to examine a
phenomenon, i.e., interdigitation of neighboring cells, which is
widespread in stratified animal tissues. Our finding that inter-
digitation is associated with resistance to shear stress may
reflect a key aspect of its physiological function. Mammary
ducts are subject to significant mechanical stresses and have
to withstand dramatic volume changes during lactation. Other
systems in which interdigitation can be observed in vitro
include kidney podocytes and keratinocytes (Hoelzle and Svit-
kina, 2012; Mundel and Kriz, 1995; Vasioukhin et al., 2000).
However, in neither case has a molecular cue controlling this
process been defined. In the keratinocyte system, so-called
adhesion zippers progress to a smooth boundary in a process
that requires actin reorganization, recalling the reversal process
we have characterized (Vaezi et al., 2002; Vasioukhin et al.,
2000). A distinguishing feature of the system described here
is that we can invoke interdigitation within a preformed adhe-
sive monolayer. EGFR inhibitors are normally assessed in
growth or invasion assays where cells are necessarily subcon-
fluent or dispersed. We propose this system may be useful to
assess the efficacy of EGFR inhibitors within a different
in vitro context, i.e., cell confluency. The tonic suppression of
interdigitation by EGF and the rapid dissolution of established
interdigitations by acute administration represent distinct path-
ways that offer exciting opportunities for further characteriza-
tion by screening and proteomic strategies.
Figure 4. Differential Abilities of Growth Factors to Reverse Interdigitation
(A) Transient reversal of interdigitation in MCF10A cells (1–3 hr) when medium is exchanged with fresh medium containing FBS, but no EGF supplement.
(B) Status of interdigitations at 1 hr, 3 hr, and 24 hr after addition of indicated growth factors (GF) EGF (20 ng/ml), HGF (20 ng/ml), NRG1 (6 ng/ml), or TGF-a
(20 ng/ml). Images were taken using the Leica confocal DMIRE microscope at 633 magnification, zoom 1.5. Scale bar, 40 mm.
(C) MCF10A cell lysates following addition of growth factors at indicated times, probed with anti-EGFR, anti-pAKT, anti-pERK, and actin. Cells were grown in
growth medium lacking EGF for 69.5 hr before addition of growth factors.
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We suggest that a particular feature of MCF10A cells, which
may underlie this phenomenon, is that they are untransformed,
nontumorigenic cells. They are distinct from commonly used
breast cancer cell lines, which form smooth boundaries in the
absence of EGF (e.g., MCF7).Most such cell lines aremaintained
in simpler media, which are not supplemented with EGF. An
exception is the HMT-3522 cell line, which forms similar interdig-
itations in media lacking EGF (Figure 3C; Holm et al., 1993). Note
that these cells are cultured in serum-free media. A specific
feature accompanying interdigitation is the shackling of cells to
a fixed position within a confluent monolayer. One may envision
that this has consequences for normal mammary development
and for the development of mammary tumors.
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Figure 5. Interdigitation Dictates MCF10A
Cell Monolayer Properties
(A) Cells cultured in complete growth medium or
medium lacking EGF for 93 hr were subjected to a
dispase mechanical dissociation assay in tripli-
cate. The number of fragments was assessed
sequentially after 30, 45, and 60 pipetting strokes.
Left: relative fractions of fragments for cells grown
±EGF (average of two independent experiments,
error bars indicate range). Right: cumulative num-
ber of fragments of a representative experiment.
(B) Differential cell migration into scratch wounds
upon incubation with EGF (20 ng/ml), HGF
(20 ng/ml), and NRG1 (6 ng/ml). Cells were
cultured in medium lacking EGF for 72 hr. A wound
was scratched onto the well 30–40 min prior to
live-cell imaging at 103 magnification.
(C) Schematic summary figure.
EXPERIMENTAL PROCEDURES
Antibodies and Other Reagents
The following primary antibodies or reagents were
used for fluorescence microscopy: mouse anti-E-
cadherin clone HECD1 (Cancer Research UK Lab-
oratories), AF594-phalloidin (Invitrogen), mouse
anti-Desmoplakin and anti-Desmoglein (kindly
provided by David Garrod, University of Manches-
ter) (North et al., 1999; Vilela et al., 1995). Anti-
bodies used for western blotting included rabbit
anti-EGFR clone D38B1, rabbit anti pEGFR
Y1068, rabbit anti-pAKT, rabbit anti-pERK, rabbit
anti-Vav2, rabbit anti-CDC42, (Cell Signaling),
mouse anti-Rac1 (Cytoskeleton), mouse anti-b
actin (Abcam), rabbit anti-ZO1 (Zymed), and rabbit
anti-Claudin-1 (Invitrogen). Inhibitors used were
Gefitinib, AZD6244 (Stratech), Cytochalasin D,
Latrunculin A and blebbistatin (Sigma), and
LY294002 (Calbiochem). Growth media and sup-
plements were from the following suppliers: Dul-
becco’s modified Eagles’s medium (DMEM)/F12
Glutamax and fetal bovine serum (FBS) (Invitro-
gen), horse serum (HS) (First Link), EGF, TGF-a,
NRG1 (Preprotech), hydrocortisone, insulin, and
cholera toxin (Sigma).
Cell Culture and EGFR Inhibitor Treatment
MCF10A parental and EGFR DE746-A750 cells
(Horizon Discovery) were cultured in 5% CO2 in
DMEM/F12Glutamax supplementedwith 5%HS, 20 ng/ml EGF, 500 ng/ml hy-
drocortisone, 0.01mg/ml insulin, and100ng/mlcholera toxin.MCF10Aparental
cellswere seeded in six-well plates at a density of 1.03105 cells/well (onplastic
dish) and 1.53 105 cells/well (on glass coverslips). Medium was exchanged to
replace the 5%HSwith 10%FBS,with orwithout 20 ng/ml EGF. Inhibitorswere
added directly to wells or together with fresh or conditioned medium. In the
reversal experiments, the growth factors were added directly to cells cultured
in medium without EGF. HMT-3522 S1 cells were cultured in serum-free
DMEM/F12 Glutamax supplemented with 250 ng/ml insulin, 10 ng/ml EGF,
10 mg/ml transferrin, 2.6 ng/ml Na-selenite, 27.2 pg/ml 17b-estradiol,
0.5 mg/ml hydrocortisone, and 5 mg/ml human prolactin.
Immunofluorescence
Cells on coverslips were rinsed twice with PBS (37C, supplemented with
1 mM CaCl2, 1 mM MgCl2), fixed in 4% paraformaldehyde (PFA) in PBS,
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permeabilized with 0.2% Triton X-100, blocked in 10% goat serum, and incu-
bated with primary and secondary antibodies in 5% goat serum (20 min each),
all in PBS. Secondary antibodies were conjugated to either Alexa 488 or Alexa
Fluor 594. Bright-field and immunofluorescence images were taken using a
Nikon Eclipse Ti-E microscope (CFI Super Plan Fluor 203/ 0.45 NA or CFI
Plan Apochromat 403/ 0.45NA objective lens) and a digital camera (CoolSNAP
EZ Turbo 1394; Photometrics). Confocal images were taken using a Leica SP2
microscope (HCX PL Apo 63x/ 1.40NA objective lens at 1.50 or 1.90 zoom).
The images were then processed using NIS-Elements Software (Nikon), Leica
Confocal Software (LeicaMicrosystem), PhotoshopCS5 Version 12.0 x64, and
Illustrator CS5 version 15.0.0 (Adobe).
Electron Microscopy
Confluent dishes of MCF10A cultured ±EGF were washed with 0.1 M sodium
cacodylate buffer (pH 7.4) before fixing with 2.5% (w/v) glutaraldehyde,
1 mg/ml ruthenium red in sodium cacodylate buffer at room temperature
for 1 hr. Following rinses with 0.1 M sodium cacodylate buffer, cells were
postfixed with 1% osmium tetroxide, 1 mg/ml ruthenium red in 0.1 M caco-
dylate buffer at room temperature for 2 hr. After rinsing with dH2O, cells
were stained with 1% aqueous uranyl acetate (Agar) at room temperature
for 1 hr and then dehydrated in a graded series of ethanol on ice. Cells
were flat embedded using gelatine capsules in Epon and polymerized at
60C for 2 days. Ultrathin serial sections (70–85 nm) were cut longitudinally
through the whole cell and stained with uranyl acetate and lead citrate before
viewing at 100 KV in a FEI Tecnai G2 Spirit. To quantify the number of junc-
tions, a total of 33 micrographs were taken using AnalySIS (SIS, GmbH) with a
final magnification of 16,5003 for both ±EGF cells incorporating two biolog-
ical repeats. Seven different grids from six separate resin capsules were used
for EGF and four grids from two different resin capsules for +EGF. Areas
imaged were chosen at random where cells were observed to be adjacent
and membranes close enough for cell-to-cell adhesion. Touching mem-
branes were measured using AnalySIS and junctions counted and expressed
as the number of junctions per mm.
Wound-Healing Assay and Time-Lapse Microscopy
MCF10A cells were grown to confluency, in media with FBS ± EGF for 71 hr.
A scratch wound was made with a pipette tip (multichannel tip 250 ml; Ana-
chem). To remove dead cells, the medium was exchanged for reconditioned
media of a parallel plate. Cells were imaged for 3 hr within 30–40 min of
scratching before addition of growth factors (EGF and HGF 20 ng/ml,
NRG1 6 ng/ml) and followed by time-lapse microscopy using a fully motor-
ized Nikon Ti-E eclipse microscope. Movies were processed using NIS-Ele-
ments software (Nikon), FijiIsJust ImageJ 1.48 (NIH), and MPEG Streamclip
v1.9.2 (Squared5).
Dispase Dissociation Assay
MCF10A cells were seeded in 60-mm-diameter dishes (+EGF, 1.75 3 105
cells/dish; EGF, 3.3 3 105 cells/dish), and 93 hr after seeding, dishes were
washed three times in PBS and incubated in 2 ml Dispase (2.4 U/ml; Roche)
for 30–40 min at 37C. A total of 5 ml of PBS was added into each dish, and
dislodged cell sheets were centrifuged at 4 min at 200 rcf. Supernatant was
removed, and cell sheets were disrupted using a p1000 pipette tip by pipetting
in 1 ml PBS for the given number of repetitions. Cell fragments (more than one
cell) were counted using a hemocytometer.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and five movies and can be found with this article online at
http://dx.doi.org/10.1016/j.celrep.2014.08.026.
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Supplemental data 
Figure S1 (related to Fig. 1C,D). Maintenance of interdigitation does not require actin 
polymerisation or contractility.  MCF10A cells were cultured in growth medium lacking EGF for 67 
hours before treatment with vehicle (DMSO) (A) Cytochalasin D (5µM) or (B) 25µM Blebbistatin. 
Coverslips were fixed with 4% PFA at indicated times and stained for E-cadherin, F-actin and with 
DAPI. Cells were visualised using immunofluorescence microscopy at 40x magnification. Scale; 
40µm. 
Figure S2 (related to Figure 2). (A) Characterisation of other junctional markers in the MCF10A cell 
line. MCF10A cell lysates were lysed following culture for 65 hours in growth medium ± EGF, and 
probed with anti-ZO1, anti-Claudin-1, anti-E-cadherin and Actin. Levels of tight junction and 
adherens junction proteins are EGF-independent for MCF10A parental cells and ∆E746-A750 cells 
(B) Desmosomal protein levels remain elevated up to 24 hours after dissolution of fingers. 
MCF10A cell lysates were prepared from cell cultures incubated for 68 hours in growth medium ± 
EGF. Other cells were subsequently treated for 1hr, 3hrs and 24 hrs with EGF before lysis. (C) 
immunofluorescence for cells treated as in (B) showing desmoplakin retention at the plasma 
membrane during dissolution of interdigitations. Single confocal sections (63x), scale bar; 40µm. 
Figure S3 (related to Figure 3). Transient transfection of constitutively active GFP-RacG12V 
negates the interdigitations invoked by EGF withdrawal. Cells were cultured in the absence of EGF 
for 48 hours then transfected for 18 hours. Cells on coverslips were fixed with 4% PFA and stained 
with E-cadherin. Cells were visualised using immunofluorescence microscopy at 40x magnification. 
Scale; 40µm.  
Figure S4. (related to Figure 3) (A) Inhibition of signaling pathways induces interdigitation within 
confluent monolayers. Combinations of Gefitinib (300nM), AZD6244 (300nM) and LY294002 
(20µM), added to confluent MCF10A cells in the presence of EGF, induced highly developed 
interdigitations. Formation of fingers by EGF withdrawal was not impeded by the presence of the 
same inhibitors. (B) Dissolution of interdigitations proceeds normally in the presence of MEK 
(AZD6244) and PI3K (LY294002) inhibitors. Cells were cultured in growth medium without EGF for 
67 hrs to induce interdigitation before addition of 20ng/ml EGF with vehicle control DMSO. 
Coverslips were fixed after 1hr, 3hrs and 24hrs with 4% PFA and stained with E-cadherin. Cells 
were visualised using immunofluorescence microscopy at 40x magnification. Scale; 40µm. 
Figure S5. (related to Figure 3) Vav activated Rac1 is not required for reversal of interdigitations. 
GST-PAK pulldown from (A) MCF10A cells grown for 62 hrs without EGF then stimulated for 3 
minutes with 20ng/ml EGF. Lysates were probed with anti-Rac1, anti-CDC42 and anti-pY1068 
EGFR. Lanes were loaded with 4.6% of the input lysate was probed alongside the bound protein 
fraction isolated with GST-PAK-CRIB beads. (B) Rac1-GTP activation is substantively reduced by 
Vav2 depletion. MCF10A cells were treated with 40nM siRNA specific for Vav2 and otherwise 
grown as described in (A). (C) Reversal of interdigitation is unaffected by Vav2 depletion. Cells 
were cultured in growth medium lacking EGF for 67 hrs to induce interdigitations. Cells treated 
essentially as described in (B) were incubated for the indicated times with 20ng/ml EGF. 
Coverslips were fixed after 1hr, 3hrs and 24hrs with 4% PFA and stained with E-cadherin. Cells 
were visualised using immunofluorescence microscopy at 40x magnification. Scale; 40µm. 
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Movies S1-S5 
Movie S1 (related to Figure 1): 
Withdrawal of EGF leads to loss of cellular lateral mobility. MCF10A monolayers grown in 
complete growth medium, +EGF (left panel) or –EGF (right panel).  
Left panel. MCF10A cells were cultured in complete growth medium (+EGF) for 46 hrs before 
exchange for fresh medium (+EGF), from which point images were collected by time-lapse phase 
contrast microscopy . Frames were taken every 15 mins for 24 hrs saved for playback at 100ms 
intervals. 
Right panel. MCF10A cells were cultured in growth medium lacking EGF for 67 hrs. Images were 
captured by time-lapse phase contrast microscopy. Frames were collected every 15 mins for the 
final 24 hrs saved for playback at 100ms interval.  
Movie S2 (related to Figure 3): 
Induction of interdigitation in MCF10A cells upon removal of EGF (+EGF→ –EGF). 
MCF10A cells were cultured in complete growth medium (+EGF) for 46 hrs before exchange of 
medium to (-EGF) (20ng/ml). Images were captured by time-lapse phase contrast microscopy 
using an inverted microscope (Eclipse Ti-E, Nikon). Frames were colected every 15 mins for 24 
hrs saved for playback at 100ms interval. 
Movie S3 (related to Figure S3) 
Transient transfection of constitutively active GFP-RacG12V negates interdigitations. 
MCF10A cells were cultured in growth medium lacking EGF for 96 hrs. Cells were transfected with 
GFP-RacG12V expression plasmid 24hrs before imaging. Images were captured by time-lapse 
phase contrast and fluorescence microscopy using an inverted microscope (Eclipse Ti-E, Nikon). 
Frames were collected every 3.24 mins for 2.5 hrs saved for playback at 100ms interval. 
Movie S4 (related to Figure 3) 
Dissolution of interdigitation in MCF10A cells upon addition of EGF (-EGF → +EGF). 
MCF10A cells were cultured in growth medium lacking EGF for 68.8 hrs before addition of EGF 
(20 ng/ml). Interdigitations started to resolve at time 1:30 hrs (addition of EGF). Images were 
analysed by time-lapse phase contrast microscopy using an inverted microscope (Eclipse Ti-E, 
Nikon). Frames were collected every 2 mins for 13 hrs saved for playback 100ms interval. Imaging 
started 1.5 hrs before addition of EGF and lasted for 13 hrs.  
Movie S5 (related to Figure 4,5) 
Wound closure of MCF10A cells is specific to addition of EGF. 
MCF10A cells were cultured in growth medium lacking EGF for 69 hrs before addition of growth 
factor; EGF (20ng/ml), HGF (20ng/ml) or NRG1 (6ng/ml). Wound closure is most efficient upon 
addition of EGF (bottom left). Images were analyzed by time-lapse phase contrast microscopy 
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using an inverted microscope (Eclipse Ti-E, Nikon). Imaging started 3 hrs before addition of growth 
factors and frames were collected every 15 mins for 19 hrs, saved for playback at 100ms interval.  
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Supplemental experimental procedures: 
 
Transfection of MCF10A cells 
MCF10A parental cells were transfected with pEGFP-C1 (Clontech), GFP-LifeAct, GFP-RacG12V 
or GFP-T17N (gifts of Laura Machesky, Beatson Institute, Glasgow), using the Lipofectamine LTX 
transfection reagent (Invitrogen) according to the manufacturer’s instructions. Medium was 
exchanged 5-8 hours post seeding, and cells were transfected 36-48 hours later once they had 
reached a minimum of 50% confluence. Transfection medium was replaced by complete medium 
with or without 20ng/ml EGF 5-6 hours after transfection. Transfected cells were left for another 
18-24 hours prior to fixation with 4% paraformaldehyde for immunofluorescence microscopy. For 
the Vav2 depletion, cells were treated with 40nM of pooled oligos; NT1 or siVav2 
(Thermoscientific) on the day of seeding. Medium was exchanged  5-6 hrs later on the same day. 
Cells were transfected again on day 2 before GST pull-down of activated Rac1 on day 3. 
 
GST pull-down of activated Rac1 
GTP-bound forms of Rac1 were pulled down using bacterially expressed, purified GST-PBD (p21-
binding domain of PAK; interacts with GTP-boundRac1 and Cdc42; Cytoskeleton) [1]. Cells were 
washed with ice-cold PBS three times and lysed in the RIPA buffer (50mM Tris. 7.2, 500mM Nacl, 
1% Triton X-100, 0.1% SDS w/v, 10mM MgCl2, 1:250 mammalian protease inhibitor (Sigma), 1:10 
phosphatase inhibitor cocktail (Roche). The cell lysates were rocked at 4°C for 10 min and clarified 
of insoluble material by centrifugation at 20,000g at 4°C for 10 min. Equal aliquots of lysates were 
incubated with Glutathione-Sepharose beads coated with 30µg purified GST-PBD fusion proteins 
(Cytoskeleton) at 4°C for 1 hour. The beads were washed three times with wash buffer (50 mM 
Tris. pH 7.5, 1%,Triton X-100, 150 mM NaCl, 5 mM MgCl2 and 1 mM DTT, 1:250 mammalian 
protease inhibitor (Sigma).  
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Appendix 2. Catalogue of figures cross-referenced to experiment numbers. 
This table is compiled to cross-reference figures presented in this thesis to the 
experiments recorded separately for record-keeping purposes. 
Figure 
 
Figure legends Expt 
Figure 1.1.  The secondary structure of the EGF motif in human EGF.  
Figure 1.2. A simplified schematic view of EGFR showing key 
phosphorylation residues and main downstream cascades. 
 
Figure 1.3. Main effector pathways activated by EGFR.  
Figure 1.4. Simplified schema of mammary duct and terminal end bud.  
Figure 1.5. Structure of AAV targeting construct.  
Figure 1.6. A simplified scheme representing the concept of synthetic 
lethality. 
 
Figure 1.7 Schematic representation of junctional complex in epithelial cells.  
Figure 1.8. A simplified model of desmosomal components.  
Figure 1.9. Schematic representation of modulation of Rac activity by GEFs 
and GAPs. 
 
Figure 1.10 Graphical abstract of the plasticity of mammary epithelial 
cells governed by EGF and actin remodeling. 
 
Figure 3.1. Growth requirements of subconfluent MCF10A cells. 13,  
13.1 
Figure 3.2. EGF withdrawal induces interdigitations in MCF10A cells. 24 
Figure 3.3 EGFR signaling suppresses interdigitations of MCF10A cells. 51 
Figure 3.4. Interdigitations observed in different clones of MCF10A parental 
cells. 
101.1 
Figure 3.5. Variable E-cadherin staining and ability to form interdigitated 
structures in PIK3CA mutated MCF10A cells. 
103, 
101.1 
Figure 3.6. MCF10A PI3K H1047R (clone 1) cells of two distinct phenotypes. 84 
Figure 3.7. Optimisation of lysis buffers and EGFR antibodies for MCF10A 
cell lysates. 
59, 
76.1 
Figure 3.8. EGFR profile of MCF10A parental, PI3K H1047R and EGFR 
∆E746-A750 mutants. 
84.1 
Figure 3.9. EGFR associated profiles of MCF10A parental, PI3K H1047R and 
E545K mutants of different clones.  
105 
Figure 3.10. MCF10A spheroidal acinar structures. 41 
Figure 3.11. Similar cross sectional area distributions of MCF10A parental and 
PI3K H1047R acini. 
41 
Figure 3.12. Cross sectional areas of MCF10A PTEN WT and PTEN null acini 
show similar distribution. 
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Figure 3.13. EGFR signaling retards growth of MCF10A acini. 144 
Figure 4.1. EGF receptor and junctional stains along interdigitated 
monolayers of MCF10A cells. 
24.1, 
72 
Figure 4.2. Timecourse for the formation of interdigitations. 42, 85 
Figure 4.3. Gefitinib induces interdigitations in the presence of EGF. 43, 
108 
Figure 4.4. Formation of digits independent of short-term inhibition of EGFR 
and canonical downstream targets. 
86.2 
Figure 4.5.  Long-term inhibition of EGFR and canonical downstream targets 
recapitulates the phenotype induced by EGF removal. 
89.1, 
96.3 
Figure 4.6. Alternative ErbB family and PI3K inhibitors induces interdigitations 
at 48 hours. 
109.2 
Figure 4.7. Reversibility of interdigitations in MCF10A cells. 43 
Figure 4.8. Transient reversal of interdigitations upon exchange to fresh 
medium. 
60 
Figure 4.9. Hypotheses for the transient reversal of interdigitations. 60 
Figure 4.10. Conditioned medium without EGF maintains interdigitations. 71 
Figure 4.11. FBS transiently resolves interdigitations. 85 
Figure 4.12. Differential abilities of ligands to reverse interdigitations. 82, 
82.1 
Figure 4.13. Resolution of interdigitations independent of ErbB family and MEK 
signaling pathways. 
91 
Figure 4.14. Resolution of interdigitations independent of PI3K and MEK 
signaling pathways. 
95 
Figure 4.15. Reversible interdigitations in non-malignant mammary epithelial 
HMT 3522 S1 cells. 
132, 
132.5 
Figure 5.1. Ultrastructural and confocal visualisation of interdigitations contain 
actin. 
44.1, 
47 
Figure 5.2.  Interdigitations are independent of actomyosin contractility. 135.2 
Figure 5.3. Maintenance of interdigitations does not require actin 
polymerisation or contractility. 
87.2, 
123 
Figure 5.4. Levels of select actin associated proteins independent of EGF 
withdrawal. 
140 
Figure 5.5. Transient transfection of constitutively active GFP-RacG12V 
negates the interdigitations invoked by EGF withdrawal. 
117.3, 
104.2 
Figure 5.6. Induction of interdigitations independent of Rac1 inhibition.  125.2 
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Figure 5.7. EGF addition activates Rac. 112 
Figure 5.8. Resolution of interdigitations requires actin polymerisation and 
actomyosin contractility. 
87.2, 
123 
Figure 5.9. EGF addition activates Rac but not Cdc 42. 112.2 
Figure 5.10. Maintenance and reversal of interdigitations independent of Rac1 
inhibition. 
123 
Figure 5.11. Rac1 activity reduced by inhibitors and RacGEF knockdown. 121 
Figure 5.12. Optimisation of Rac1 knockdown in the induction and reversal of 
interdigitations. 
118.3 
Figure 5.13. Reversal of interdigitations independent of Rac1 knockdown. 118.3 
Figure 5.14. Vav activated Rac1 is not required for reversal of interdigitations. 124, 
124.3 
Figure 5.15. Interdigitations accompanied by an increase in the number of 
desmosomes.  
47, 76 
Figure 5.16. Interdigitated cell processes decorated with Desmoplakin. 62 
Figure 5.17. Co-localisation of Desmoplakin and early endosome marker, 
EEA1.  
88 
Figure 5.18. Subcellular localisation of caveolin-1 in MCF10A cells. 47, 
136 
Figure 5.19. Subcellular localisation of caveolin-1, Golgi markers and 
microtubules. 
139 
Figure 5.20. Cycloheximide treatment impedes induction of interdigitations. 135, 
138 
Figure 5.21. Desmoplakin levels remain elevated after resolution of 
interdigitations. 
81, 83 
Figure 5.22. Demoplakin levels remain basal after interdigitations are induced. 142 
Figure 5.23. Minimal closure of scratch wounds without ligand stimulation. 128 
Figure 5.24. Resolution of interdigitations is specific to EGF. 134 
Figure 5.25. Differential cell migration into scratch wounds. 134 
Figure 5.26. Interdigitated cells resist mechanical shear stress. 129, 
129.2, 
142 
Figure 5.27. Interdigitated cells withstand hypo-osmotic stress. 141.2 
230
